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Abstract 
The Dbf4/Cdc7 kinase complex is required for the initiation of DNA replication and 
promotes this by acting upon members of the Mcm2-7 helicase. In addition to its role in 
replication, Dbf4/Cdc7 is a target of the S-phase checkpoint response through the Rad53 
checkpoint kinase. In the budding yeast Saccharomyces cerevisiae, the regulatory subunit of 
this complex, Dbf4, is essential for kinase activity. Dbf4 is conserved throughout eukaryotes 
and contains three regions of discrete homology, termed the N, M, and C motifs, based on 
their location in the polypeptide chain.  
Motif C shows the highest conservation of all the motifs of Dbf4 and contains a 
CCHH type zinc finger. Mutation of the conserved cysteine and histidine residues of this zinc 
finger impair interactions with origin DNA and the Mcm2-7 helicase subunit Mcm2, but do 
not disrupt associations with Cdc7, Orc2, or Rad53. Cells where the endogenous Dbf4 
CCHH zinc finger has been mutated exhibit slowed growth, and are delayed in their entry to, 
and progression through S-phase. These cells also display sensitivity upon long-term 
exposure to the ribonucleotide reductase inhibitor hydroxyurea (HU) and the DNA alkylating 
agent methyl methanesulfonate (MMS). 
The crystal structure of an amino-terminal region of Dbf4 containing motif N folds as 
a BRCA1-carboxy-terminal (BRCT) domain. This domain is required for the interaction with 
Rad53, but is not sufficient. A fragment of Dbf4 containing the BRCT domain and its fifteen 
preceding amino acids is sufficient to interact with Rad53 and folds as a modified BRCT 
domain containing an integral amino-terminal helical projection. Denoted the Helix-BRCT 
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(HBRCT) domain, mutations that destabilize it abrogate the interaction with Rad53, and 
result in sensitivity to genotoxic agents. 
Dbf4 is recognized by the forkhead-associated FHA1 domain of Rad53, and the 
HBRCT domain of Dbf4 interacts directly with FHA1 in vitro. This interaction is 
phosphorylation independent and relies on a conserved lateral surface of FHA1, distinct from 
the phosphoepitope binding surface, which when mutated abrogates the interaction between 
Dbf4 and Rad53 and results in sensitivity to HU and MMS. The in vitro interaction between 
FHA1 and HBRCT does not require the ability of FHA1 to bind a phosphoepitope, while the 
in vivo interaction between full-length Rad53 and Dbf4 does. The FHA1 domain of Rad53 
can simultaneously bind to a phosphopeptide and HBRCT, indicating that Rad53 recognition 
of Dbf4 may occur through a bipartite interaction using two surfaces of FHA1. 
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Chapter 1 
General Introduction & Project Goals 
 
1.1 Yeast as a research model 
 Commonly known as baking or brewing yeast, the budding yeast, Saccharomyces 
cerevisiae is one of the most useful organisms in studying cellular and molecular biological 
processes in eukaryotes. Indeed much of what we know today about the molecular 
mechanisms that govern how eukaryotic cells function has been gleaned from work in S. 
cerevisiae and similar organisms (Botstein & Fink 1988; Fields & Johnston 2005; Botstein & 
Fink 2011). Insights into processes including DNA replication, gene regulation, protein 
secretion, cell signalling, and metabolism have all been gained, from work with S. cerevisiae 
(Fields & Johnston 2005; Dolinski & Botstein 2007; Botstein & Fink 2011). The ability of 
yeast to help elucidate underlying mechanisms in these processes resides in conservation of 
sequence and function. It is becoming increasingly clear that not only are genes conserved 
between species, the gene products function within the context of larger interaction networks, 
giving rise to conserved processes and pathways. Even in the case of a disease process that is 
restricted to metazoans, such as cancer, the underlying causative mechanisms that contribute 
to genomic instability, a hallmark of cancer, are conserved within yeast. This provides an 
opportunity to utilize yeast to provide insight into mechanisms of human disease. 
1.1.1 Characteristics of yeast 
The term yeast is a generic description used to describe a variety of single celled 
fungi, which can be classified into two phyla, Ascomycota and Basidiomyota. S. cerevisiae 
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fits into the former phylum based on its ability to form spores in a sac (ascus). Yeasts can 
commonly be found in a diverse array of environments ranging from soil, plant leaves, 
flowers, and fruit, to the skin and intestinal tracts of animals (Walker 1998; Landry et al. 
2006). As chemoorganotrophs, yeast require an external carbon source to produce energy. 
This ability to metabolize sugars to alcohol and carbon dioxide has resulted in the 
domestication of S. cerevisiae for the production of wines, beer, and as a leavening agent in 
the baking of breads. In fact, molecular evidence from wine containers dating to one of the 
first Egyptian kings indicates that S. cerevisiae has been used for the fermentation of wine 
from at least 3150 B.C.E. and evidence for the production of fermented beverages in China 
dates to 7000 B.C.E. (Cavalieri et al. 2003; McGovern et al. 2004). 
While the size of yeast cells can vary greatly between 2-50 μm in length to 1-10 μm 
in width, S. cerevisiae cells are ovoid in shape with typical dimensions ranging from 5-6 μm 
by 4-5 μm (Walker 1998; Herskowitz 1988). S. cerevisiae is viable in both a haploid and 
diploid state, where haploids tend to be smaller and more spherical compared to diploids. For 
both diploid and haploid cells, vegetative mitotic growth occurs through the process of 
budding in S. cerevisiae, where an emerging cell will bud from a mother cell eventually 
pinching off resulting in a new daughter cell. 
Haploid cells exist as one of two mating types, a or α. Fusion of haploid cells of 
opposite mating types results in a diploid cell which may grow vegetatively or in times of 
nutrient starvation undergo meiosis to form a tetrad of haploid spores in an ascus (discussed 
in Neiman 2011). This fusion process relies on the fact that cells of each mating type secrete 
mating pheromones (α-factor by α-cells and a-factor by a-cells) which synchronize the cell 
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cycles of mating cell pairs. Exposure to mating pheromone from cells of the opposite mating 
type causes a cell to transiently arrest in late G1, just before the initiation of DNA synthesis, 
thus ensuring that mating cells will have only one copy of each chromosome, resulting in 
exactly two copies of each chromosome in the resulting diploid after fusion (discussed in 
Herskowitz 1988; Landry et al. 2006).  
The physical anatomy of a yeast cell is much the same as any other eukaryotic cell, 
which is one of the main draws to using yeast as a model for eukaryotic cellular processes. A 
yeast cell consists of an outer cell wall and inner cellular membrane which contain a central 
vacuole that functions as the cellular lysosome. Within the confines of the cell membrane, the 
same organelles as would be seen in metazoan cells can be found, including a nucleus, 
ribosomes, Golgi apparatus, endoplasmic reticulum, and mitochondria (Barnett & Robinow 
2002a; Barnett & Robinow 2002b; Walker 1998). Two important differences between yeast 
and metazoan cells involve the cell wall and the nucleus. Yeast maintain a 100-200 nm thick 
cell wall which is essential to protect cellular contents and to provide structural support for 
the cell. Metazoan cells undergo an open mitosis, the nucleus is dissolved to allow 
chromosome segregation, whereas in the case of S. cerevisiae the nuclear membrane is 
maintained and the nucleus migrates to the bud neck,  pinching in half as the cell divides 
(Walker 1998). 
1.1.2 Genetics of S. cerevisiae 
 The results from sequencing the first entire eukaryotic genome show that S. 
cerevisiae has a genome size of 12,068 kilobases, spanning 16 unique chromosomes which 
range in size from 230 kilobases to 1,532 kilobases (Goffeau et al. 1996). The genome of S. 
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cerevisiae contains 6,607 total open reading frames (ORFs) of which over 75% (5,065) of 
these have been experimentally verified to produce a gene product. Of the fewer than 25% of 
ORFs remaining approximately half (755) are classified as uncharacterized, sequences that 
likely encode an expressed protein but have yet to be verified, while the other half (787) are 
classified as dubious, meaning it is uncertain if they encode a gene product (SGD, 2013). 
Compared to metazoans, the genome of S. cerevisiae is relatively compact with genes 
representing over 70% of the total genome sequence (Sherman 2002). Interestingly, less than 
250 genes in S. cerevisiae contain an intron and fewer than ten genes are known to have more 
than one intron (Ares et al. 1999). In addition to 16 chromosomes, most strains of S. 
cerevisiae also carry an extra chromosomal 2 micron plasmid which, despite its presence in 
most strains provides little to no obvious phenotype (Futcher 1988). The presence of a 
naturally occurring plasmid in eukaryotic cells is exceedingly rare, and the 2 micron plasmid 
has provided an excellent platform on which many recombinant yeast vectors have been 
based. 
Descended from strains originally characterized by Carl Lindegren in the 1940s, the 
S288C and W303 strains of S. cerevisiae (the former is primarily used  in this study) are two 
of the most prevalent for use in laboratory research (Mortimer & Johnston 1986; Ralser et al. 
2012). Both strains capitalize on one of the largest advantages of S. cerevisiae as a model 
organism, its ability to readily undergo homologous recombination. This single attribute 
makes S. cerevisiae extremely amenable to genetic manipulation. Combined with an ability 
to efficiently be transformed with single stranded or circular DNA, this allows for quick 
single step modifications to the genome (Longtine et al. 1998). This straightforward 
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procedure allows for additions or deletions to be made with ease; proteins can be epitope 
tagged, gene promoters may be swapped, and mutant alleles of genes inserted with 
specificity into the genome, allowing investigation into gene function. 
 Nearly all lab strains contain mutations within biosynthetic pathways for amino or 
nucleic acids. These auxotrophic mutations are utilized as genetic markers. As a result, large 
collections of deletion mutants are available the world over. In addition to this, collections of 
temperature sensitive mutants also exist which have been amassed over generations of 
investigation into how the eukaryotic cell functions. These large collections of mutants can 
be used to capitalize on the power of yeast genetics. 
Many human diseases can be attributed to genetic factors.  It has been estimated that 
as many as 40% of genes involved in human genetic diseases are conserved in S. cerevisiae 
(Foury 1997; Kelly et al. 2001). In humans it is often unfeasible or unethical to conduct the 
experiments necessarily to completely discern the genetic contribution to disease aetiology. 
However in yeast these issues are not a concern. In a collaborative effort to identify gene 
function, the yeast genome deletion project successfully deleted 96% (5,916 genes) of 
annotated ORFs in S. cerevisiae, of which almost 19% (1,105) were found to be essential 
(Giaever et al. 2002; Winzeler et al. 1999). Taking advantage of the ability of yeast to grow 
as either haploid or diploid cells, a single copy of an essential gene may be deleted in a 
diploid host, while non-essential genes deleted in a haploid host allow for the consequences 
of loss of gene function to be assessed. Utilizing the different mating types of S. cerevisiae, it 
is possible to cross different genetic mutants with one another, allowing exploration into gene 
function by observing genetic interactions. This typically involves screening a known mutant 
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with other genetic mutants to observe suppression or enhancement of the original mutants 
phenotype (Hartman et al. 2001). This has been the basis for the development of several high 
throughput, parallel screening techniques to better understand genetic interaction networks, 
identify disease associated genes, and point to potential drug targets (Yan et al. 2008; 
Breslow et al. 2008; Giaever et al. 1999; Lum et al. 2004; Steinmetz et al. 2002; Yuen et al. 
2007). All of these features combined in a host which is able to double in number every 90 
minutes, and can be easily and inexpensively cultured, makes S. cerevisiae an excellent 
model to use for molecular based studies of the eukaryotic cell cycle. 
1.2 The cell cycle 
 Cell cycle research has benefitted immensely from work with yeasts. In fact, two of 
the three winners of the 2001 Nobel Prize in Physiology or Medicine conducted their award 
winning research in yeast (S. cerevisiae and the fission yeast S. pombe). Awarding Leland 
Hartwell, Paul Nurse, and Timothy Hunt the Nobel Prize for their discoveries of key 
regulators of the cell cycle served to underscore the importance of understanding the 
mechanisms by which cell growth and division are regulated. The cell cycle represents a 
series of coordinated events, temporally separated, which must occur in order for a cell to 
grown and divide. The cycle can be divided into four parts, Gap1 (G1), Synthesis (S), Gap2 
(G2), and Mitosis (M), all of which will be discussed below. The timing of these events 
depends on the actions of a cycling group of proteins, not so coincidently called the cyclins, 
which drive the activity of cyclin-dependent-kinases (CDKs) (Bertoli et al. 2013). The 
synthesis and degradation of cyclins modulates their temporal expression which mediates the 
transition between cell cycle stages. In S. cerevisiae, the primary CDK is Cdc28, the activity 
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of which is driven by its various cell cycle phase-specific binding partners (Bloom & Cross 
2007). The morphology of S. cerevisiae changes as cells progress through the different stages 
of the cell cycle. This is a useful characteristic, making it possible to approximate the 
position of a cell in the cell cycle by its shape or bud morphology (Figure 1.1) (Hartwell 
1974).  
1.2.1 G1 
The first of two gap phases and the longest stage of the cell cycle in S. cerevisiae, G1, 
is dedicated to cell growth and the accumulation of nutrients necessary to proceed through 
the cell cycle. During this period the cell has several options. It may proceed through the cell 
cycle to duplicate itself or in times of nutrient starvation, exit the cell cycle and enter into a 
quiescent G0 phase where it may remain or return to the cell cycle when nutrients are more 
abundant (Forsburg & Nurse 1991). An additional option exists depending on growth 
conditions and cell ploidy. During this time haploid cells may mate and diploid cells, if 
nutrient starved, may initiate a meiotic cycle to undergo sporulation (Herskowitz 1988; 
Forsburg & Nurse 1991). Cells that choose to proceed through the cell cycle must pass the 
START point. After this point cells are required to complete a full round of genome 
duplication and cell division before returning to a state where mating, meiosis, or exit from 
the cell cycle are possible. In order to pass START cells must have sufficient nutrients, and 
be in the absence of factors that promote meiosis or pheromone from cells of the opposite 
mating type (Hartwell 1974). Passing START for a cell coincides with the first emergence of 
a tiny bud that will go on to form the daughter cell. As cells reach sufficient size Cln3/Cdc28, 
activates the transcription factor SBF, which sets in motion events leading to the activation of 
  8 
factors which prepare the cell for entry into the replicative phase of the cell cycle (discussed 
in Bertoli et al. 2013; Bloom & Cross 2007; Nasmyth 1996). Once replication competent 
origins fire the cell has moved on to the next stage of the cell cycle, synthesis. 
 
Figure 1.1: The Saccharomyces cerevisiae cell cycle. 
Representation of the characteristic morphologies of a budding yeast cell as it progresses 
through the phases of the cell cycle. Once the cell has passed the START point it is 
irrevocably committed to cellular reproduction. Entry into or exit from G0 must occur before 
START. (Adapted from Herskowitz 1988) 
 
1.2.2 S-phase 
 The process of genome duplication begins as the replicative helicases processively 
unwind DNA in a bi-directional manner, moving away from origins of replication. The 
resulting single stranded DNA is acted upon by an assortment of factors ultimately resulting 
in the duplication of template by DNA polymerases (discussed in section 1.3). The 
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unwinding of DNA by helicase activity presents a topological issue. As DNA is unwound 
positive supercoiling is induced ahead of the moving replication machinery. This poses a 
problem as the buildup of torsional stress can impede the progress of the replication 
machinery and lead to unfavorable replication intermediates (discussed in Schvartzman et al. 
2013). The enzyme topoisomerase, specifically Top2, is able to alleviate this stress. By 
relaxing positive supercoils ahead of the active helicase Top2 relieves the buildup of 
torsional tension. 
Since replication is not initiated at the very end of chromosomes this results in two Y-
shaped replication forks moving away from each other, creating a bubble of replicated DNA 
between them. S. cerevisiae contains 337 identified origins of replication spanning all 16 
chromosomes (SGD, 2013). Every origin does not necessarily fire each time the genome is 
duplicated, as such some will remain dormant and be passively replicated through by 
replication forks originating from neighbouring origins that have been activated. These 
bubbles, or replicons, continue to expand until they merge with neighbouring replicons, 
resulting in the complete replication of the genome (Sclafani & Holzen 2007). The 
progression of cells through S-phase is promoted by CDK activity which during S-phase is 
primarily due to Cdc28  interaction with the B-type cyclins, Clb5 and Clb6 (Bloom & Cross 
2007). During this time the tiny bud that first appeared as the cell passed START begins to 
grow, giving the cell the distinct appearance attributed to budding yeast. 
1.2.3 G2 
 The second gap phase, G2, provides yet another opportunity for the cell to grow, 
ensuring sufficient cellular size before initiating cell division. At this point the cell and bud 
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both continue to increase in size and volume and the nucleus begins to migrate to the bud 
neck (Hartwell 1974). In S. cerevisiae G2 is rather brief, with cells seeming to transition from 
S-phase to mitosis relatively quickly (Nurse 1985). It is absolutely imperative that genome 
duplication is complete before chromosome segregation, failure to do so would be 
catastrophic for cell viability. G2 allows the cell to ensure replication is complete and 
provides a last chance to check the fidelity of replicated DNA, as any changes will become 
permanent in the daughter cell. 
1.2.4 Mitosis 
 Nuclear and cellular division mark the final stage of the cell cycle. Mitosis can be 
broken down into four phases, prophase, metaphase, anaphase, and telophase, which are 
subsequently followed by cytokinesis, marking the complete division of mother and daughter 
cells. Here the mitotic B-type cyclins, Clb1-4, drive Cdc28 activity promoting nuclear 
division (discussed in Bloom & Cross 2007). 
Prophase marks the beginning of mitosis as microtubules extending from opposite 
spindle poles attach to sister kinetochores. Both spindle poles are charged with recruiting a 
copy of each chromosome, one for the emerging daughter cell and one to remain in the 
mother cell. For equal segregation of chromosomes the bi-oriented attachment of sister 
kinetochores to spindle poles is essential as tension from each pole is required to align and 
separate chromosomes (reviewed in Tanaka 2008). Once chromosomes are aligned in 
metaphase, the anaphase promoting complex/cyclosome (APC/C) is activated which allows 
separation of sister chromatids to commence. The APC/C is an ubiquitin ligase that directs 
the degradation of proteins that inhibit the transition to anaphase. Securin, Pds1 in S. 
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cerevisiae, functions to ensure sister chromatids are secure by preventing the degradation of 
cohesin. This is accomplished by inhibiting separase, encoded by ESP1 in yeast, which is 
responsible for the cleavage of the kleisin subunit of cohesin (discussed in Nasmyth 2005). 
Both securin and separase play a role in the regulation of mitotic exit in addition to initiation 
of anaphase (Tinker-Kulberg & Morgan 1999; Cohen-Fix & Koshland 1999). The cleavage 
of cohesin rings marks the entry to anaphase. Sister chromatids are now free to be pulled 
apart and travel to opposite spindle poles via their attached kinetochores. One of these 
spindle poles will then migrate to the daughter cell, while the other will remain in the mother 
(Zhang & Oliferenko 2013; Weiss 2012). As the end of mitosis nears in telophase, the 
spindle disassembles and the nuclear membrane constricts separating each complement of 
chromosomes, completing nuclear division (Winey & O’Toole 2001). 
In preparation to exit mitosis CDK activity must return early G1 levels. This requires 
down regulation of the M-phase cyclins as they inhibit mitotic exit and cytokinesis (Bloom & 
Cross 2007). To ensure this occurs, the polo-like-kinase, Cdc5, helps to activate the mitotic 
exit network (MEN), a series of cascading events which results in the degradation of the M-
phase cyclins and dephosphorylation of cytoplasmic CDK substrates, by the Cdc14 
phosphatase (reviewed in Weiss 2012; Bosl & Li 2005). As the emerging daughter cell is 
ready to be released from the mother cell a contractile actomyosin ring forms around the bud 
neck. The next step in cytokinesis is the formation of a septum between mother and daughter. 
As the ring contracts and the septum is degraded, the two cells divide, leaving a concave 
chitinous bud scar on the mother and a reciprocal convex birth scar on the daughter 
(discussed in Weiss 2012; Barnett & Robinow 2002b; Hartwell 1974). 
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1.3 DNA replication 
 In eukaryotic cells the genome is spread over mutiple chromosomes, each of which is 
completely replicated from multiple origins of DNA replication. This feat requires careful 
organization as it is imperative that the entire genome be replicated once and only once per 
cell cycle. Failure to accurately and completely replicate the genome can be catastrophic for 
cell viability. Defects in the duplication of the genome are some of the major causes of 
genomic instability, a major contributing factor to cancer (reviewed in Abbas et al. 2013). 
This emphasizes the importance of understanding the cellular processes that govern the 
synthesis of new DNA. 
Replication is an essential component of the cell cycle. The processes that allow 
genome duplication span both G1 and S-phases. Thus DNA replication can be broken down 
into several phases, the setup of replication competent origins, the initiation of DNA 
replication and the active process of elongation where the duplicated genome is completely 
synthesized. 
1.3.1 Formation of replication competent origins 
The initiation of DNA replication requires the formation of pre-replicative complexes 
(pre-RCs) at origins of replication (Figure 1.2). S. cerevisiae contains discrete origins of 
replication which span defined nucleotide sequences. These origins, termed Autonomously 
Replicating Sequences (ARSs), are distinguished by a specific 11 base pair ARS Consensus 
Sequence (ACS) (Brewer & Fangman 1987). In S. cerevisiae an origin spans 100-150 base 
pairs with a highly conserved core 17 base pair A element flanked by several B elements 
(Stillman 2005; Sclafani & Holzen 2007; S. P. Bell & Dutta 2002). 
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The setup of replication competent origins actually precedes S-phase and occurs in 
late M and early G1 phase when CDK activity is low. The genome must be duplicated once 
and only once per cell cycle. Cellular mechanisms have evolved to achieve this imperative by 
limiting the time in which replication competent origins can be assembled to one phase of the 
cell cycle. Cdc28 activity, driven by the cyclins Clb5 and Clb6, is required for the initiation 
of replication (Bloom & Cross 2007). However if pre-RCs were to be assembled in a time of 
CDK activity precocious activation of origins would occur resulting in over replication of 
portions of the genome. The temporal separation of pre-RC assembly and activation provide 
a level of control to prevent precocious origin firing. This temporal separation is a result of 
CDK activity being inhibitory to pre-RC assembly (Dahmann et al. 1995; Detweiler & Li 
1998). Thus pre-RC formation can only occur in late M-phase and early G1 and these 
replication competent origins must be sufficient in number to allow the cell to traverse S-
phase. 
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Figure 1.2: Assembly of pre-RCs at origins during G1. 
Origins of replication are bound by ORC which recruits Cdc6. Heptamers of Mcm2-7 and 
Cdt1 then loosely associate with origins. Upon ATP hydrolysis requiring ORC,Cdc6, and 
Cdt1, the Mcm2-7 complex is loaded on DNA and Cdt1 is displaced. Formation of the pre-
RC is complete once a double hexamers of Mcm2-7 are loaded. The activity of DDK is then 
required for the association of the complex of Sld3, Sld7, and Cdc45. (Adapted from Labib 
2010) 
 
  15 
The first step in pre-RC assembly is the binding of origins by the origin recognition 
complex (ORC) (Bell & Stillman 1992). This hexameric complex acts as the scaffold to 
which the rest of the factors required for pre-RC formation can be recruited. ORC 
specifically binds the A and B1 origin elements (Rao & Stillman 1995). Marked by ORC, 
Cdc6 then Cdt1 with the replicative helicase, Mcm2-7, are now able to sequentially associate 
with origins (Aparicio et al. 1997; Speck et al. 2005; Chen et al. 2007; Chen & Bell 2011) 
(Figure 1.2). This association of the Mcm2-7 complex with origins is dependent on a 
conserved C-terminal domain of Mcm3 (Frigola et al. 2013). At this stage the Mcm2-7 
complex is loosely associated with origins and has yet to be loaded around DNA. The 
loading reaction requires a coordinated series of ATP hydrolysis reactions requiring ORC 
and Cdc6, which are stimulated by the C-terminal domain of Mcm3, and Cdt1 (Tanaka et al. 
1997; Bowers et al. 2004; Randell et al. 2006; Kawasaki et al. 2006; Frigola et al. 2013). This 
reaction results in a set of head-to-head double hexamers of Mcm2-7 being loaded onto DNA 
(Remus et al. 2009; Evrin et al. 2009). The presence of double hexamers on DNA appears to 
be the result of sequential loading (Frigola et al. 2013; Fernández-Cid et al. 2013). 
Reconstitution of this loading reaction with purified proteins indicates that the first Mcm2-7 
hexamer is quickly (taking only seconds) loaded via hydrolysis, while the second hexamer 
appears to be loaded relatively slowly (taking several minutes) (Fernández-Cid et al. 2013; 
Riera et al. 2013).  Once the Mcm2-7 helicase complex is loaded, Cdc6 and Cdt1 are thought 
to be dispensable. Both are removed in a CDK dependent manner, where Cdc6 is targeted for 
degradation and Cdt1 for nuclear export (Drury et al. 2000; Tanaka & Diffley 2002). The 
stably loaded Mcm2-7 helicase complex is now ready for activation by CDK and another 
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important kinase complex, Dbf4 Dependent Kinase (DDK). The activation of CDK and DDK 
signals the transition from G1 to S-phase. 
1.3.2 Initiation of DNA replication 
For DNA synthesis, the timing of individual origin activation can vary. This allows 
origins to be classified early, mid, or late origins, based on when they fire (reviewed in 
Aparicio 2013). As cells transition into S-phase, Sld3, Sld7, and Cdc45 associate with early 
firing origins in a DDK dependant manner, not requiring CDK activity (Heller et al. 2011; 
Tanaka & Araki 2011). These early origins are then joined by several factors in what has 
been termed a pre-loading complex (pre-LC) (Figure 1.3). Identified by immunoprecipitation 
of cross-linked cell extracts, the pre-LC is composed of Polε, GINS (Go Ichi Ni San), Sld2, 
and Dpb11, requiring only CDK activity for formation (Muramatsu et al. 2010). The merger 
of the pre-RC and pre-LC is dependent on the scaffold protein Dpb11 and CDK activity. 
Dpb11 is a BRCT (BRCA1 C-Terminal) domain containing protein with two amino-terminal 
and two carboxyl-terminal repeats, tandem repeats of this domain are known as 
phosphopeptide binding modules (Araki 2010; Glover et al. 2004). Sld2 and Sld3 have been 
shown to be the minimal set of S-Phase CDK targets required for DNA replication, and are 
bound by the C-terminal and N-terminal BRCT repeats of Dpb11 respectively (Zegerman & 
Diffley 2007; Tanaka et al. 2007; Tak et al. 2006). Thus Dpb11 serves as a bridge between 
the pre-RC and pre-LC, forming what has been referred to as the pre-initiation complex (pre-
IC) (Diffley & Labib 2002; Diffley 2010). The formation of the pre-IC unites Cdc45-Mcm2-
7-GINS (CMG) which together constitute the active replicative helicase. Sld2, Sld3, Sld7, 
and Dpb11 then dissociate from the pre-IC, resulting in the formation of the active replisome 
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which will travel with replication forks (Gambus et al. 2006; Moyer et al. 2006; Labib & 
Gambus 2007; Gambus et al. 2009; Labib 2010). 
It is not entirely clear when and where Mcm10 associates with origins or the exact 
molecular mechanisms of how it acts (discussed in Thu & Bielinsky 2013). What is clear is 
that Mcm10 is essential for DNA replication and appears to play an important role in DNA 
unwinding required for the firing of origins (Solomon et al. 1992; van Deursen et al. 2012; 
Kanke et al. 2012; Watase et al. 2012; Merchant et al. 1997; Homesley et al. 2000). 
Additionally Mcm10 is required for the recruitment of primase and the lagging strand DNA 
polymerase, although whether it is a stable component of the replisome remains to be 
elucidated (van Deursen et al. 2012; Kanke et al. 2012; Ricke & Bielinsky 2004; Heller et al. 
2011). 
 It is interesting to note that many of the factors discussed above that are required for 
the initiation of DNA synthesis are in limited supply. Overexpression of Cdc45, Dpb11, 
Sld2, Sld3, Sld7, and DDK have been shown to advance the timing of origin firing, where 
late firing origins will fire earlier in S-phase (Mantiero et al. 2011; Tanaka et al. 2011). As 
Dpb11, the Sld proteins, and DDK do not travel with the replisome after early origins have 
fired it is likely these factors are recycled to initiate late firing origins (Gambus et al. 2006; 
Gambus et al. 2009; Mantiero et al. 2011). Knowing that Cdc45 and Sld3 association with 
the pre-RC corresponds to the timing with which these origins fire and suggests a mechanism 
whereby DDK dependent recruitment of Cdc45 and Sld3 regulates the temporal pattern of 
origin activation (Aparicio et al. 1999; Kamimura et al. 2001; Heller et al. 2011; Tanaka et al. 
2011). 
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Figure 1.3: The initiation of DNA replication. 
Upon the DDK dependent association of Sld3, Sld7, and Cdc45 with origins, CDK is 
required for pre-IC formation. CDK dependent phosphorylation of Sld2 and Sld3(depicted as 
red circles) allows the pre-LC to join the pre-RC to form the pre-IC, mediated by Dpb11. 
Disassociation of Sld2, Sld3, Sld7, and Dpb11 from the pre-IC results in active CMG 
helicase allowing bi-directional DNA replication to proceed. (Adapted from Labib 2010) 
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1.3.3 Elongation and DNA synthesis 
As the template strands of DNA are separated, single stranded DNA is exposed in the 
5’ to 3’ as well as 3’ to 5’ direction. The eukaryotic single strand binding protein, Replication 
Protein A (RPA), binds to these stands preventing them from re-annealing with one another. 
DNA polymerase is only able to synthesise DNA in the 5’ to 3’ direction, thus two different 
systems for synthesis of each strand are needed (Figure 1.4). The leading strand can be 
synthesized in a continuous fashion while the lagging strand must be synthesized semi-
discontinuously by the joining of Okazaki fragments. S. cerevisiae utilizes three different 
polymerases (Polα, Polδ, and Polε) during times of unperturbed replication (Burgers 2009). 
On the leading strand, template is read in the 3’ to 5’ direction allowing 5’ to 3’ 
synthesis to occur in long continuous stretches, this activity is carried out by the processive 
enzyme Polε. The association of Polε with origins is interdependent with CMG formation 
(Takayama et al. 2003; Zou & Stillman 2000). Loaded by Replication Factor C (RFC), the 
sliding clamp Proliferating Cell Nuclear Antigen (PCNA), encoded by the POL30 gene, has 
been shown to assist processivity of Polε, helping tether it to DNA (Dua et al. 2002; Burgers 
1991; Hamatake et al. 1990). On the lagging strand Okazaki fragment synthesis is required, 
where shorter fragments of DNA are synthesized and joined. Polymerases on both the 
leading and lagging strand require a primer to initiate synthesis of nascent DNA. The Polα-
primase complex acts on both these strands, producing a short 8-12 nucleotide RNA primer 
which it then extends approximately 20 nucleotides which is eventually continued by the 
lagging strand polymerase (Garg & Burgers 2005). The association of the Polα-primase 
complex with DNA and its ability to initiate primer synthesis is dependent on Mcm10 and 
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Cdc45 (Ricke & Bielinsky 2004; Zou & Stillman 2000; Melendy & Stillman 1993; Collins & 
Kelly 1991). One primer should theoretically be sufficient for synthesis on the leading strand 
extending from a single origin of replication. However Okazaki fragments are 100-200 
nucleotides long, with each one requiring its own primer, this means on the lagging strand 
approximately 100,000 primers are needed to complete replication of the genome (Garg & 
Burgers 2005). After the synthesis of each primer and its extension the switch from Polα to 
the primary lagging strand polymerase, Polδ, must occur. This is dependent on the action of 
the clamp loader RFC in complex with PCNA (Garg & Burgers 2005; Moldovan et al. 2007). 
Similar to Polε, PCNA stimulates Polδ activity (Burgers 1998). 
 The maturation and processing of Okazaki fragments relies on the activity of a flap 
endonuclease, Rad27, and the Cdc9 DNA ligase. Two pathways exist for maturation, the 
long and short flap pathways, where the latter is predominant in conditions of unperturbed 
replication (Burgers 2009). In the short flap pathway Polδ bumps into the 5’ end of the 
downstream Okazaki fragment displacing 1-2 nucleotides of the RNA primer which are 
subsequently removed by Rad27. This process is iteratively repeated in a process known as 
nick translation until the RNA primer is completely removed, leaving a DNA-DNA junction 
that can be ligated by Cdc9 (Garg & Burgers 2005). Long flaps may be generated as a result 
of processive displacement of the downstream Okazaki fragment by Polδ. Once a flap is long 
enough to form secondary structure or bind proteins, such as RPA, Rad27 is unable to 
mediate its removal and requires the help of the nuclease/helicase Dna2 to trim the long flap 
to a size manageable by Rad27 (Ayyagari et al. 2003). Thus, the coordinate action of Polδ, 
Rad27, and Cdc9 is required to ensure efficient maturation of Okazaki fragments. 
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Figure 1.4: The eukaryotic DNA replication fork. 
Replication proceeds bi-directionally from origins of replication following the replication 
fork. The CMG complex unwinds the DNA duplex and ssDNA is coated by RPA. Polα-
primase produces the RNA primer (red strand), which is required for both leading and 
lagging strand synthesis. Polε is the processive leading strand polymerase while Polδ 
synthesizes Okazaki fragments on the lagging strand. Both Polε and Polδ are aided in 
processivity by the ring clamp PCNA. (Adapted from Burgers 2009) 
1.4 The DNA damage & replication checkpoints 
Checkpoints represent a collection of surveillance mechanisms that are integral to the 
maintenance of genome fidelity. In response to DNA damage or other stimuli the checkpoint 
provides a mechanism to arrest cell cycle progression and trigger repair. The factors involved 
in checkpoint signalling are very well conserved from single celled eukaryotes to mammals 
where their inactivation or mutation often results in a predisposition to cancer (discussed in 
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Aguilera & Gómez-González 2008; Negrini et al. 2010; Abbas et al. 2013). Thus the 
checkpoint response prevents the accumulation and transmission of heritable abnormalities 
by providing an opportunity to repair defects before cell division. 
The checkpoint response typically functions through an integrative signalling network 
of proteins each with specialized functions. Broadly the proteins involved in checkpoint 
signalling can be stratified into three main classes, namely sensors, transducers, and 
effectors, based on how they perpetuate the checkpoint signal (Figure 1.5). At the heart of 
the checkpoint signaling response are the PI3K (phosphoinositide 3-kinase) like kinases, 
Mec1 and Tel1 (homologues of mammalian ATR and ATM). These kinases integrate signals 
from a variety of sources to initiate a signal cascade that through the mediators Rad9 and 
Mrc1 will activate the effector kinases Chk1 and Rad53 (Chk2 in mammals) (reviewed in 
Carr 2002; Nyberg et al. 2002). 
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Figure 1.5: The replication and DNA damage checkpoint in S. cerevisiae. 
The checkpoint is perpetuated as a signal that is detected by sensors and mediated by 
transducers to effectors which can elicit a variety of responses. The signal pathways specific 
to replication stress are shown in green while the cascade for DNA damage is shown in red.  
The central signaling pathway common to stresses is shown in blue. (Adapted from Schleker 
et al. 2009) 
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1.4.1 Signals for checkpoint activation 
The signals that alert the sensors Mec1 and Tel1 vary depending on the type of DNA 
damage or lesion that is present. Tel1 is primarily activated in response to double stranded 
DNA breaks (DSBs), while Mec1 responds to the accumulation of ssDNA, which results 
from stalled replication forks and the repair of a variety of DNA damage including single 
stranded DNA (ssDNA) breaks , DSBs, bulky adducts, and ionizing radiation (reviewed in 
Cimprich & Cortez 2008; Sancar et al. 2004). 
1.4.1.1 Stalled replication forks 
During S-phase checkpoint activation occurs in response to replication fork stalling. 
Fork progress can be halted by impeding either the replicative helicase or DNA polymerases 
(Zegerman & Diffley 2009). Helicase stalling is typically the result of bulky DNA lesions, 
protein cross-linking, or inter-strand cross-links, while polymerase stalling may be caused by 
dNTP depletion, DNA alkylation, or exposure to pharmacological polymerase inhibitors 
(discussed in Labib & Hodgson 2007; Zegerman & Diffley 2009; Lambert & Carr 2013). 
Uncoupling the helicase from the replisome results in large stretches of ssDNA (Sogo et al. 
2002). The accumulation of ssDNA recruits RPA, which in complex is required to bind 
Ddc2, an activating co-factor for Mec1 (discussed in Cortez 2005; Friedel et al. 2009; Zou & 
Elledge 2003). In addition to RPA, it appears the presence of a primer-template junction is 
also required for complete checkpoint activation (Byun et al. 2005; MacDougall et al. 2007). 
This is consistent with the observation that replication fork formation is required for 
checkpoint activation during S-phase as replication forks are a ready source of primed 
ssDNA (Tercero et al. 2003). 
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Mec1/Ddc2 activation also requires interaction with the 9-1-1 (mammalian Rad9-
Rad1-Hus1, Rad17-Ddc1-Mec3 in S. cerevisiae) checkpoint clamp (Majka, Binz, et al. 2006; 
Navadgi-Patil & Burgers 2009). The 9-1-1 complex is recruited to DNA damage by ssDNA 
and is loaded by the alternate clamp loader Rad24-RFC (Navadgi-Patil & Burgers 2011; 
Harrison & Haber 2006). In addition to its role in DNA replication, Dpb11 is also required 
for checkpoint signalling and activation of Mec1/Ddc2 (Mordes et al. 2008; Navadgi-Patil & 
Burgers 2008). The 9-1-1 complex can activate Mec1/Ddc2 via two mechanisms. The Ddc1 
subunit of the clamp directly binds to and robustly activates Mec1/Ddc2, while also 
recruiting Dpb11 (Majka, Niedziela-Majka, et al. 2006; Navadgi-Patil & Burgers 2009). 
Activation of the effector kinase Rad53 by Mec1 in response to stalled replication 
forks is dependent upon the signal transducer Mrc1 (Alcasabas et al. 2001; Osborn & Elledge 
2003). As a component of the replisome, Mrc1 is required for the normal progression of 
replication forks (Osborn & Elledge 2003). In the absence of Mrc1 replication forks progress 
slowly and do not collapse when the checkpoint is invoked, however when checkpoint 
conditions are lifted these forks are unable to restart (Szyjka et al. 2005; Tourrière et al. 
2005; Hodgson et al. 2007). Since replication forks do not collapse in Mrc1 null cells, 
phosphorylation of Rad53 dependent on Mrc1 is dispensable for fork integrity (Tourrière et 
al. 2005). Mrc1 is partially redundant to the other checkpoint transducer, Rad9,  in that they 
both mediate the checkpoint signal between sensor and effectors (Alcasabas et al. 2001). 
Rad9 and Mrc1 null cells show the same phenotype as Rad53 null cells with respect to fork 
collapse (Lee et al. 2004). While Mrc1 activity is important for propagation of the checkpoint 
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response and resumption of stalled forks it appears dispensable for the most important 
function of the replication checkpoint, fork stabilization (Tercero et al. 2003). 
1.4.1.2 DNA damage  
Interestingly, the accumulation of ssDNA and recruitment of RPA appears to be a 
common event signaling DNA damage. Most lesions are processed in a similar manner 
undergoing resection that produces ssDNA bound by RPA (discussed in Huertas 2010; 
Mimitou & Symington 2009; Majka, Binz, et al. 2006). Similar to fork stalling, Mec1 is then 
activated by Ddc2 bound by RPA and ssDNA, which is subsequently activated by the 9-1-1 
complex and Dpb11 (Zou & Elledge 2003; Majka, Niedziela-Majka, et al. 2006; Mordes et 
al. 2008). However in response to DNA damage, the checkpoint signal is mediated by the 
transducer Rad9 not Mrc1 (Harrison & Haber 2006; Sancar et al. 2004; Carr 2002). 
Interestingly, while Dpb11 contributes to Mec1/Ddc2 activation, it also required for efficient 
Rad9 phosphorylation (Pfander & Diffley 2011; Puddu et al. 2008). Rad9 is a scaffold 
protein that is essential to perpetuate the checkpoint signal in response to DNA damage 
(Weinert & Hartwell 1988; Branzei & Foiani 2009). Mec1 dependent phosphorylation of 
Rad9 recruits Rad53 (Schwartz et al. 2002; Sweeney et al. 2005). Rad9 then facilitates 
recognition and activation of Rad53 by Mec1 and acts as a scaffold for Rad53 mediated 
autotransactivation (Sweeney et al. 2005; Gilbert et al. 2001; Ma et al. 2006). 
DSB formation is directly detected by the MRX (Mre11-Rad50-Xrs2) complex where 
it can activate either of the checkpoint sensors Mec1 or Tel1 (Williams et al. 2010; Rupnik et 
al. 2010). The Mec1 mediated response relies on ssDNA formation by nuclease activity as 
discussed above (Mimitou & Symington 2009; Huertas 2010). The checkpoint sensor Tel1 
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functions in parallel with Mec1, also resulting in effector kinase activation, and requires 
MRX for activation, although the exact molecular mechanisms as to how this occurs are still 
unclear (reviewed in Gobbini et al. 2013). 
1.4.2 The response to checkpoint activation 
 In S. cerevisiae the primary effector of the checkpoint response is Rad53. This 
effector kinase is composed of a central kinase domain flanked by two FHA domains. While 
Chk1 is present in yeast, its role in checkpoint signaling appears to be restricted to mitosis 
where it prevents degradation of securin (Pds1) (Sanchez et al. 1999). These checkpoint 
effector kinases act upon a variety of targets to complete the checkpoint response.  
1.4.2.1 Ribonucleotide reductase (RNR) regulation 
 The RNR genes function to produce dNTPs required for replication and repair. Levels 
of dNTPs are cell cycle dependent with an increase in production during S-phase, the result 
of increased expression of RNR subunits and degradation of the RNR inhibitor Sml1(Chabes 
et al. 2003; Zhao et al. 2001; Elledge & Davis 1990). Checkpoint induction results in a six to 
eight fold increase in dNTP levels, which improves survival following DNA damage (Chabes 
et al. 2003). Up-regulation of RNR transcription by the Rad53 target Dun1 is the result of 
Sml1 degradation and inhibition of the RNR repressor Crt1 (Zhao & Rothstein 2002; Huang 
et al. 1998; Allen et al. 1994). Even in the absence of checkpoint induction Mec1 and Rad53 
are essential for cell survival (Desany et al. 1998). Cells lacking Mec1 and Rad53 are only 
viable in unperturbed conditions if RNR expression is increased or Sml1 is deleted (Desany 
et al. 1998; Zhao et al. 1998; Zhao et al. 2001). However, even a modest two fold constitutive 
increase in dNTP levels results in increased rates of mutation (Chabes et al. 2003). Thus, 
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regulation that allows dNTP levels to fluctuate is important for replicative fidelity. While the 
essential role of Mec1 and Rad53 appears to be the regulation of dNTP levels, cells that lack 
either are still checkpoint defective and extremely sensitive to DNA damage (Desany et al. 
1998). 
1.4.2.2 Transcriptional activation 
 In response to DNA damage a myriad of transcriptional profiles change. Similar to 
the bacterial SOS response, eukaryotes execute a large program of change in response to 
DNA damage and other external stresses (reviewed in Fry et al. 2005; Jelinsky & Samson 
1999). In response to both the DNA alkylating agent MMS (methyl methanesulfonate) and 
ionising radiation (IR), but not to other environmental stresses, a group of unique genes are 
markedly up-regulated in S. cerevisiae; of note are the kinase Dun1, RNR subunits Rnr2 and 
Rnr4, and contributors to homologous recombination Rad51 and Rad54 (Gasch et al. 2001). 
Other genes up-regulated were involved in glycosylation, mitochondrial function, and 
plasmid maintenance (Gasch et al. 2001). As discussed in the previous section, RNR 
regulation by Dun1 plays an important role in response to DNA damage (Huang et al. 1998; 
Zhou & Elledge 1993). In addition to increasing dNTP pools, Dun1 phosphorylation of Crt1 
prevents Crt1 from repressing genes involved in the nucleotide excision repair (NER) and 
mismatch repair (MMR) DNA damage repair pathways (Huang et al. 1998; Gasch et al. 
2001; de la Torre Ruiz & Lowndes 2000). In response to DSBs, a form of DNA damage 
frequently caused by ionizing radiation, homologous recombination is a particularly 
important repair mechanism (reviewed in Li & Heyer 2008; Wyman et al. 2004; Huertas 
2010; Mimitou & Symington 2009). Thus in response to IR the up-regulation of genes 
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involved in homologous recombination would be expected. The transcriptional response to 
checkpoint invocation results in the activation of pathways that will allow DNA repair to 
occur. 
1.4.2.3 Chromatin conformation 
 The importance of transcriptional regulation of genes in response to checkpoint 
activation has been discussed. Chromatin conformation not only plays an important role in 
gene transcription, but also in DNA repair and replication fork stability (reviewed in Schleker 
et al. 2009). In response to DSBs the histone H2A (H2AX in mammals) is phosphorylated at 
Ser129, in a Mec1/Tel1 dependent manner (Downs et al. 2004; Fillingham et al. 2006). As 
phosphorylated H2A (γH2A) flanks DSBs it provides an excellent marker for DNA breaks, 
serving to recruit DNA repair proteins (Downs et al. 2004). Acetylation of histone H4 is also 
important for DSB repair and to recruit chromatin remodelling complexes (Downs et al. 
2004). Additionally, acetylation of histone H3 at lysine 56 (H3K56) has importance for cells 
enduring replicative stress as impediments to the acetylation of H3 results in cells sensitive to 
DNA damaging agents known to cause DSBs (Masumoto et al. 2005). H3K56 functions to 
create favorable chromatin conditions to facilitate DSB repair (Masumoto et al. 2005). 
1.4.2.4 Cell cycle arrest 
 The most widely known of all check point responses, cell cycle arrest, functions to 
provide an opportunity for cells to undertake repair of DNA damage before progression to 
the next stage of the cell cycle. This arrest is particularly important in the case of DNA 
damage as improperly or unrepaired lesions have the potential to become permanent in future 
generations, and the accumulation of damage over generations would be disastrous.  
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 The G1/S transition is blocked in response to DNA damage in a Mec1 dependent 
manner. Rad53 phosphorylates the Swi6 subunit of the SBF/MBF transcription factors, 
resulting in inhibition of Cln1 and Cln2 production (Sidorova & Breeden 1997). In the 
absence of Cln1 and Cln2, the positive feed-back loop that inactivates the Cdc28 inhibitor, 
Sic1, is not engaged and CDK is not activated to signal the transition to S-phase. 
During mitosis, DNA damage inhibits the transition from metaphase to anaphase by 
preserving cohesin and preventing sister chromatid segregation. The checkpoint effectors 
Chk1 and Rad53, regulated by Mec1 and Rad9, engage separate mechanisms to prevent the 
APC/C mediated degradation of securin (Sanchez et al. 1999; Agarwal et al. 2003). Chk1 
phosphorylates securin preventing its ubiquitination and targeting for destruction, while 
Rad53 inhibits the interaction between the Cdc20 activator of the APC/C and securin 
(Agarwal et al. 2003; Sanchez et al. 1999). Chk1 and Rad53 also play roles in preventing 
mitotic exit through inhibition of the Cdc14 phosphatase (Sanchez et al. 1999; Liang & 
Wang 2007). 
1.4.2.5 Inhibition of late origin firing 
 In S-phase, origins of replication fire stochastically, with some firing earlier than 
others, while others rarely fire at all (Raghuraman et al. 2001). The block to late origin firing 
provides a mechanism to preserve the late-firing subset of origins in times of replication 
stress or DNA damage. As pre-RC formation can only occur in G1, there are a finite number 
of available origins for activation, which cannot be reloaded until the next cell cycle 
(Detweiler & Li 1998; Dahmann et al. 1995). During an unperturbed S-phase the odds of a 
particular origin firing may be low and it is often passively replicated, during a perturbed S-
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phase such an origin may be key to completing genome replication in the event replication 
forks from early origins stall and irreparably collapse. In this situation the reserve late and 
dormant origins are the only hope to complete genome replication. Consistent with this 
model, an increase in the number of origins fired is observed in mammalian cells recovering 
from checkpoint arrest (Ockey & Saffhill 1976; Taylor 1977). 
 The suppression of origin firing absolutely requires the Mec1 dependent activation of 
Rad53 in response to DNA damage or fork stalling (Shirahige et al. 1998; Santocanale & 
Diffley 1998; Santocanale et al. 1999). As stalled replication forks can signal checkpoint 
activation, the block to origin activation primarily affects late and dormant origins as these 
constitute the bulk of unfired origins (Tercero et al. 2003). Origin activation requires both 
CDK and DDK activity, thus to block firing, the activity of these kinases on pre-RCs must be 
inhibited (Pasero et al. 1999). Rad53 acts to inhibit both kinase pathways, supressing origin 
firing (Lopez-Mosqueda et al. 2010; Zegerman & Diffley 2010). Rad53 directly 
phosphorylates Dbf4, the regulatory subunit of DDK, and the CDK target Sld3, which 
prevents interaction with the pre-LC, inhibiting helicase activation (Zegerman & Diffley 
2010; Lopez-Mosqueda et al. 2010). As CDK activity at origins is inhibited through Rad53 
phosphorylation of Sld3, the role of S-phase CDK in preventing new pre-RC formation is 
unhampered (Zegerman & Diffley 2010; Bloom & Cross 2007).  
1.4.2.6 Replication fork stabilization 
 When replication forks encounter DNA damage, their progress is impeded leading to 
a drastic reduction in the rate of fork progression independent of Mec1 or Rad53 (Tercero & 
Diffley 2001). Depletion of Cdc7, the kinase subunit of DDK, during an S-phase arrest 
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prevents pre-RC activation leading to the formation of new replication forks; upon removal 
of the block cells are able to complete replication albeit at a reduced rate (Bousset & Diffley 
1998). Since new origins could not be activated it stands to reason that replication must have 
been completed by previously stalled forks. The checkpoint kinases Mec1 and Rad53 are 
essential for completion of replication following a replication arrest as cells without either 
kinase are unable to complete synthesis (Desany et al. 1998; Tercero & Diffley 2001; Paciotti 
et al. 2001). Work with the separation of function mutant mec1-100, which is defective for 
inhibition of late origin firing but not for replication fork stabilization, does not display the 
marked sensitivity to MMS and IR seen in cells lacking Mec1 (Paciotti et al. 2001; Tercero et 
al. 2003). This demonstrates that the maintenance of stalled replication forks is the most 
important function of the checkpoint response during S-phase (Tercero et al. 2003). 
Failure to stabilize stalled forks results in forks that are no longer able to resume 
synthesis after the replication block is removed. This irreversible collapse of forks is 
characterized by the dissociation of replication factors, such as DNA polymerase and RPA, 
from the fork (Tercero et al. 2003; Katou et al. 2003; Cobb et al. 2003; Lucca et al. 2004). 
The irreversibility of fork collapse likely stems from the loss of proteins that cannot be 
reloaded be at the fork, such as Mcm2-7 (Tercero et al. 2003; Labib et al. 2000).  
Interestingly, a member of the replisome, Tof1, is required for fork pausing at 
programmed sites in the genome and for the stable association of replisome components in a 
S-phase arrest (Gambus et al. 2006; Katou et al. 2003; Hodgson et al. 2007). However, the 
mechanisms between programmed fork pausing and fork stalling appear to differ as 
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programmed pausing does not require the Mec1 and Rad53 checkpoint kinases (discussed in 
Lambert & Carr 2013; Lambert et al. 2007; Calzada et al. 2005). 
Rad53 functions at sites of stalling to prevent the formation of precarious DNA 
structures such as reversed forks and the accumulation of ssDNA (Lopes et al. 2001; Sogo et 
al. 2002; Feng et al. 2006). The Exo1 nuclease is recruited to sites of stalled replication and 
under checkpoint conditions contributes to fork collapse in the absence of Rad53 (Cotta-
Ramusino et al. 2005; Segurado & Diffley 2008). Curiously, deletion of Exo1 in cells lacking 
Rad53 completely suppresses the sensitivity phenotype to several DNA damaging agents 
(Segurado & Diffley 2008). While the mechanism for this suppression is not known it does 
indicate that the primary role of Rad53 in response to DNA damage is the stabilization of 
stalled forks. 
1.5 The Dbf4/Cdc7 kinase complex (DDK) 
Composed of the serine-threonine kinase Cdc7 and its regulatory subunit Dbf4, the 
conserved Dbf4 dependent kinase complex (DDK) is essential for mitotic cell growth 
(Culotti & Hartwell 1971; Chapman & Johnston 1989; Jackson et al. 1993). The catalytic 
subunit of the kinase complex, Cdc7, is stable and present at constant levels throughout the 
cell cycle, while levels of the activating subunit Dbf4 vary (Cheng et al. 1999). DDK activity 
fluctuates in a cell cycle dependent manner in connection with Dbf4 levels, which are high 
from late G1 through to late M-phase where it is degraded in an APC/C dependent manner 
(Cheng et al. 1999; Weinreich & Stillman 1999). 
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1.5.1 The three conserved motifs of Dbf4 
Sequence alignment between Dbf4 orthologues in yeast and metazoans has identified 
three regions of discrete homology, despite little overall sequence similarity. These 
conserved regions have been named motif N, motif M, and motif C based on their location 
within the Dbf4 polypeptide (Figure 1.6) (Masai & Arai 2000). Each of these motifs have 
demonstrated importance in mediating intermolecular interactions vital to maintaining the 
distinct roles of DDK in replication and the checkpoint response. 
1.5.1.1 Motif N 
Dispensable for cellular proliferation in S. cerevisiae and the fission yeast, 
Schizosaccharomyces pombe, motif N is essential for viability in mouse embryonic stem 
cells (Ogino et al. 2001; Fung et al. 2002; Varrin et al. 2005; Gabrielse et al. 2006; 
Yamashita et al. 2005). Interestingly, the loss of viability seen in mouse embryonic stem cells 
lacking motif N occurs despite an intact ability to activate Cdc7 in vivo and in vitro, 
suggesting that interactions with other protein factors mediated by this region are crucial for 
proper Dbf4 function (Yamashita et al. 2005). In both yeasts, cells lacking motif N are 
sensitive to DNA damaging agents, and in budding yeast these cells also display slowed 
growth (Takeda et al. 1999; Fung et al. 2002; Varrin et al. 2005; Gabrielse et al. 2006) 
The amino-terminus of Dbf4 interacts with the checkpoint kinase Rad53 and Orc6, of 
the Origin Recognition Complex, and this interaction requires motif N (Duncker et al. 1999; 
Varrin et al. 2005). An amino-terminal deletion of Dbf4 that interrupts the interaction with 
Rad53 compromises the block to late origin firing in a sld3-38A background (Chen et al. 
2013). A portion of the amino-terminus of Dbf4, including motif N shows some primary 
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sequence similarity to a BRCT domain however, prior to this study no conclusive evidence 
has been provided to prove the true identity of the region (Masai & Arai, 2000). 
1.5.1.2 Motif M 
For both spDbf4 and scDbf4, motif M is essential for viability (Ogino et al. 2001; 
Fung et al. 2002; Varrin et al. 2005). In budding yeast, two-hybrid analysis has found that 
when motif M alone is deleted the interaction with Cdc7 is largely preserved however, the 
Mcm2 interaction is drastically reduced (Varrin et al. 2005).Interestingly, a temperature 
sensitive point mutation within motif M, P277L, imparts resistance to genotoxic stress at 
semi-permissive growth temperatures, where presumably a reduction in interaction with 
Mcm2 at this temperature facilitates Rad53 mediated removal of Dbf4 from chromatin under 
checkpoint conditions (Varrin et al. 2005). 
1.5.1.3 Motif C 
Of the three conserved regions, motif C is the most similar between species and is 
predicted to constitute a CCHH type zinc finger (Masai & Arai 2000). Although traditionally 
thought of as being involved in interactions with nucleic acid, there are now numerous 
examples of zinc fingers mediating protein-protein interactions (reviewed in Brayer & Segal 
2008). Prior to this study little was known about how motif C modulates DDK activity in 
S.cerevisiae. 
Truncation of spDbf4 (Dfp1) resulting in the removal of motif C yields cells 
specifically sensitive to MMS and results in severe meiotic defects (Fung et al. 2002; Dolan 
et al. 2010; Le et al. 2013).  Expression of human Dbf4 in COS-7 cells has demonstrated that 
motif C is required for in vitro huCdc7 activation and in vivo phosphorylation of Mcm2 (Sato 
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et al. 2003). In the same study it was determined that motifs M, C and the intervening 
sequence constituted the minimal region of Dbf4 required for Cdc7 activation, agreeing with 
studies from budding yeast showing that regions encompassing motif M and most of motif C 
mediate the interaction with Cdc7 (Sato et al. 2003; Hardy & Pautz 1996). In mouse 
embryonic stem cells, both motif M and C are sufficient for Dbf4 activation of Cdc7 but not 
for cellular proliferation (Yamashita et al. 2005). 
 
Figure 1.6: Conserved motifs of Dbf4. 
Schematic representation of Dbf4 from S. cerevisiae, S. pombe, and H. sapiens depicting the 
conserved motifs N, M, and C. Length of each protein is indicated as well as relative position 
of the motifs for each species. (Adapted from Masai & Arai 2000) 
 
1.5.2 DDK is required for helicase activation  
The primary target of DDK activity appears to be the activation of the replicative 
helicase. Mcm2, Mcm3, Mcm4, Mcm6, and Mcm7 have all been shown as in vitro substrates 
for DDK activity (Lei et al. 1997; Weinreich & Stillman 1999). Additionally, the replisome 
components Cdc45,and Polα are also targets of phosphorylation by Dbf4/Cdc7 (Nougarède et 
al. 2000; Weinreich & Stillman 1999). DDK activity is required in vitro for recruitment of 
the helicase activating proteins Sld3 and Cdc45 to the pre-RC (Heller et al. 2011; Tanaka & 
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Araki 2010), ultimately resulting in the formation of chromatin bound CMG complex, which 
evidence from a variety of organisms indicates forms the active helicase complex (Gambus et 
al. 2006; Moyer et al. 2006; Aparicio et al. 2009). Using in vitro pre-RC assembly assays, it 
has been found that DDK preferentially phosphorylates pre-RC incorporated Mcm2-7, and 
that in this context DDK activity is yet still greater for DNA bound, licensed, Mcm2-7 
complex (Francis et al. 2009). Interestingly, it appears that certain sites within Mcm2 are 
phosphorylated with different affinity depending on chromatin association (Montagnoli et al. 
2006). 
 The essential role of Dbf4/Cdc7 is the modification of members of the replicative 
helicase. Proof of this stems from the ability to bypass the essential need for DDK by 
mutating components of the Mcm2-7 complex (Hardy et al. 1997; Sheu & Stillman 2010). 
The first mutation to bypass DDK requirement was found in Mcm5, ironically the only 
component of the Mcm2-7 complex not phosphorylated by DDK. The mcm5-bob1 allele, 
which is a single point mutation P83L, is thought to induce a conformational change in the 
Mcm2-7 complex, mimicking the effect of DDK phosphorylation (Hardy et al. 1997; 
Fletcher et al. 2003). Similarly, deletion of an amino terminal serine/threonine rich domain 
(NSD) of Mcm4 alleviates the essential requirement for DDK (Sheu & Stillman 2010). It is 
important to note that although these mutations allow mitotic growth in the absence of 
Dbf4/Cdc7 these cells are by no means healthy, exhibiting slowed growth, sensitization to 
DNA damaging agents and failure to activate the intra-S-phase checkpoint (Weinreich & 
Stillman 1999; Sheu & Stillman 2010). The slowed growth and DNA damage phenotypes 
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seen in DDK null mutants suggests the likelihood that other interactions, while not essential, 
are important for vegetative growth in both perturbed and unperturbed environments. 
1.5.3 Activity outside of the initiation of replication 
Knowing DDK is regulated in a cell cycle dependent manner, it is not hard to imagine 
that Dbf4/Cdc7 would be a candidate to regulate targets beyond the initiation of replication, 
and indeed DDK activity has been found to play a role in the events of mitosis and meiosis. 
The initiation of meiotic recombination and separation of homologous chromosomes during 
meiosis I have both been implicated as cell cycle events where the activity of DDK is 
important (Matos et al. 2008; Wan et al. 2008; Sasanuma et al. 2008). Dbf4/Cdc7 promotes 
the initiation of meiotic recombination via interaction with the meiosis specific DSB protein 
Mer2, the phosphorylation of which is necessary for the association of DSB machinery with 
chromatin during meiosis (Wan et al. 2008; Sasanuma et al. 2008). DDK also promotes the 
recruitment of the monopolin complex to kinetochores of sister chromatids during meiosis I 
(Matos et al. 2008). This recruitment is essential for monopolar spindle pole attachment, 
which ensures that sister chromatids remain together and only homologous chromosomes are 
separated in meiosis I. In a mcm5-bob1 background lacking Cdc7, chromosome segregation 
fails during meiosis I due to failure to preserve mono-oriented sister chromatids, resulting in 
only two diploid spores (Matos et al. 2008). Additionally, the activity of DDK is required to 
cleave the Req8 kleisin subunit of cohesin during meiosis I (Katis et al. 2010). The final step 
in meiotic recombination is the resolution of chiasmata by cleavage of cohesin along 
chromosome arms, thus initiation and exit from meiotic recombination both require 
Dbf4/Cdc7 activity. 
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The activity of Dbf4/Cdc7 (as previously discussed) is essential for the initiation of 
replication, the result of which is individual replicons proceeding from origin DNA. This 
requires constant changes in chromatin conformation as the replication machinery interacts 
with template DNA. Dynamic changes in chromatin are governed by post-translational 
modification of histones, which play a role in transcription regulation, mitosis, cell death, 
DNA damage repair, replication, and recombination (discussed in Ito 2007). 
Histone H3 has been implicated as yet another target of Dbf4/Cdc7 in budding yeast 
(Baker et al. 2010). Serine 45 of histone H3 is phosphorylated by DDK, and mutations that 
prevent Ser45 phosphorylation result in growth defects and sensitivity to DNA damaging 
agents (Baker et al. 2010). Interestingly, a phosphomimetic mutation of Ser45 resulted in loss 
of viability, possibly causing a disruption in interaction between H3 and DNA (Baker et al. 
2010). Consistent with this thought, the equivalent residue, Thr 45, in Xenopus has been 
shown to affect interactions with DNA (Ferreira et al. 2007). This indicates a mechanism 
where DDK activity can disrupt H3 association with DNA, resulting in changes in chromatin 
conformation. 
The interaction between Dbf4 and Cdc5 appears important for mitotic cell division. A 
physical interaction between these two appears to be mediated by amino acids 78-96 of Dbf4 
in S. cerevisiae (Hardy & Pautz 1996; Miller et al. 2009; Chen & Weinreich 2010). DDK can 
phosphorylate the Cdc5 polo-box-domain (PBD), and phosphorylation of Ser 84 abolishes 
the interaction between the two (Miller et al. 2009; Chen & Weinreich 2010). Conversely, 
mutations in Dbf4 that retard the interaction with the PBD suppress a temperature sensitive 
mutation in Cdc5 (Chen & Weinreich 2010). Dbf4 inhibits Cdc5 mediated activation of the 
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mitotic exit network (MEN), and it appears that this inhibition is caused by direct interaction 
between Dbf4/Cdc7 and Cdc5 (Miller et al. 2009; Chen & Weinreich 2010) 
1.6 Project goals 
Dbf4 motif C is the most conserved of three regions of homology between species 
(Masai & Arai 2000). Despite this it had been the most poorly understood Dbf4 motif in S. 
cerevisiae. My first research objective was to characterize the role the motif C of Dbf4 plays 
in DNA replication and the checkpoint response. Toward this aim a mutational study was 
undertaken to investigate the role conserved residues predicted to constitute a zinc finger 
have on the function of Dbf4. Of key interest was the protein-protein and protein-DNA 
interactions mediated by this motif, and the implications these interactions have on 
replication and the checkpoint response.  
The role Dbf4 plays in the checkpoint response to regulate late origin firing has been 
identified (Zegerman & Diffley 2010; Lopez-Mosqueda et al. 2010). However how Dbf4 
interacts with Rad53 had not been defined. The amino-terminus of Dbf4 mediates this 
interaction and motif N is required, but prior to this study it was not clear what constituted 
the minimal region of Dbf4 sufficient to interact specifically with FHA1 of Rad53 (Duncker 
et al. 2002; Varrin et al. 2005). A region of Dbf4 predicted to form a BRCT domain overlaps 
with portions of Dbf4 identified in the interaction with Rad53. Thus, the second objective of 
this study was to identify the minimal discrete unit of Dbf4 that interacts with Rad53 and 
determine if this region constitutes a BRCT domain using a crystallographic approach. 
Additionally, as FHA domains are known to bind phosphorthreonines, an attempt to identify 
a phosphoepitope within the Rad53 interacting region of Dbf4 was made. 
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The third and final objective was to explore the possibility of a phosphorylation 
independent mode of interaction between Dbf4 and Rad53. Using a combination of 
bioinformatic, mutational, and NMR spectroscopy strategies unique features of FHA1 were 
investigated. Toward this aim an important question to be studied will be how FHA1 binds 
Dbf4. 
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Chapter 2 
Materials & Methods 
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2.1 Yeast strains 
Table 2.1: List of yeast strains used. 
Strain Genotype Source 
DY-1 MATa, ade2-1, can1-100, trp1-1, his3-11, his3-15, ura3-1, leu2-3, leu2-112, 
pep4::LEU2 
(Duncker et al. 2002) 
DY-2 MATa, can1-11, ura3-52, dna52-1(dbf4) (Varrin et al. 2005) 
DY-26 MATa, his3Δ200, leu2Δ0, met15Δ0, trp1Δ63, ura3Δ0 ATCC 
DY-27 MATa/α, his3Δ1/ his3Δ1, leu2Δ0/ leu2Δ0, ura3Δ0/ ura3Δ0, lys2Δ0, met15Δ0 ATCC 
DY-145 MATa, ade2-1, can1-100, his3-11,15, leu2-3, trp1-1, ura3-1, SML1::HIS3 RAD5 (Tam et al. 2008) 
DY-146 MATa, ade2-1, can1-100, his3-11,15, leu2-3, trp1-1, ura3-1, SML1::HIS3 RAD5, 
RAD53::rad53-R70A 
(Tam et al. 2008) 
DY-147 MATa, ade2-1, can1-100, his3-11,15, leu2-3, trp1-1, ura3-1, SML1::HIS3, RAD5, 
RAD53::URA3 
(Tam et al. 2008) 
DY-159 MATa, His3Δ0, leu2Δ0 .lys2Δ0, met15Δ0, ura3Δ0; dbf4Δ0 This study 
DY-165 MATa, his3Δ200, leu2Δ0, met15Δ0, trp1Δ63, ura3Δ0, DBF4::dbf4-H680C This study 
DY-166 MATa, his3Δ200, leu2Δ0, met15Δ0, trp1Δ63, ura3Δ0, DBF4::dbf4-H680A This study 
DY-167 MATa, his3Δ200, leu2Δ0, met15Δ0, trp1Δ63, ura3Δ0, DBF4::dbf4-H674A-H680A This study 
DY-168 MATa, his3Δ200, leu2Δ0, met15Δ0, trp1Δ63, ura3Δ0, DBF4::dbf4-C661A C664A This study 
DY-195 MATα, his3Δ200, leu2Δ0, ura3Δ0, lys2Δ0 This study 
DY-259 MATa his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, RAD5::KanMX ATCC 
DY-260 MATa his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, REV3::KanMX ATCC 
DY-282 MATα , his3Δ200, leu2Δ0, ura3Δ, DBF4::dbf4- H680C This study 
DY-297 MATa his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, RAD30::KanMX ATCC 
DY-319 MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, DFB4:: dbf4-H680C, REV3::KanMX This study 
DY-324 MATa, his3Δ1, leu2Δ0, ura3Δ0, DBF4:: dbf4-H680C, RAD30::KanMX This study 
DY-331 MATa, his3Δ1, leu2Δ0, ura3Δ0, DBF4:: dbf4-H680C, RAD5::KanMX This study 
 
 
Dbf4 motif C mutant strains (DY-165, DY-166, DY-167, and DY-168) were generated in by 
replacing DBF4 in the DY-26 parental strain via standard two-step gene replacement 
protocols using yeast integrating plasmid pRS406 derived vectors linearized with BglII 
(Burke et al. 2000). Genotype of the resulting strains was confirmed by sequencing (Robarts 
Research Institute, University of Western Ontario). The mating-type-α strain containing 
dbf4-CCHC (DY-282) was generated by mating DY-165 to DY-195. The resulting diploid 
was sporulated and spore genotypes were determined by arrest in the presence of (5 μg/mL) 
α-factor, sequencing of the genomic DBF4 allele, and growth on synthetic complete medium 
lacking either histidine, uracil, tryptophan, methionine, leucine, or lysine. Double mutants 
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containing dbf4-CCHC and either rad5Δ, rad30Δ, or rev3Δ were constructed by mating DY-
282 to DY-259, DY-297, or DY-260. The resulting diploids were sporulated and genotype 
was determined by α-factor arrest, sequencing of genomic DBF, PCR flanking deleted 
genomic loci, and growth on synthetic complete medium lacking histidine, uracil, 
tryptophan, methionine, leucine, or lysine. 
2.2 Yeast mating and sporulation 
Equal sized colonies from freshly streaked plates containing opposite mating type 
yeast cells were taken and mixed into ~5mm circles on a new YPD (Yeast extract, Peptone, 
Dextrose) plate and incubated at 30ºC for 3 hours. After incubation the mating mixture was 
streaked along the edge of a fresh YPD plate and for isolation using a MSM 
micromanipulator (Singer Instruments). Zygotes resulting from fusion of opposite mating 
type cells were identified by their distinctive tri-lobed appearance and isolated to an 
untouched section of the YPD plate. Plates were then grown for 2-3 days until colonies 
formed by the isolated zygote were detected. The resulting cells were analysed by FACS 
analysis (see below section for method) to identify the presence of 2C and 4C peaks, 
confirming cells were indeed diploid. 
Diploid cells were grown to stationary phase, and 500 μl of the culture was washed 
with sterile ddH2O (double distilled water) and the pellet was resuspended in 5 ml 
sporulation media (0.3% potassium acetate, 0.502% raffinose) in a 50 ml falcon tube. 
Cultures were incubated at 23ºC for 4-7 days or until ascospores were observed. Once 
ascospore formation was observed 500 μl of the sporulation culture was resuspended in 
zymolyase solution (0.5 mg/ml in 1M sorbitol) for 8-10 minutes at 30ºC. After incubation, 
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800 μl sterile ddH2O was slowly added down the side of the tube, cells were allowed to rest 
for 5 minutes on ice, and 800 μl was removed from the top of the tube. From the remaining 
mixture 10 μl was spotted onto the edge of a fresh YPD plate which was then tilted to allow 
the spotted mixture to drip along the edge of the plate. Tetrads were then dissected with a 
MSM micromanipulator (Singer Instruments) and individual spores were genotyped as 
discussed above. 
2.3 Genomic DNA isolation 
 Yeast cells were grown to stationary phase in 10 ml media, washed with 30 ml 
ddH2O, and resuspended in 2 ml screw cap tubes with 200 μl yeast genomic prep mix (2% 
Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-Cl (pH 8), 1 mM EDTA). To this 0.3g of 
0.5 mm glass beads and 200 μl phenol:chloroform:isoamylalcohol (25:24:1) were added.  
The mixture was then vortexed for 4 minutes after which 200 μl of TE was added and the 
mixture centrifuged at 13,200 rpm for 5 minutes. The supernatant was then transferred to a 
new tube and 1 ml of 100% ethanol was added. Tubes were inverted ten times and then 
centrifuged for 2 minutes at 13,200 rpm. The supernatant was discarded and the pellet was 
resuspended in 400 μl of TE. Following resuspension 10 μl of RNaseA (10 mg/ml; Sigma) 
was added and samples were incubated at 37ºC for 10 minutes. To this 10 μl of 4M 
ammonium acetate and 1 ml of 100% ethanol was added and mixed by inversion ten times. 
The mixture was centrifuged at 13,200 rpm for 2 minutes. The supernatant was discarded, the 
pellet was allowed to air dry for ten minutes and was then resuspended in 50 μl ddH2O. 
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2.4 Plasmid construction 
Unless otherwise indicated, DY-27 genomic DNA was used as template for PCR 
amplification of genes of interest and all point mutations and deletions of less than 45 base 
pairs were created using the QuikChange multi or QuikChange II XL site-directed 
mutagenesis kits (Stratagene). Mutations were generated following QuikChange kit protocols 
with the minor deviations. DpnI digestion times were increased to 1.5 hours, and reaction 
volumes used for transformation were increased to 5 μl. For the QuikChange II XL kit, 2.5 μl 
of QuikSolution was added to the initial reaction mixtures. All constructs were completely 
sequenced to ensure no second site mutations were present (Robarts Research Institute, 
University of Western Ontario). 
 The pCM190 motif C mutants pCM190-dbf4CCHC pCM190-dbf4CCHA, pCM190-
dbf4CCAA, and pCM190-dbf4AAHH were generated by QuikChange using pCM190-DBF4 
as template. The triple and quadruple motif C mutants pCM190-dbf4AAHA, and pCM190-
dbf4AAAA were generated by QuikChange using pCM190-dbf4AAHH as template. The yeast 
integrating vector pRS406 derived constructs pRS406-dbf4CCHC pRS406-dbf4CCHA, 
pRS406-dbf4CCAA, and pRS406-dbf4AAHH were generated by amplifying the motif C 
mutant alleles from the pCM190 series and cloning them into the EcoRI and BamHI sites of 
pRS406. Similarly, the pEG202 bait series of motif C mutants were made by PCR 
amplification of the pCM190 motif C mutant set using EcoRI and NcoI containing forward 
and reverse primers respectively resulting in pEG202-dbf4CCHC pEG202 -dbf4CCHA, 
pEG202-dbf4CCAA, pEG202-dbf4AAHH, pEG202-dbf4AAHA, and pEG202-dbf4AAAA. The 
prey pJG4-6-CDC7, was generated by amplifying the CDC7 open reading frame from 
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genomic DNA with forward and reverse primers containing EcoRI and BglII sites 
respectively. 
 The bait pEG202-DBF4 was generated by amplification of genomic DBF4 from DY-
26, and ligation of that fragment into the EcoRI and NcoI sites of pEG202. All pEG202 
derivatives containing fragments of DBF4 were created using pRS315-DBF4 (formerly 
pPD32) as template, and fragments were cloned into the EcoRI and XhoI sites of pEG202. 
The bait pEG202-dbf4Δ66-119 was created by ligating two separate fragments into pEG202. 
The region corresponding to amino acids 1 to 65 of Dbf4 (Fragment 1) was amplified using 
an EcoRI containing forward primer and a reverse primer ending at an internal BglII site 
within DBF4. The region corresponding to amino acids 120 through till the end of Dbf4 
(Fragment 2) was amplified by a forward primer containing an in frame BglII site and a 
reverse primer containing an NcoI site. Fragment 1 was digested with EcoRI and BglII, 
fragment 2 was digested with BglII and NcoI, and pEG202 was digested with EcoRI and 
NcoI. Both fragments and the vector were joined together in a single ligation. The pEG202 
constructs containing fragments of Dbf4 with the amino acids 66-119 deleted were made 
using pEG202-dbf4Δ66-119 as template. All Dbf4 amino terminal point mutations were 
made using QuikChange with pEG202-DBF4 as template. To generate pRS315-dbf4T171R, 
pRS315-dbf4W116DM120A, and pRS315-dbf4Δ135-179, the Bsu36I fragment of pRS315-
DBF4 was replaced with the equivalent fragment from pEG202-dbf4T171R, pEG202-
dbf4W116DM120A, and pEG202-dbf4Δ135-179. 
 The prey vectors pJG4-6-RAD53 and pJG4-6-rad53R70A were made by cloning 
genomic sequence encoding Rad53 from DY-145 and DY-146 respectively into the NcoI and 
  48 
EcoRI sites of pJG4-6. Point mutations within FHA1 were generated by QuikChange using 
pJG-Rad53 as template.  Sequence encoding amino acids 1-165 of the resulting constructs 
was then sub-cloned into the NcoI and EcoRI sites of pJG4-6 to create FHA1 prey vectors. 
The RAD53 open reading frame, along with 500bp each of flanking upstream and 
downstream sequence, was PCR amplified from genomic DNA and cloned into the XbaI and 
PstI sites of the CEN vector pRS315 to create pRS315-RAD53. The SexAI to BglII fragment 
of the pJG-FHA1 variants, pJG4-6-FHA1N112A/E129A, pJG4-6-
FHA1N112A/E129A/V144N/F146A, and pJG4-6-FHA1V144N/F146A, were used to replace 
the equivalent fragments in pRS315-RAD53 to generate pRS315-rad53N112A/E129A, 
pRS315-rad53N112A/E129A/V144N/F146A, and pRS315-rad53V144N/F146A, respectively. 
Table 2.2: List of primers used. 
Primer Name Sequence (5’-3’) Primer Use 
pJG-Seq For tgcctcctacccttatgatgtgcc Reverse primer to sequence pJG4-6 
insert 
pJG-Seq Rev tggagacttgaccaaacctctggc Forward primer to sequence pJG4-
6 insert 
pEG202 insert For ccaattgtcgtagatcttcgtcagc Reverse primer for sequencing 
pEG202 insert 
pEG202 insert Rev  gcttggctgcaggtcgactcg Forward primer for sequencing 
pEG202 insert 
BamHI Dbf4 For  gcaatcgggatccatggtttctccaacgaaaatg Cloning primer from start of DBF4 
with BamHI site 
Dbf4NcoRev gactta ccatgg ctatatttgaaatctgagattttc Cloning primer from end of DBF4 
with NcoI site 
Dbf4 AA65 For Eco ctccaacagcagcagcattt Cloning primer from AA65 of 
DBF4 with EcoRI site 
Dbf4 AA120 Eco For tatatatagaattcatgaaaagagattctcgcatttac Cloning primer from AA120 of 
DBF4 with EcoRI site 
Dbf4 AA135 For Eco gagatgaatacatataataa Cloning primer from AA135 of 
DBF4 with EcoRI site 
Dbf4 120 NcoI For tatatatccatgggcatgaaaagagattctcgcatttactttgac Cloning primer from AA120 of 
DBF4 with NcoI site 
Dbf4 AA109 Rev Xho STOP tatatatctcgagctacaattccttaggcgtaaccc Cloning primer from ending at 
AA109 of DBF4 with XhoI site 
Dbf4 AA179 Rev Xho STOP tatatatctcgagctaaacagaccttcttgtgataa Cloning primer from ending at 
AA179 of DBF4 with XhoI site 
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Primer Name Sequence (5’-3’) Primer Use 
Dbf4 AA221 StopXhoRev atatatatctcgagctacaaatgatccaaatcaacatcaagat Cloning primer from ending at 
AA221 of DBF4 with XhoI site 
Dbf4 AA250 StopXhoRev atatatatctcgagctagtctctatccgttggtccatata Cloning primer from ending at 
AA250 of DBF4 with XhoI site 
Dbf4 296 StopRev XhoI tatatatactcgagctagtaaggtagttcgtctaagtttg Cloning primer from ending at 
AA296 of DBF4 with XhoI site 
Dbf4 250 EcoRI Rev atatatatgaattcctagtctctatccgttggtccatataattttt Cloning primer from ending at 
AA250 of DBF4 with EcoRI site 
Dbf4105EcoFor tatatatagaattcacgcctaaggaattgctggaa Cloning primer from AA105 of 
DBF4 with EcoRI site 
Dbf494EcoFor tatatatagaattcggtacgggtctgaaaaatgtcg Cloning primer from AA94 of 
DBF4 with EcoRI site 
Dbf4 SacI 65 REV tatatatagagctcgaggcgctcaagag Cloning primer from ending at 
AA65 of DBF4 with SacI site 
Dbf4 SacI 120 For tatatatagagctcatgaaaagagattctcgc Cloning primer from AA120 of 
DBF4 with SacI site 
Dbf4 476 FOR gtgcgcaaataactcaattttttgac Primer to sequence Dbf4 from 
indicated NT 
Dbf4 527 REV cttgtgataactattgtgacagtagtg Primer to sequence Dbf4 from 
indicated NT 
Dbf4 730 FOR caatcttctacacaatgaaaaattat Primer to sequence Dbf4 from 
indicated NT 
Dbf4 975 FOR gagatactcgagagacaaagcaaac Primer to sequence Dbf4 from 
indicated NT 
Dbf4 1020 REV aagttgcagtgcatattttttgtttgc Primer to sequence Dbf4 from 
indicated NT 
Dbf4 1508 FOR atgtggcaacctcttttggcaatgg Primer to sequence Dbf4 from 
indicated NT 
Dbf4 1510 REV catcattagattgatgtgcaccact Primer to sequence Dbf4 from 
indicated NT 
Rad53 K22 NcoI For tatatatacccatgggcaagttttctcaagaacag Cloning primer from AA22 of 
Rad53, with NcoI site 
Rad53 165 EcoRI Rev Stop tatatatagaattcctaagatcttatgcgatcaacttt Cloning primer from AA165 of 
Rad53, with EcoRi site 
RAD53NCOFOR ctgattgccatgggcatggaaaatattacacaaccc Cloning primer from start of 
Rad53, with NcoI site 
RAD53ECOREV gacttagaattcttacgaaaattgcaaattctc Cloning primer from end of Rad53, 
with EcoRi site 
Rad53 494 For aaagttgatcgcataagatc Primers used to sequence Rad53 
from indicated NT 
Rad53 1120 For cagaggtaaagatacatccg Primers used to sequence Rad53 
from indicated NT 
Rad53 1675 For ctagagaacaaaaacttttac Primers used to sequence Rad53 
from indicated NT 
Rad53 510 Rev caggagaagctattttagag Primers used to sequence Rad53 
from indicated NT 
Rad53 1061 Rev tgccaaagtgccacagaagg Primers used to sequence Rad53 
from indicated NT 
Rad53 1621 Rev cttttgggctgtgtatatcg Primers used to sequence Rad53 
from indicated NT 
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Primer Name Sequence (5’-3’) Primer Use 
Rad53 2222 Rev tgaagaagaagccgagggtt Primers used to sequence Rad53 
from indicated NT 
QC Dbf4 H674A cgaatctttagaacaagccatagtttctgagaaggc QuikChange Primer to make 
indicated Dbf4 mutation 
QC Dbf4 H674A H680A ctttagaacaagccatagtttctgaagaaggctttgtctttcgct
g 
QuikChange Primer to make 
indicated Dbf4 mutation 
QC Dbf4 H680C cacatagtttctgagaagtgtttgtctttcgctg QuikChange Primer to make 
indicated Dbf4 mutation 
QC Dbf4 C661A C664A V2 cggtaaaaaattccggatacgctgaaaatgctcgtgtaaaata
cgaatc 
QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T163A cattgggtgcgcaaatagctcaattttttgacactac QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T171A caattttttgacactactgtcgctatagttatcacaagaaggtc QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T157A gaaaagagggtttcttgcattgggtgcgcaaatac QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T224A ggatcatttgagcaaggctaaatctgcttctttagc QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T163R cttacattgggtgcgcaaatacgtcaattttttgacactactgtc QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T171R caattttttgacactactgtccgaatagttatcacaagaaggtc QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T157R attgaaaagagggtttcttcgattgggtgcgcaaatacgtc QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T224R gatttggatcatttgagcaagcgtaaatctgcttctttagctgcg QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T163A RevComp gtagtgtcaaaaaattgagctatttgcgcacccaatg QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T171A RevComp gaccttcttgtgataactatagcgacagtagtgtcaaaaaattg QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T163R RevComp gacagtagtgtcaaaaaattgacgtatttgcgcacccaatgta
ag 
QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T171R RevComp gaccttcttgtgataactattcggacagtagtgtcaaaaaattg QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4T175A    gacactacgtcacaatagttatcgcaagaaggtctgttgagaa
c 
QuikChange Primer to make 
indicated Dbf4 mutation 
DBF4 GA159LL gatttattgaaaagagggtttcttacattgcttctgcaaataactc QuikChange Primer to make 
indicated Dbf4 mutation 
DBF4 (T171AT175A)    gacactactgtcgcaatagttatcgcaagaaggtc QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 W202E                           ctacatgaaagttgagagttacgaaaaggctgccag QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 T105A For gtcgagccaagggttgcgcctaaggaattgctg QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 T105A RevComp cagcaattccttaggcgcaacccttggctcgac QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T171D caattttttgacactactgtcgatatagttatcacaagaaggtc QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 QC T171E caattttttgacactactgtcgaaatagttatcacaagaaggtc QuikChange Primer to make 
indicated Dbf4 mutation 
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Primer Name Sequence (5’-3’) Primer Use 
Dbf4 QC T171E RevComp gaccttcttgtgataactatttcgacagtagtgtcaaaaaattg QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 W116E QC For ggaattgctggaatggcaaacaaatgagaaaaagataatga
aaagagattctcgc 
QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 W116E QC RevComp gcgagaatctcttttcattatctttttctcatttgtttgccattccag
caattcc 
QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 M120A W116E For gctggaatggcaaacaaatgagaaaaagatagcgaaaaga
gattctcgcatttac 
QuikChange Primer to make 
indicated Dbf4 mutation 
Dbf4 M120A W116E RC gtaaatgcgagaatctcttttcgctatctttttctcatttgtttgcca
ttccagc 
QuikChange Primer to make 
indicated Dbf4 mutation 
Rad53 N71A QC For gaaagtttggacatttggtagagccccagcctgtgactatcatt
tagg 
QuikChange Primer to make 
indicated Rad53 mutation 
Rad53 N71A QC RevComp cctaaatgatagtcacaggctggggctctaccaaatgtccaa
actttc 
QuikChange Primer to make 
indicated Rad53 mutation 
Rad53 V144N F146A QC For ggcgtggaatcagatattttatctctgaacattgccataaacga
caaatttaagcagtgcc 
QuikChange Primer to make 
indicated Rad53 mutation 
Rad53 V144N F146A QC RC ggcactgcttaaatttgtcgtttatggcaatgttcagagataaaa
tatctgattccacgcc 
QuikChange Primer to make 
indicated Rad53 mutation 
Rad53 I37A T39A QC cgaaaacattgtgtgcagggtcgcttgtgccacgggtcaaatt
cccatc 
QuikChange Primer to make 
indicated Rad53 mutation 
Rad53 I37A T39A QC RC gatgggaatttgacccgtggcacaagcgaccctgcacacaa
tgttttcg 
QuikChange Primer to make 
indicated Rad53 mutation 
Rad53 E129A QC gttactgtctcaaggtgatgcaataaccgttggtgtaggc QuikChange Primer to make 
indicated Rad53 mutation 
Rad53 E129A QC RevComp gcctacaccaacggttattgcatcaccttgagacagtaac QuikChange Primer to make 
indicated Rad53 mutation 
Rad53 N112A QC ccactaatgggacctggttagctgggcaaaaagtcgagaag QuikChange Primer to make 
indicated Rad53 mutation 
Rad53 N112A QC RevComp cttctcgactttttgcccagctaaccaggtcccattagtgg QuikChange Primer to make 
indicated Rad53 mutation 
Rad53QC V134DI140A F gatgaaataaccgttggtgacggcgtggaatcagatgctttat
ctctggtcattttc 
QuikChange Primer to make 
indicated Rad53 mutation 
Rad53QC V134DI140A RC gaaaatgaccagagataaagcatctgattccacgccgtcacc
aacggttatttcatc 
QuikChange Primer to make 
indicated Rad53 mutation 
   
2.5 Synchronizing yeast cultures 
 Exponentially growing yeast cultures were synchronized in late G1 phase with 
synthetic yeast mating pheromone α-factor (New England Peptide). Cultures of mating-type-
a cells were grown to a density of 5x106 cells/ml, washed twice in sterile ddH2O, and 
resuspended in fresh media containing α-factor (10 μg/ml). After 2.5-3 hours incubation at 
30ºC, 10 μl culture aliquots were taken and analyzed by light microscopy for the presence of 
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schmooed cells to confirm arrest. To release cells from the arrest, cultures were spun down 
and washed with sterile ddH2O twice, then resuspended in fresh medium containing 50 μg/ml 
Pronase E (Sigma). 
2.6 FACS analysis 
Aliquots of 1 ml were taken from experimental yeast cultures, immediately 
centrifuged at 13,200 rpm for 30 seconds, resuspended in 1 ml of cold 70% ethanol, and 
stored at 4ºC until processing. Half of each sample aliquot was spun down and washed with 
1ml ddH2O, centrifuged for 30 seconds at 13,200 rpm and resuspended in 500 μl RNaseA 
(200 μg/ml in 50 mM Tris-HCl, pH8) for 2-4 hours at 37ºC. After incubation cells were 
centrifuged for 30 seconds at 13,200 rpm and resuspended in 500 μl Proteinase K (2 mg/ml 
in 50 mM Tris-HCl, pH7.5) for 30-60 minutes at 50ºC. Cells were then spun down for 30 
seconds at 13,200 rpm and resuspended in 100 μl FACS buffer (200mM Tris-HCl pH 7.5, 
200mM NaCl, 78mM MgCl2) then transferred into 5 ml Falcon tubes (BD Biosciences) 
containing 500 μl Sytox solution (50mM Tris-HCl pH 7.5, 1:5000 dilution Sytox Green 
[Molecular Probes]). Samples were then analyzed on a BD FACSVantage SE flow cytometry 
system. 
2.7 Yeast whole cell extract preparation and western blotting 
 A 20 ml volume of yeast cultures (~1x107 cells/ml), was spun down in 50 ml tubes at 
4000 rpm for 3 minutes at room temperature, and resuspended in 400 μl ice cold lysis buffer 
(10 mM Tris-HCl, pH 8; 140 mM NaCl; 1% Triton X-100; 1 mM EDTA, PMSF) 
supplemented with 10 μl/ml protease inhibitor cocktail (Fisher). The mixture was then 
transferred to 2 ml screw cap tubes containing 0.3g of 0.5 mm glass beads and stored on ice. 
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Samples were lysed at 4ºC with a mini-beadbeater-16 (Biospec), following 8 cycles of 1 
minute length each. Each cycle consisted of 30 seconds of agitation followed by 30 seconds 
cooling on ice. Samples were then centrifuged at 4ºC for 30 seconds at 13,200 rpm, then the 
supernatant (whole cell extract) was transferred to 1.5 ml tubes on ice. Protein concentration 
was determined by Bradford assay using Bio-Rad protein assay (BioRad).  
Whole cell extracts were mixed with one-half their volume of sample loading buffer 
(60% 4x buffer [15% SDS; 40% glycerol, 166 mM tris-base]; 0.26 M DTT; 7% bromophenol 
blue), and boiled for 10 minutes. Samples were then either run directly on SDS 
polyacrylamide gels or stored at -20ºC until electrophoresis. Prepared samples were run on 
7.5% or 10% SDS polyacrylamide gels with a 5% stacking gel, with equal total amount of 
protein loaded in each lane as determined by Bradford assay. After electrophoresis, protein 
from the polyacrylamide gel was transferred to nitrocellulose via wet transfer. The gel and 
nitrocellulose were sandwiched by Whatman paper and sponges, then completely submerged 
in transfer buffer (200 mM glycine; 25 mM tris-base; 20% methanol; 0.05% SDS). The 
transfer process was carried out for 2-16 hours at 50-30 volts. After transfer, blots were 
stained with 0.1% Ponceau S and imaged. Blots were then destained in TEN+T (20 mM Tris-
HCl; 1mM EDTA; 0.14 M NaCl; 0.05% Tween 20), and blocked for 1-16 hours in TEN+T 
with 5% skim milk powder. After blocking the membranes are rinsed 3 times with ddH2O, 
and probed with primary antibody in TEN+T with 3% Bovine Serum Albumin (Sigma) for 1 
hours with gentle shaking. Before addition of secondary antibody in TEN+T with 5% skim 
milk powder, membranes were washed with TEN+T for 10 minutes, three times. Secondary 
detection is performed in the dark and blots were covered. After incubation in secondary 
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antibody for 1 hour, blots were again washed three times in TEN+T for 10 minutes each, and 
finally stored in ddH2O. Blots were imaged with either a Typhoon 9400 (GE Healthcare) or a 
Pharos FX Plus (BioRad). 
Table 2.3: List of antibodies used for western blot detection. 
Antibody Source Catalog # Concentration Dilution 
AlexaFluor 488 donkey anti-goat Invitrogen A11055 2mg/ml 1:3000 
AlexaFluor 488 goat anti-mouse Invitrogen A11001 2mg/ml 1:3000 
AlexaFluor 647 goat anti-rabbit Invitrogen A21446 2mg/ml 1:3000 
anti-MYC (mouse monoclonal) Sigma M5546 2mg/ml 1:5000 
anti-HA (mouse monoclonal) Sigma H9658 2mg/ml 1:5000 
anti-LexA (rabbit polyclonal) Cedarlane PA1-4966 2mg/ml 1:3000 
anti-Rad53 (goat polyclonal) Santa Cruz SC6749 0.2mg/ml 1:500 
2.8 Kinase assays 
 Yeast whole cell extracts were prepared as described above, and 2 μg of whole cell 
extract, 10 μg of purified recombinant budding yeast Mcm2 and 2.5 μCi γ32P ATP (Perkin 
Elmer Life Sciences) were incubated in 20 μl kinase buffer (40 mM HEPES pH 7.5, 0.5 mM 
EDTA, 2 mM DTT, 10 mM magnesium acetate, 0.1 mM ATP, 80 mg/ml BSA, PhosSTOP 
phosphatase inhibitor cocktail [Roche]), at 30°C for 30 minutes. The reaction was stopped by 
addition of 10 μl sample loading buffer and samples size seperated on a 10% SDS 
polyacrylamide gel. The gel was air dried at 50ºC then exposed to x-ray film. 
2.9 Co-immunoprecipitation 
 DY-1 cells were transformed with pJG4-6 or pCM190 derived expression vectors and 
grown to a density of 1x107 cells/ml in synthetic complete medium lacking uracil and 
tryptophan as described previously (Varrin et al. 2005). Cultures were then centrifuged at 
4000 rpm for 3 minutes, washed with sterile ddH2O, then resuspended in 2% galactose 1% 
raffinose media lacking uracil and tryptophan, then grown for 6 hours at 30°C. All 
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subsequent steps were performed at 4°C. Whole cell extracts were then prepared as 
previously described with the exception that 450 μl IP lysis buffer was used (50 mM Hepes, 
pH 7.5; 140 mM NaCl; 1 mM Na-EDTA; 1% Triton X-100) supplemented with 10 μl/ml 
Halt Protease Inhibitor Cocktail (Thermo-Fisher). Whole cell extracts were diluted to the 
same concentration with IP lysis buffer, and 400 μl each extract was incubated overnight on a 
rotating wheel with 15 μl Protein A sepharose beads (Sigma) saturated with mouse 
monoclonal anti-Myc antibody (Sigma). After 16-18 hours, the supernatant was removed and 
saved. Sepharose beads were washed 3 times with 500 μl IP lysis buffer, and resuspended in 
a final volume of 35 μl IP lysis buffer. 
2.10 Complementation 
Dbf4 complementation was performed as described previously (Varrin et al. 2005). 
The DY-2 strain harbouring a temperature-sensitive allele of dbf4 was transformed with 
pCM190 derived vectors expressing either wild-type or mutant Dbf4. Transformants were 
grown to a density of 1x107 cells/ml, and a total of 5x106 cells of each transformant were 
streaked in duplicate onto synthetic complete media lacking uracil. One plate was incubated 
at the permissive temperature 23°C, while the other was incubated at the non-permissive 
temperature 37°C. After three days growth, plates from each growth temperature were 
compared for growth. 
The rad53Δ strain, DY-147, was transformed with pRS315 derived centromeric 
vectors expressing wild-type RAD53 or the rad53 mutant allele under its own promoter. The 
isogenic RAD53 strain, DY-145, was used as a wild-type control and was transformed with 
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empty vector pRS315 (Sikorski & Hieter 1989). Spot plate genotoxic sensitivity assays were 
then conducted as described below on synthetic complete media lacking leucine. 
2.11 Plasmid shuffle 
 Viability of the DY-159 yeast strain harbouring the dbf4Δ deletion is achieved by 
ectopic expression of Dbf4 from pCM190-Dbf4. Vectors derived from the centromeric vector 
pRS315, expressing wild-type or mutant Dbf4, were transformed into DY-167 and cells were 
selected on synthetic complete media lacking uracil and leucine. These cells were then 
streaked onto plates containing 5’ fluoroorotic acid to counter select against the URA3 
marker in pCM190. The resulting cells were solely supported for growth by pRS315 based 
expression. Cell synchronization, FACS analysis, and genotoxin sensitivity assays were then 
performed with these transformants as described in this chapter. 
2.12 Yeast two-hybrid assay 
 The liquid culture yeast two-hybrid assay was performed as described previously 
(Duncker et al. 2002). DY-1 cells were transformed with pEG202 derived bait, pJG4-6 
derived prey, and the lacZ reporter pSH18-34. Transformants were grown in synthetic 
complete medium lacking uracil, histidine, and tryptophan to a density of 1x107 cells/ml. 
Approximately 1x108 total cells were harvested and washed once with sterile ddH2O, 
resuspended in 20 ml of 2% galactose 1% raffinose medium lacking uracil, histidine, and 
tryptophan, and allowed to grow for 6 hours at 30°C. 5x106 total cells were isolated for 
analysis and the remainder of cultures was processed for western blot analysis as previously 
described. Isolated cells were resuspended in 500 μl Z-buffer (60mM Na2HPO4, 40mM 
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NaH2PO4, 10mM KCl, 1mM MgSO4, 0.5M β-mercaptoethanol). From a P200 pipette, 2 
drops of chloroform and 1 drop of SDS were added to each sample, which were then 
vortexed for 10 seconds and then incubated at 28°C for 5 minutes. After incubation 100 μl of 
ONPG (ortho-Nitrophenyl-β-galactoside) was added simultaneously to each sample and the 
reaction was monitored until a pale yellow colour appears. At this point 250 μl of 1M sodium 
carbonate was added simultaneously to all tubes to stop the reaction. β-galactosidase activity 
was calculated seing the following formula: β-galactosidase activity = 1,000 x A420 / (t x V x 
A600), where t = time of the reaction, V = volume of culture used in the assay (to obtain 5x106 
total cells), A420 = absorbance of the reaction, and A600 = absorbance of the cell culture used. 
2.13 Yeast one-hybrid assay 
 Liquid culture one-hybrid analysis was performed as described for yeast two-hybrid 
assay above with the following deviations. DY-1 cells were transformed with the pLI-ARS1+ 
reporter plasmid and pJG4-6 derived prey. Transformants were originally grown in synthetic 
complete medium lacking uracil and tryptophan, and later resuspended in 2% galactose 1% 
raffinose medium lacking uracil and tryptophan. 
2.14 Short-term viability assay 
 Viability assays were performed as described previously (Varrin et al. 2005). Yeast 
strains were grown overnight in YPD (~1x107 cells/ml) then diluted to1x106 cells/ml. The 
diluted culture was divided into a series of 10 ml aliquots. Each aliquot was treated at one of 
the indicated concentrations of HU (50mM, 100mM, 150mM, 250mM), MMS 
(0.015%,0.02%, 0.025%, 0.03%), or left as an untreated control. After 4 hours incubation at 
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30°C, 50 μl of culture from each treatment was removed, diluted 200-fold, and plated in 
triplicate on YPD plates. After 2 days growth at 30°C, the number of colonies was counted 
and the percentage of viable colonies was determined relative to untreated cells. 
2.15 Genotoxin sensitivity assay 
 Serial dilution genotoxin sensitivity assays were performed as described previously 
(Varrin et al. 2005). Yeast cultures were grown to stationary phase (~1x108 cells/ml), and 10-
fold serial dilutions were made ranging from 1x107 cells/ml to 1x104 cells/ml. 5 μl of each 
diluted yeast culture was spotted onto media containing the indicated concentration of HU 
(50-300 mM), MMS (0.005-0.03%), or Phleomycin (5-20 μg/ml). Plates were incubated at 
30°C for 3 days. 
2.16 Recombinant protein purification and crystallization 
A codon optimized version of the HBRCT domain of Dbf4 (amino acids 105-220) 
was synthesized by GeneArt® (Invitrogen) and subcloned into an expression vector 
including a (His)6-SUMO tag. The HBRCT-W116D/M120A was also subcloned in the 
pSUMO vector. Plasmids encoding wild type and (His)6-SUMO-tagged HBRCT variants 
were transformed in RosettaTM cells (Novagen). Cultures were grown to OD600 of 0.7, 
induced by addition 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and incubated 
overnight at 16°C with orbital agitation.  
Two variants of the Rad53 FHA1 domain, including amino acids 14-164 and 4-165, 
were subcloned in pPROEX HTa vectors (Invitrogen). The two variants were produced in 
RosettaTM cells (Novagen). Protein expression was induced with 1 mM IPTG and the 
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cultures were subsequently incubated for 4 hours at 30°C with orbital agitation. Cell pellets 
were resuspended in 20 ml of buffer A (20 mM Tris pH 8.0, 500 mM NaCl, 1.4 mM β -
mercaptoethanol, and 5% glycerol) supplemented with 15 mM imidazole and lysed by 
sonication. Lysates were cleared by centrifugation at 39,000 g and the supernatants were 
loaded onto HiTrap Ni-chelating HP columns (GE Healthcare). (His)6-SUMO-HBRCT and 
(His)6-FHA1 variants were eluted with linear gradients to 300 mM imidazole. Tags were 
removed with TEV protease and aliquots of the purified HBRCT and FHA1 were stored at    
-80°C in 20 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 5 mM DTT, and 5% glycerol. 
The His-tagged version of the BRCT domain of Dbf4 was obtained by transforming 
the pAG8206 plasmid encoding amino acid residues 120-250 from S. cerevisiae Dbf4 
(NP_010337) in either BL21(DE3) or B834(DE3) cells carrying the pRARELysS plasmid. 
Sel-Met labeled protein was subsequently overproduced in minimal media supplemented 
with Sel-Met as described (Hendrickson et al. 1990). Protein over-production and 
purification for both native and Sel-Met labeled Dbf4 was performed as previously described 
(Matthews et al. 2009). The histidine-tag was removed with thrombin (Sigma) and the 
protein was further purified by ionic exchange in a MonoS (10/100) GL column (GE 
Healthcare). Purified tagged and untagged Dbf4 were concentrated to 5 mg/ml in 20 mM Tris 
pH 8.0, 1 mM DTT, 100 mM NaCl, and 5% glycerol (storage buffer). Longer fragments of 
Dbf4 (encoding amino acid residues 65-221 and 105-220, pAG8391 and pAG8209 
respectively) were produced and purified similarly. Protein concentration was determined 
using the Beer-Lambert law with an extinction coefficient of 23,950 M-1 cm-1. 
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 Sel-Met crystals of a 6xHis tagged Dbf4 fragment encompassing the predicted BRCT 
domain (amino acid residues 120-250) were grown using the hanging-drop method in 0.1 M 
Tris pH 8.5, 0.05 M MgCl2 and 29% PEG400 (v/v). Native crystals of the untagged BRCT 
domain were grown in 100 mM NaK phosphate buffer pH 7.1 and 22% MPD (v/v) and 
cryoprotected by increasing the MPD concentration to 40% (v/v). Crystals of the minimal 
domain of Dbf4 sufficient for the interaction with Rad53 (residues 65-221, Helix-BRCT) 
were grown in 1.9 M (NH4)2SO4, 0.014 M MgSO4, 0.05 M (CH3)2AsO2Na pH 6.5, and 
0.03 mM CYMAL-7, improved by streak seeding and cryoprotected by addition of 20% 
glycerol to the mother liquor prior to data collection. All crystals were grown from 
crystallization drops set at 4˚C by mixing 1 µL of protein with 1 µL of reservoir solution 
(Matthews et al. 2009). Complete data sets of Sel-Met labeled tagged and untagged BRCT 
domain crystals were collected using the X29 beamline, while data for the crystals of the 
Helix-BRCT domain were collected using the X25 beamline, at the National Synchrotron 
Light Source (Brookhaven National Laboratory). All data sets were processed with 
HKL2000 (Otwinowski & Minor 1997). 
2.17 Crystal structure determination and refinement 
The structure of the His-tagged BRCT domain was determined by the single 
anomalous diffraction (SAD) method. Thirty of the forty selenium sites were found and 
refined using standard protocols in PHENIX (Adams et al. 2002). The initial model was 
refined by iterative cycles of manual model building in Coot (Emsley & Cowtan 2004) and 
refinement using PHENIX and imposing non-crystallographic symmetry constraints that 
related the ten molecules in the asymmetric unit pair wise. This protocol yielded a final 
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model that includes amino acid residues 122-224 and has 93.6% of the residues in the most 
favored region of the Ramachandran plot and none in the disallowed regions. One BRCT 
monomer from this structure was subsequently used as the search model to solve the 
structure of the untagged BRCT domain using molecular replacement with Phaser (McCoy et 
al. 2007). The structure of the untagged BRCT domain was refined using standard protocols 
in Coot and PHENIX and the final model includes amino acid residues 119-242 for one of 
the five monomers in the asymmetric unit and residues 122-220 for the other four, has 94.2% 
of the residues in the most favored region of the Ramachandran plot and none in the 
disallowed regions. 
The structure of the sufficient domain (H-BRCT) was solved by molecular 
replacement using the BRCT domain as the search model. The final model includes amino 
acid residues 98-220 and has 94% residues in the most favored regions of the Ramachandran 
plot and none in the disallowed regions. The refinement statistics for the three structures are 
presented in Table 4.1. Figures depicting molecular structures were generated using PyMol 
(Schrödinger). Atomic coordinates and structure factors for the three structures have been 
deposited in the Protein Data Bank (accession codes 3OQ0, 3OQ4 and 3QBZ, respectively). 
2.18 NMR Spectroscopy 
All experiments were conducted using a 700 MHz AV Bruker NMR spectrometer 
with a TCI cryoprobe. HBRCT samples were uniformly labeled by expressing the domain 
(amino acid residues 105-220) in M9 media containing 15NH4Cl and 13C-D-glucose 
(15N,13CHBRCT) or 15NH4Cl alone (15NHBRCT). Labeled HBRCT was purified and stored as 
described above. All experiments with labeled HBRCT were conducted at 306 K in 20 mM 
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TRIS pH 8.0, 100 mM NaCl, 5 mM DTT, 1 mM EDTA, and 5% glycerol. The FHA1 domain 
of Rad53 (amino acid residues 14-164) was similarly labeled to produce 13C,15NFHA1 or 
15NFHA1. The protein was purified as described above and stored in 10 mM sodium 
phosphate buffer pH 6.5, 1 mM EDTA, and 5 mM DTT. All experiments with labeled FHA1 
were conducted at 293 K as described previously (Yongkiettrakul et al. 2004). Experiments 
including both 15NFHA1 and HBRCT (or BRCT) were also performed in 10 mM sodium 
phosphate buffer pH 6.5, 1 mM EDTA, and 5 mM DTT. 
To assign resonances for 13C,15NHBRCT (0.5 mM), triple resonance experiments (HNCA, 
HNCO, HNCOCA, and CBCA(CO)NH) were collected as described previously 
(Selvaratnam et al. 2012). The 13C,15NFHA1 sample (0.3 mM) was first mixed with an 
equimolar amount of HBRCT prior to collecting HSQC, HNCO, HNCACB, and 
CBCA(CO)NH spectra. All data were processed with NMRPipe (Delaglio et al. 1995) and 
resonance assignment was carried out using SPARKY 
(http://www.cgl.ucsf.edu/home/sparky/). 
1H15N NOE experiments were conducted using a 0.1 mM sample of 15NHBRCT 
prepared as described above. 1H15N NOE data were acquired using a 3 second recycle delay, 
with and without proton saturation in alternate scans (Farrow et al. 1994). The 15N dimension 
was digitized with 256 complex points for a spectral width of 31.82 ppm and the 1H 
dimension was digitized with 1024 complex points for a spectral width of 14.28 ppm. After 
16 dummy scans, a total of 128 scans were accumulated for each data set, with and without 
proton saturation. The steady state NOE values were computed as the ratio of the intensities 
in saturated to unsaturated spectra. The error for the NOE values were gauged based on the 
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standard deviation between fit heights in replicate spectra. Selected cross peaks were not 
included in the relaxation analyses due to line broadening and/or overlap. 
2.19 Peptide titration experiments 
Lyophilized phosphorylated peptide derived from Cdc7 (pPEP: 
480DGESpTDEDDVVS491) and a nonphosphorylated control (PEP: 480DGESTDEDDVVS491) 
were synthesized by Biomatik. The peptides were resuspended in 10 mM sodium phosphate 
buffer pH 6.5 and titrated into a sample containing 0.12 mM 15NFHA1 with an equimolar 
amount of HBRCT. HSQC spectra were collected after each addition and the total volume of 
peptide added was < 20% of the sample volume. 
2.20 Trypsin Proteolysis 
In a total reaction volume of 11 μl, 9 μl of HBRCT (20 μM in storage buffer) were 
mixed with 1 μl of 50 mM MgCl2 and 1 μl of trypsin (0.195-12.5 μg/ml) and incubated for 1 
hour at room temperature. The reaction products were subsequently visualized useing 15% 
SDS-polyacrylamide gels.  
2.21 Statistical Analysis 
The intensity losses for peaks in the 15NFHA1 HSQC spectrum after addition of 
HBRCT were analyzed based on a method published previously (Farrow et al. 1994). The 
peak fit height was measured with SPARKY using a Lorentzian fit to integrate the peaks. 
Overlapping peaks were rejected (E26, I32, T39, K57, K64, C74, L99, Q114, S120, and 
N158). The remaining values were normalized dividing by the intensity of the most intense 
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peak, which was the C-terminal residue Arg164, prior to being compared with a similarly 
analyzed data set from a sample lacking HBRCT. The peak height ratio was expressed as a 
percentage. The average peak height ratio was computed excluding Arg164 to avoid bias. In 
addition, Ile163 was also excluded as its value exceeded the average beyond four standard 
deviations. Perturbed residues were defined as having a peak height ratio below one standard 
deviation from the average.  
2.22 Bioinformatics analysis 
To identify patterns of amino acid conservation in the FHA1 and FHA2 domains of 
Rad53, representative protein sequences were retrieved using PSI-BLAST (Altschul et al. 
1997) run with an E-value cutoff of E=1e-6. Full length Rad53 from Saccharomyces 
cerevisiae (Uniprot ID: P22216) was used to query the UniRef90 database using PSI-
BLAST, and sequences containing both FHA1 and FHA2 domains were retained. A total of 
28 sequences were identified (Uniprot IDs: P2216, G3AR58, G3BDW6, H8X5Q1, 
B9WDY3, C5MJH1, B5RTA3, G8YJ57, C4Y319, A5DJY0, F2QUG7, C4R6G9, K0KML2, 
J7SAK5, Q6CKF2, G8JNR2, Q75CE9, I2GYM1, C5DF05, Q6FK01, H2AZ96, A7TKN4, 
G8BVR8, G8ZMW0, C5DXS2, G0WBA8, G0VCB8, E7NNR4), with no further sequences 
meeting the criteria after three PSI-BLAST iterations. The multiple sequence alignment 
produced by PSI-BLAST was edited to contain only regions corresponding to the FHA1 and 
FH2 domains. The Consurf server (http://consurf.tau.ac.il) was used to visualize conserved 
surface residues (Ashkenazy et al. 2010). A single PDB file containing both FHA1 and 
FHA2 domains was created by combining PDB files 1G6G and 1J4K. The combined file was 
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used to map patterns of residue conservation onto the protein surfaces using the same 
conservation scale.   
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Chapter 3 
 The Dbf4 motif C zinc finger promotes DNA replication and mediates 
resistance to genotoxic stress 
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3.1 Introduction 
The Dbf4-dependent kinase (DDK) complex, Dbf4-Cdc7, plays an essential and 
conserved role in the initiation of eukaryotic DNA replication (reviewed in Sclafani & 
Holzen 2007). Several replication factors have been identified as DDK substrates, including 
DNA polymerase α, Cdc45, and multiple members of the Mcm2-7 helicase complex 
(reviewed in S. Bell & Dutta 2002; Weinreich & Stillman 1999; Nougarède et al. 2000). Of 
these, the most important physiological targets are likely to be Mcm2-7 subunits, since a 
P83L mutation in Mcm5 and deletion of an amino-terminal region of Mcm4 are able to 
bypass the requirement of DDK for cell cycle progression (Hardy et al. 1997; Hoang et al. 
2007; Sheu & Stillman 2010). Moreover, data from several studies suggest that the 
association of DDK with origins of DNA replication is dependent on interactions with 
Mcm2-7 (Varrin et al. 2005; Sheu & Stillman 2006; Francis et al. 2009; Sheu & Stillman 
2010).  
When budding yeast cells are treated with the ribonucleotide reductase inhibitor 
hydroxyurea (HU), the depletion of cellular dNTP pools leads to replication fork stalling and 
triggers the intra-S phase checkpoint. Under these conditions, the Rad53 checkpoint kinase 
(ortholog of mammalian Chk2 kinase) is activated, Dbf4 is removed from chromatin in a 
Rad53-dependent manner, and the rate at which new initiation events occur at origins of 
DNA replication is greatly reduced (Weinreich & Stillman 1999; Pasero et al. 1999; Alvino 
et al. 2007). The inhibition of late origin firing may be important for keeping unfired origins 
in reserve during a prolonged checkpoint arrest or in mutant backgrounds where replication 
fork stability could be compromised. However, studies of both Mec1 and Mrc1 have shown 
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that certain mutant strains for these checkpoint proteins, in which suppression of late origin 
firing has been compromised, are nevertheless tolerant of genotoxic stress (Alcasabas et al. 
2001; Tercero et al. 2003). It has been suggested that an additional checkpoint role for DDK 
may be the stabilization and/or restart of replication forks (Duncker & Brown 2003).  
Sequence comparisons between Dbf4 orthologs from multiple species has revealed 
the presence of three relatively well conserved regions, termed motifs N, M and C in 
accordance to their position within the protein (Masai & Arai 2000). Motif N is dispensable 
for viability in both fission and budding yeast, and its deletion results in hypersensitivity to 
genotoxic agents (Varrin et al. 2005; Ogino et al. 2001; Fung et al. 2002; Gabrielse et al. 
2006). Studies with the latter organism have determined that this region mediates interactions 
with both Rad53 and the Orc2 subunit of the origin recognition complex (ORC) (Varrin et al. 
2005). In contrast, motif N was found to be essential in murine embryonic stem cells 
(Yamashita et al. 2005). Motif M is required for proliferation in all of the above cell types, 
and has been shown to mediate the interaction between Dbf4 and Mcm2-7 (Varrin et al. 
2005; Francis et al. 2009; Ogino et al. 2001; Fung et al. 2002; Yamashita et al. 2005). 
Despite being the most highly conserved of these three Dbf4 regions, motif C is the least well 
understood. One study with the fission yeast Schizosaccharomyces pombe reported that it 
was essential for cell viability (Ogino et al. 2001). However, another investigation revealed 
that cells for which the region encoding this motif was removed from the single genomic 
copy of dfp1 (S. pombe DBF4 orthologue) were viable, and sensitive to the DNA alkylating 
agent methyl methanesulfonate (MMS) but not to other genotoxic agents (Fung et al. 2002).  
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Here, we present a functional characterization of Saccharomyces cerevisiae Dbf4 
motif C. We demonstrate that a Dbf4ΔC mutant is unable to support mitotic growth, and that 
removal of motif C likely causes a major conformational change, since interactions with all 
known ligands examined were disrupted. Reduced interactions with origins of DNA 
replication and Mcm2, and defects in S-phase progression resulted from mutating the 
conserved histidines and cysteines, comprising a motif C zinc finger, to alanines. 
Furthermore, motif C mutant strains were sensitive to prolonged exposure to HU and MMS, 
both of which provoke checkpoint responses. Thus, motif C represents a region of Dbf4 that 
is required for DNA replication, likely through an interaction with Mcm2-7, and plays an 
additional role in protection against genotoxic agents.  
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Figure 3.1: Dbf4 motif C mutants can support cell growth. 
(A) Dbf4 expression cassettes (B) DY-2 cells (with the temperature-sensitive DBF4 allele, 
dna52-1) were transformed with pCM190-Dbf4WT, -Dbf4ΔN, -Dbf4ΔM, -Dbf4ΔC, -Dbf41-
659 or empty vector pCM190 (V), and a complementation assay was carried out as described 
in materials and methods. Western blot analysis to confirm plasmid based expression was 
conducted using a mouse monoclonal anti-Myc antibody (Sigma) and Alexa Fluor 488 goat 
anti-mouse IgG polyclonal secondary antibody (Invitrogen). (C) DY-2 cells were 
transformed with pCM190 -Dbf4WT, -Dbf4CCHC, -Dbf4CCHA, Dbf4CCAA, Dbf4AAHH, 
or empty vector pCM190 (V) and analyzed as in (B).  
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3.2 Results  
3.2.1 Motif C mutants support essential Dbf4 function. 
We previously investigated Dbf4 motifs N and M, and found that the former mediates 
DDK interactions with both Rad53 and Orc2, and is dispensable for growth, while the latter 
binds to Mcm2 and is required for viability (Varrin et al. 2005). In order to characterize the 
third and most highly conserved of these regions, we constructed a version of the DBF4 gene 
with a precise excision of motif C (Dbf4ΔC ; Figure 3.1A). Plasmid based expression of 
Dbf4ΔC did not complement growth of a strain with a temperature-sensitive (ts) DBF4 allele 
at restrictive temperature (Fig. 1B). Given the previous findings that a S. pombe strain in 
which dfp1 (DBF4 ortholog) motif C had been removed was viable, and that a version of S. 
cerevisiae Dbf4 lacking amino acids 417–704 could complement a DBF4-ts sensitive strain, 
we decided to determine if additional motif C mutants could support cell growth (Fung et al. 
2002; Dowell et al. 1994). Dbf4 1– 659 consisted of a complete truncation of the C-terminal 
45 amino acids, including the entire C motif (Fig. 1A), and was also unable to complement 
the DBF4-ts strain at 37°C, however this mutant was less stable than the others tested as 
judged by western blot (Figure 3.1B). 
Analysis of motif C has shown that it includes a sequence that appears to encode a 
CCHH-type zinc finger (Masai & Arai 2000). We next generated three DBF4 alleles in 
which point mutations were made to change conserved cysteines (positions 661,664) and 
histidines (positions 674, 680) to alanines, dbf4-AAHH, dbf4-CCAA and dbf4-CCHA (Figure 
3.1A). One further mutant, dbf4-CCHC, resulted from a mutation changing a histidine to a 
cysteine, thus more closely resembling a CCHC-type zinc finger in terms of the critical zinc 
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chelating residues. Each of these mutant forms of Dbf4 was able to support cell division at 
restrictive temperature when expressed from a plasmid in the DBF4-ts strain (Figure 3.1C).  
 
Figure 3.2: Dbf4 motif C mutants have weakened interactions with ARS1 and Mcm2, but not 
other replication factors. 
(A) one-hybrid and (B-E) two-hybrid analyses were carried out as described in materials and 
methods. ß-galactosidase activity values represent the averages of three independent 
experiments, and the error bars indicate standard deviation.  
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3.2.2 Interaction with ARS1 and Mcm2 is impaired in Dbf4 motif C mutants. 
To determine whether mutation of highly conserved motif C cysteines and histidines 
had an effect on the interaction of Dbf4 with replication origin DNA, one-hybrid analysis 
was carried out where expression of Dbf4 and its variants as fusion proteins with a 
transcriptional activation domain was used in conjunction with a reporter plasmid for which 
the ARS1 origin has been placed upstream of a ß-galactosidase gene (Dowell et al. 1994). 
For each of the motif C mutants, the interaction with ARS1 was reduced relative to that 
observed for wild-type Dbf4 (Figure 3.2A). This drop was not due to a change in the 
stability of Dbf4 as protein expression levels of the mutants are equivalent to that of wild-
type Dbf4 (Figure 3.1C). Since a reduction in origin association could be mediated through 
other factors, and CCHH zinc fingers have been shown to mediate a wide variety of protein-
protein interactions (reviewed in Brayer & Segal 2008) we assessed the ability of the motif C 
mutants to interact with a number of Dbf4 binding partners by two-hybrid analysis (Figure 
3.2B-E). Association of the motif C mutants with Cdc7 was similar to that observed for wild-
type Dbf4. When compared to wild-type Dbf4, the interactions with Orc2 and Rad53 were 
either comparable, or enhanced. In contrast, all four motif C mutants had reduced interaction 
with Mcm2. In all cases, the Dbf4ΔC mutant resulted in abrogated binding, consistent with 
large conformational changes to the protein as a consequence of removing the entire C motif, 
as has been previously found with removal of certain regions of Dbf4 motif N (Gabrielse et 
al. 2006). Since both the AAHH and CCAA mutants affected interactions with Mcm2, we 
were curious to see the effect of changing conserved cysteines and histidines to alanines 
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simultaneously. Both dbf4-AAHA and dbf4-AAAA mutants showed no greater reduction in 
Mcm2 association than the other motif C mutants (Appendix A Figure 1).  
 
Figure 3.3: Mutation of Dbf4 motif C reduces the amount of co-immunoprecipitated Mcm2 and 
phosphorylation of Mcm2. 
(A) Coimmunoprecipitation experiments were carried out as described in materials and 
methods, for DY-1 cells transformed with pJG-Mcm2 and either pCM190-Dbf4WT, 
pCM190-Dbf4CCHA, pCM190-Dbf4CCHA, pCM190-Dbf4CCAA or pCM190-
Dbf4AAHH. An anti-Myc antibody (Sigma) was used to immunoprecipitate and detect Myc-
tagged Dbf4, and an anti-HA antibody (Sigma) was used to detect HA-tagged Mcm2. Shown 
are immunoblots of the input whole cell extracts (12 µg each; WCE), supernatants (12 µg 
each; SUP) and immunoprecipitates (one third each of final bead suspensions; IP). (B) 
Kinase assays were carried out using recombinant purified Mcm2 and whole cell extract 
from the indicated strains as described in materials and methods.  
 
3.2.3 Mutation to motif C impairs entry and progression through S-phase. 
Given the reduction in Mcm2 interaction with the motif C mutations, we decided to 
explore this changed association further. We first confirmed the two-hybrid results by 
performing co-immunoprecipitation assays with whole cell extracts, in which 
  75 
immunoprecipitated wild-type Dbf4 indeed pulled down more Mcm2 than any of the Dbf4 
variants with mutations in motif C (Figure 3.3A). Given that DDK association with Mcm2-7 
is required to promote S phase progression (Varrin et al. 2005; Sheu & Stillman 2006), and 
that Dbf4 interacts more strongly with Mcm2 than with other subunits of the helicase 
complex (Ramer et al. 2013), we hypothesized that a diminished Dbf4-Mcm2 interaction 
should lead to cell growth defects. To test this, we created a series of haploid yeast strains in 
which the wild type DBF4 gene was replaced with sequence encoding the AAHH, CCAA, 
CCHA or CCHC mutants. We determined that all four motif C mutations resulted in reduced 
levels of Mcm2 phosphorylation (Figure 3.3B). Furthermore, cell counts of exponentially 
growing cultures indicated that all four mutant strains experienced impaired growth 
compared to an isogenic wild-type strain (Figure 3.4A). Since the Dbf4-Mcm2 interaction 
should promote DNA replication, we tested entry into and progression through S phase by 
first synchronizing cells in late G1 phase by addition of the mating pheromone α-factor, and 
then monitoring DNA content by FACS analysis following release of the cultures from the 
block. Whereas the wild-type strain had clearly entered S phase by 20 minutes after α-factor 
removal (as judged by DNA content between 1C and 2C), the earliest this was evident for 
any of the mutant strains was at 40 minutes, consistent with defects in origin firing (Figure 
3.4B). Completion of S phase similarly lagged by at least 20 minutes in the mutant strains, 
with the wild-type showing a peak centred at 2C by 40 minutes, and the fastest of the mutants 
(dbf4-AAHH and dbf4-CCHC) showing equivalent profiles by 60 minutes.  
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Figure 3.4: Mutation of Dbf4 motif C impairs entry and progression through S phase. 
(A) Asynchronous wild-type and motif C mutant strain cultures were diluted to a starting 
concentration of 2 x 106 cells/ml and cell counts were taken every two hours. Each data point 
represents the average of three independent experiments. Error bars represent standard errors. 
(B) The same yeast strains as above were grown to a concentration of 5 x 106 cells/ ml, 
arrested in late G1 phase for 3 h with 5 µg/ml α-factor, washed once in sterile dH2O, then 
resuspended in fresh medium without α-factor to release them from the block. Shown is 
FACS analysis of culture aliquots taken at the indicated time points following release from 
the a-factor block as well as from the original asynchronous cultures (Async). The positions 
of 1C and 2C DNA peaks are indicated. 
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3.2.4 Motif C mutants are sensitive to chronic but not acute exposure to HU or MMS. 
Previously, we reported that a point mutation in Dbf4 motif M that weakens 
interaction with Mcm2 and compromises DNA replication actually has a protective effect 
when cells are exposed to genotoxic agents (Varrin et al. 2005). We reasoned that this might 
be due to a more efficient Rad53-mediated removal of Dbf4 from unfired origins as part of 
the checkpoint response. Thus, we might expect our Dbf4 motif C mutants to exhibit a 
similar phenotype, given that they indeed displayed an enhanced association with Rad53 
(Figure 3.2C). On the other hand, if the interaction between motif C and Mcm2 is important 
for replication fork stabilization and/or restart, mutations to motif C that affect these potential 
roles could render cells more sensitive. To explore these alternative models, we first 
subjected the four mutant motif C strains to varying concentrations of HU and MMS for 4 h 
and then determined the effects of exposure to these compounds on cell viability (Figure 
3.5). Relative to the isogenic wildtype strain, the motif C mutants showed similar rates of 
survival over the full range of HU concentrations tested (50 –250 mM), and trials with MMS 
exposure also revealed no major differences between mutant and wild-type strains. We next 
looked at long-term growth on HU and MMS media plates. Consistent with earlier 
observations (Figure 3.4), there was some impairment of growth for the motif C mutants, 
relative to isogenic wild-type cells on control plates without any HU or MMS supplement 
(Figure 3.6). This disadvantage was greatly enhanced as MMS and HU concentration was 
increased indicating that the motif C mutants were sensitive to prolonged exposure to 
genotoxic agents. 
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Figure 3.5: Motif C mutants are insensitive to short term exposure to either HU or MMS. 
Wild type, ΔRad53 and motif C mutant strains were exposed to the indicated concentrations 
of HU or MMS for 4 h, plated in triplicate and incubated at 30°C for 2 days. Colonies were 
counted and the percentages were calculated relative to untreated cells. Each data point 
represents the average of three independent experiments. Error bars represent standard 
deviation.  
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Figure 3.6: Motif C mutants are sensitive to long term exposure to either HU or MMS. 
Wild-type, ΔRad53, and motif C mutant strains were spotted in 10-fold dilution series onto 
YPD plates containing the indicated concentrations of HU or MMS. Each plate was 
incubated at 30°C for three days. 
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3.3 Discussion  
DDK has been shown to act locally at origins of DNA replication, and inactivation of 
either Dbf4 or Cdc7 in mid-S phase prevents initiation from occurring at unfired origins 
(reviewed in Pasero & Schwob 2000). The exact role that DDK carries out has not been 
precisely defined, although it almost certainly involves interaction with the Mcm2-7 helicase 
complex. Multiple Mcm2-7 subunits have been shown to be substrates for DDK 
phosphorylation in vitro (Weinreich & Stillman 1999; Francis et al. 2009; Lei et al. 1997; 
Kihara et al. 2000), and DDK-dependent phosphorylation has been shown for Mcm4 in vivo 
(Sheu & Stillman 2006; Masai et al. 2006). Moreover, a P83L mutation of Mcm5 is able to 
bypass the essential function of both Dbf4 and Cdc7 through a change of conformation that is 
thought to mimic the effect of Mcm2-7 phosphorylation by DDK (Hardy et al. 1997; Hoang 
et al. 2007). Similarly, deletion of an amino terminal domain of Mcm4 also relieves the 
requirement for DDK (Sheu & Stillman 2010). We have previously shown that deletion of 
Dbf4 motif M abrogates its interaction with Mcm2 and results in a loss of viability (Varrin et 
al. 2005), and have recently found that among Mcm2-7 subunits, Mcm2 interacts most 
strongly with Dbf4 (Ramer et al. 2013). Taken together, these data suggest that the Dbf4-
Mcm2 interaction is important to efficiently target DDK to origins of DNA replication. 
Consistent with this model, our motif C mutants show both a loss of interaction with Mcm2 
and defects in S-phase entry and progression. Interestingly, these mutants maintain a robust 
and, in some cases, enhanced association with Orc2. Orc2 has been shown to interact with 
Dbf4 through motif N (Varrin et al. 2005; Duncker et al. 2002). Furthermore, in an orc2-1 
back-ground (which completely destabilizes ORC at non-permissive temperature) the 
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punctate subnuclear foci observed for Dbf4 through immunofluorescence, thought to 
represent localization to replication centres, become diffuse (Pasero et al. 1999). Thus, it is 
likely that DDK is tethered to origins of DNA replication through multiple protein-protein 
interactions, with some being more crucial than others. The enhanced interaction with Orc2 
we observed with the motif C mutants did not compensate for the reduction in Mcm2 
association in terms of replication defects. However, it should be noted that the relative 
strength of interaction for Dbf4 with Mcm2 appears considerably stronger than with Orc2 
(see Figure 3.2 B,D). Additionally, removal of Dbf4 motif N and consequent disruption of 
the interaction with Orc2 results in some growth defects, but cells maintain viability in 
contrast to the effects of deleting motif M (Varrin et al. 2005). It is also possible that the 
overall change in origin targeting may be less important than a reduction in phosphorylation 
of Mcm2 as a consequence of compromising its interaction with DDK. Mutation of a single 
conserved histidine (His680) to alanine within the CCHH-type zinc finger of motif C was 
sufficient to disrupt the Dbf4-Mcm2 interaction. Similar results were obtained when this 
residue was changed to cysteine, although the effects on S phase progression were less 
severe. Interestingly, a previous study has shown that a CCHC zinc finger in human histone 
acetylase HBO1 mediates its association with Mcm2 (Burke et al. 2001).  
Multiple Mcm2-7 subunits have highly conserved zinc finger motifs (reviewed in 
Jenkinson & Chong 2003), and mutation of the CCCC-type Mcm4 zinc finger has been 
shown to destabilize subunit interactions (You et al. 2002). Taken together, these findings 
suggest that zinc fingers are important for mediating interactions between Mcm2-7 subunits 
and their ligands, and that specificity is imparted by the composition of the zinc binding 
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residues. Here we present evidence that the conserved cysteine and histidine residues within 
motif C comprise part of a functional domain that is required for timely replication and 
efficient response to genotoxic stress. The partial structure of the human ortholog of Dbf4 is 
now available, which encompasses motifs M and C. This structure shows unequivocally that 
motif C of Dbf4 constitutes a zinc finger and the conserved cysteine and histidine residues 
are responsible for chelation of zinc (Hughes et al. 2012). We observed no reduction in the 
interaction between Dbf4 and Cdc7 (Figure 3.2E) as a consequence of the zinc finger 
mutations, however it has been reported that Dbf4 motif C mutations in S. cerevisiae can lead 
to a reduction in DDK activity (Harkins et al. 2009). It is therefore possible that both a 
disruption of interaction with Mcm2 and reduced kinase activity contribute to motif C mutant 
phenotypes.  
We found that a weakening of the interaction with Mcm2 through Dbf4 motif C 
mutations rendered cells more sensitive to continual exposure to the checkpoint inducing 
agents HU and MMS, but did not reduce viability compared to wild-type after short term 
incubation with these compounds. This argues that the effects we observed most likely had 
less to do with any influence on the timing of late origin firing, and more with a potential role 
for DDK in replication fork stabilization and/or restart during adaptation (Clémenson & 
Marsolier-Kergoat 2009). Such a function for DDK is supported by the finding that for S. 
pombe an hsk1-ts (CDC7 ortholog) mutant is synthetically lethal with a null mutation for 
rqh1, which encodes a RecQ-type helicase, important for recovery from exposure to HU 
(Snaith et al. 2000). Furthermore, motif C mutants in this yeast have elevated levels of 
recombination and chromosome loss that are greatly enhanced with MMS treatment, which 
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could be due to an increase in fork collapse (Fung et al. 2002). Interestingly, we have found 
that overexpression of Mcm2, which might be expected to titrate some Dbf4 away from 
forks, further sensitizes motif C mutants to HU exposure (Appendix A Figure 2). 
How might DDK function in the context of S phase checkpoint responses? 
Phosphorylation of Mcm2-7 may safeguard fork integrity or trigger replication restart by 
promoting association of Cdc45 with the rest of the replisome components, as it does during 
the initiation of DNA replication (Sheu & Stillman 2006; Masai et al. 2006). Consistent with 
our finding that motif C is responsible for mediating an interaction with Mcm2 of the Mcm2-
7 helicase complex and that impairment of this interaction compromises a cells viability 
under genomic duress, two DDK phosphorylation sites important in mediating resistance to 
genotoxic stress have been found in Mcm2, S164 and S170 (Stead et al. 2011). Inability of 
Dbf4/Cdc7 to phosphorylate these residues results in sensitivity to the DNA alkylating agents 
MMS and the PI3K-like kinase inhibitor caffeine (Stead et al. 2011; Stead et al. 2012). 
Alternatively, interaction with Mcm2 may target DDK to phosphorylate either Cdc45 itself 
or DNA polymerase α, both of which are substrates of this kinase complex in vitro 
(Weinreich & Stillman 1999; Nougarède et al. 2000). The latter possibility is particularly 
intriguing since DDK has been shown to function in translesion synthesis (TLS), during 
which it is thought that normal replicative polymerases are substituted by ones capable of 
proceeding through the region of DNA damage (Pessoa-Brandão & Sclafani 2004). 
Similarly, we observe that Dbf4 motif C mutants are synergistic with mutations in the TLS 
pathway, resulting in increased sensitivity to MMS and phleomycin (Appendix A Figure 3). 
Recent work with human Dbf4 has shown that motif C mediates an interaction with the 
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amino-terminus of the ubiquitin ligase Rad18, important for translesion synthesis (Day et al. 
2010; Yamada et al. 2013). DDK directly phosphorylates a cluster of serines in the C-
terminus of Rad18 which is important for its interaction with the translesion polymerase η, 
and mutants of Rad18 unable to be phosphorylated by Dbf4/Cdc7 do not produce Polη foci 
after UV treatment, indicating Polη is not efficiently recruited to sites of DNA damage (Day 
et al. 2010). Under checkpoint conditions ATR (Mec1 ortholog) inactivates the APC/C 
preventing degradation of APC/C targets including Dbf4 (Yamada et al. 2013).Thus under 
checkpoint conditions Dbf4 is stabilized in an ATR dependent manner. Additionally, 
knockdown of DDK activity before exposure to HU results in an increase in DSB formation 
and increased H2AX phosphorylation (Lee et al. 2012), consistent with a role in preventing 
fork collapse. Rad53 has been implicated in both replication fork stabilization and restart, 
and it was suggested that it may carry out the latter role by stimulating Cdc7-Dbf4 activity at 
forks (Szyjka et al. 2008). The idea that DDK activity may be important for fork restart 
following a checkpoint response is further supported by the finding from a study with a 
Xenopus cell-free system that the block to DNA replication in an etoposide induced S-phase 
checkpoint was overcome by the addition of purified Dbf4/Cdc7 (Tsuji et al. 2008).  
While the role of DDK in meiosis has been characterized, the contributions each of 
the conserved motifs has not been elucidated (Matos et al. 2008; Wan et al. 2008; Sasanuma 
et al. 2008; Katis et al. 2010). Work with the fission yeast S. pombe has recently shown that 
motif C likely also mediates important interactions in meiosis (Le et al. 2013). C-terminal 
truncation of Dfp1 (spDbf4), results in cells that are defective for a variety of meiotic events, 
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including delayed expression of meiotic genes, disrupted chromosome segregations, and 
reduced spore viability (Le et al. 2013).  
Investigations with vertebrates have implicated DDK, Mcm2-7 and their interaction 
in cancer phenotypes (Shima et al. 2007; Montagnoli et al. 2008), and point to the need for a 
better understanding of how these factors associate with each other. Our characterization of 
conserved budding yeast Dbf4 motif C residues that mediate Mcm2 binding and 
phosphorylation, along with the consequences of mutating them, has shed important new 
light on this crucial interaction. It will now be of great interest to determine the extent to 
which these findings are paralleled for this well conserved motif in human cells.  
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Chapter 4 
Saccharomyces cerevisiae Dbf4 has unique fold necessary for interaction 
with Rad53 kinase 
 
 
 
 
 
 
 
Portions of this chapter appear in the following journal and are reproduced with permission. 
 
This research was originally published in The Journal of Biological Chemistry. Matthews 
LA, Jones DR, Prasad AA, Duncker BP & Guarné A. Saccharomyces cerevisiae Dbf4 has 
unique fold necessary for interaction with Rad53 kinase. J. Biol. Chem. 2012; 287: 2378–87. 
© the American Society for Biochemistry and Molecular Biology. 
 
Table 4.1; Figure 4.1; 4.2 B,C; 4.3A; 4.4B; 4.5;A, 4.6; Appendix B Figure 1; 2; 4; 5 were 
contributed by L.A.M. and A.G. 
 
Appendix B Figure 3 C, E was contributed by A.A.P. 
 
Figure 4.4 was contributed by A.A.P and D.R.J 
  
  87 
4.1 Introduction 
Essential for mitotic growth, Dbf4 dependent kinase (DDK), Dbf4/Cdc7, is required 
for the initiation of DNA replication whereby it functions to activate the replicative helicase 
Mcm2-7, resulting in unwinding of duplex template to allow the replicative machinery access 
(Chapman & Johnston 1989; Jackson et al. 1993; Labib 2010). The kinase component of 
DDK, Cdc7, is present throughout the cell cycle, but is only activated by the binding of Dbf4, 
thus DDK is only active from late G1 through to late mitosis when Dbf4 synthesis is at its 
highest (Cheng et al. 1999; Ferreira et al. 2000). In addition to its requirement for the 
initiation of DNA replication DDK also plays a role in mitosis, meiosis, and the checkpoint 
response. In the intra-S-phase checkpoint Dbf4/Cdc7 is a target of the effector kinase Rad53 
(mammalian Chk2), but also functions as an effector of the checkpoint response as DDK 
activity is also required for full activation of the checkpoint (Kihara et al. 2000; Ogi et al. 
2008). As a checkpoint target in Saccharomyces cerevisiae, Dbf4 is phosphorylated and 
removed from chromatin in a Rad53 dependent manner and phosphorylation of DDK by 
Rad53 results in inhibition of Dbf4/Cdc7 kinase activity (Pasero et al. 1999; Kihara et al. 
2000). The phosphorylation of Dbf4 is also critical for the block to late origin firing, 
preventing the activation of late firing origins during S-phase under times of replicative stress 
or DNA damage (Zegerman & Diffley 2010; Lopez-Mosqueda et al. 2010). It is also believed 
to have a role in the stabilization and possible restart of stalled replication forks, preventing 
their collapse and the accumulation of unstable DNA structures (Duncker & Brown 2003; 
Branzei & Foiani 2010). 
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In S. cerevisiae Rad53 is the primary effector kinase of the checkpoint response, and 
is activated by both Mec1 and Tel1 (ATR and ATM in mammals) dependant signaling 
pathways in response to DNA damage and replicative stress (reviewed in Clémenson & 
Marsolier-Kergoat 2009; Branzei & Foiani 2005; Carr 2002). Rad53 activation relies on the 
checkpoint mediators Mrc1 and Rad9, while Rad53 also autophosphorylates itself in trans to 
reach its fully activated hyperphosphorylated state (Pellicioli et al. 1999; Alcasabas et al. 
2001; Harrison & Haber 2006). Interestingly, DDK is able to phosphorylate Rad53 and in 
cells lacking Dbf4 or Cdc7, Rad53 is hypophosphorylated and displays low 
autophosphorylation activity, and checkpoint specific transcription is not induced (Ogi et al. 
2008). Thus, DDK is both an upstream regulator of the checkpoint kinase Rad53 and a 
downstream target during the replication checkpoint. 
The Rad53 checkpoint kinase is composed of a central kinase domain flanked by two 
Fork-head associated (FHA) domains. Dbf4 interacts with Rad53 primarily through the 
amino-terminal FHA1 domain, but also weakly associates with the carboxy-terminal FHA2 
domain of Rad53 (Duncker et al. 2002; Varrin et al. 2005). FHA domains are known to 
specifically bind phosphothreonine residues, and FHA1 of Rad53 specifically recognizes 
phosphothreonine residues found in unstructured loops (Durocher et al. 1999). Therefore, the 
interaction between Rad53 and most of its binding partners can be recreated using 
phosphothreonine containing peptides. We have previously identified that an FHA1 mutant 
unable to bind phosphopeptide is also compromised in its ability to bind Dbf4 (Duncker et al. 
2002). This suggests that FHA1 binds a phosphoepitope within Dbf4. However, the 
phosphothreonine responsible for the interaction between Dbf4 and FHA1 has yet to be 
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identified. Interestingly, recent work has revealed additional phosphorylation-independent 
modes of interaction between FHA domains and their binding partners (Nott et al. 2009; Pike 
et al. 2004). One such mode of interaction still utilizes the phosphorylation recognition 
surface of the FHA domain (Nott et al. 2009). Thus, this indicates that the mode of 
recognition between Dbf4 and Rad53 has the potential to be independent of phosphoepitope 
recognition by FHA1.  
 Dbf4 is conserved from yeast to humans however, only three regions of high 
sequence conservation are present, these regions are termed motifs N, M, and C based on 
their location within the polypeptide chain (Masai & Arai 2000). Motif M and the zinc finger 
containing motif C (residues 260-309 and 656-697, respectively in S. cerevisiae) are 
necessary to maintain the interaction with Cdc7 and the replicative helicase component 
Mcm2 (Hardy & Pautz 1996; Varrin et al. 2005; Jones et al. 2010). In S. cerevisiae motif N 
of Dbf4 (residues 135-179) is required for recognition by Rad53 and to mediate interaction 
with origins of replication through the Orc2 subunit of the origin recognition complex 
(Duncker et al. 2002; Varrin et al. 2005; Dowell et al. 1994; Hardy & Pautz 1996). Deletions 
or point mutations within Dbf4 motif N result in increased sensitivity to genotoxic insults. 
These mutants are compromised in their ability to tolerate both replicative stress, the result of 
nucleotide depletion by the ribonucleotide reductase (RNR) inhibitor hydroxyurea (HU), and 
DNA damage caused by the DSB inducing drug bleomycin (Varrin et al. 2005; Gabrielse et 
al. 2006). 
 Primary sequence alignment has indicated that motif N may constitute part of a larger 
structural domain which bears resemblance to a BRCT domain (Masai & Arai 2000; 
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Gabrielse et al. 2006). However, it has yet to be determined exactly how this region folds. In 
support of the idea that motif N is part of a larger structurally conserved unit, motif N does 
not constitute an independent folding unit by itself however, the region of Dbf4 
encompassing residues 120-250 can be over-produced on its own and it is well behaved in 
solution (Matthews et al. 2009). BRCT domains are commonly found in proteins that 
respond to DNA damage and many of them function as tandem repeats, which associate 
together using conserved hydrophobic residues to create an intervening hydrophobic pocket 
(Leung & Glover 2011; Mohammad & Yaffe 2009). These repeats act as a single unit to 
recognize binding partners by using both this pocket as well as a phosphoserine binding site 
contained within one of the BRCT domains (Williams et al. 2001). However, the mechanism 
by which single BRCT domains, such as the one presumably present in Dbf4, participate in 
protein-protein interactions is poorly understood. 
In an effort to clarify whether Dbf4 has a bona fide BRCT domain and whether this 
domain mediates the interaction with Rad53, we have characterized the minimal region of 
Dbf4 necessary for the interaction with Rad53 and determined its crystal structure. We have 
found that the fragment of Dbf4 encompassing residues 105-221 is sufficient to mediate this 
interaction. The crystal structures of this sufficient domain of Dbf4, as well as, a shorter 
fragment encompassing residues 120-221 unveil a structural feature that is unique to Dbf4. 
Residues 120-221 fold as a bona fide BRCT domain, but residues 105-119 form an α-helix 
that is embedded in the core of the domain defining a novel structure that we name Helix-
BRCT (H-BRCT). Using a combination of structure-guided site-directed mutagenesis and 
yeast two-hybrid analysis, we demonstrate that the presence of this N- terminal helix is 
  91 
critical for both folding of the domain and the interaction with Rad53. Collectively, our work 
demonstrates that the structural integrity of the H-BRCT domain is essential for the ability of 
Dbf4 to interact with Rad53 and promote cell survival under genotoxic stress. 
 
Figure 4.1: The fragment of Dbf4 including residues 120-250 folds as a BRCT domain. 
(A) Ribbon diagram of the structure of Dbf4 (residues 120-250) colored in blue, with 
Motif N (residues 135-179) highlighted in a darker shade of blue. The N- and C-
termini, as well as secondary structure elements are labeled. The section of helix α1 
protruding from the BRCT core is indicated. (B) Ribbon diagram of the first BRCT from 
BRCA-1 (PDB ID: 1JNX, residues 1649-1737) shown as a pale yellow ribbon and in the 
same orientation as in (A). Secondary structure elements are shown in two shades of 
yellow and labeled, with the disordered β3-α2 loop depicted as a dotted line. 
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4.2 Results 
4.2.1 Motif N of Dbf4 is part of a BRCT Domain 
We have previously shown that motif N (residues 135 to 179) does not constitute an 
independent folding unit (Matthews et al. 2009). Conversely, the fragment of Dbf4 
encompassing residues 120-250 includes the predicted BRCT domain and is well behaved in 
solution (Masai & Arai 2000; Matthews et al. 2009). The structure of this fragment of Dbf4, 
including a removable hexa-histidine tag at the N-terminus of the protein, was determined by 
single anomalous diffraction (SAD) using selenomethionine labeled crystals and 10 
molecules were readily identified in the experimental electron density maps. About twenty 
residues at the C-terminus of each monomer (Ala230-Asp250) were disordered and could not 
be included in the final model. Residues Arg122 to Thr224 define a bona fide BRCT domain, 
consisting of a central four stranded parallel β-sheet surrounded by α-helices (Figure 4.1). 
In comparison to the structures of other BRCT domains previously determined, this 
domain of Dbf4 has a significantly longer helix α1 that projects an additional β-strand (β1') 
out to the solvent (Figure 4.1).  This additional strand interacts with the β2-strand of a 
neighboring molecule, defining a mixed β-sheet with four parallel strands (β4-β3-β1-β2) 
from one molecule and one anti-parallel (β1') strand from the adjacent one. As this 
intermolecular β1'-β2 interaction propagates through the crystal, it defines a right-handed 
helical filament (Appendix B Figure 1A). Formation of this filament was not due to the 
presence of the exogenous tag, as this supramolecular organization was also found in crystals 
grown after removal of the hexa-histidine tag (Table 4.1 and Appendix B Figure 1B-C). 
However, size exclusion chromatography and analytical ultra-centrifugation experiments 
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indicated that this fragment of Dbf4 exists predominantly as a monomer in solution 
(Appendix B Figure 1D). Therefore, while the protein-protein interactions seen in the 
crystals do not reflect the oligomeric state of Dbf4, they could indicate how Dbf4 interacts 
with other cellular partners. 
Table 4.1: Data collection and refinement. 
Dbf4 Fragment 
 
Residues 120-250 
(including His-tag) 
Residues 120-250 
(without His-tag) 
Residues 65-220 
(without His-tag) 
Data Collection    
Space Group P21 P21212 P6422 
Unit Cell (Å) 
 
a=90.2, b=79.4, c=127.4 
α=γ=90º, β=110.7º 
a=83.7, b=99.7, c=127.0 
α=β=γ=90º 
a=b=83.7, c=103.7 
α=β=90º, γ=120º 
Matthews Coeff. (Å3Da-1) 2.44 3.44 2.78 
Solvent content (%) 49.6 64.2 55.9 
Wavelength (Å) 0.9796 1.081 1.1 
Monomers in ASU 10 5 1 
Resolution (Å)a 50-2.70 (2.75-2.70) 50-2.40 (2.44-2.40) 50-2.69 (2.74-2.69) 
Completeness (%)a 99.3 (99.1) 99.8 (100) 99.7 (99.7) 
Rmerge (%)a 0.10 (0.79) 0.192 (0.74) 0.06 (0.42) 
I/σ(I)a 16.9 (2.8) 8.9 (2.6) 31.0 (3.5) 
Redundancya 7.0 (7.2) 6.2 (5.9) 6.9 (6.2) 
Reflections (total) 323,273 262,516 43,786 
Reflections (unique) 46,033 42,318 6,280 
Refinement    
Resolution (Å) 35.5-2.7 46.4-2.4 38.8-2.69 
Reflections (Rwork/Rfree) 44,042/2,233 42,245/2,146 6,061/300 
Rwork/Rfree (%)  20.5/24.4 20.3/22.9 22.4/27.3 
Number of Atoms    
Protein 
Solvent 
8,276 
99 
4,362 
230 
1,058 
10 
Rms deviations    
Bonds (Å) 
Angles (°) 
0.009 
1.161 
0.007 
0.959 
0.008 
1.034 
Ramachandran Plot (%)    
Most Favored 
Additionally allowed 
93.6 
6.2 
94.2 
5.8 
94.0 
6.0 
a Data in the highest resolution shell is shown in parentheses. 
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4.2.2 The BRCT domain of Dbf4 is not sufficient to mediate the interaction with Rad53 
Using yeast two-hybrid analysis, we have found that the fragment of Dbf4 
encompassing residues 120-221 is not sufficient to sustain the interaction with Rad53 
(Figure 4.2A). However, we have previously shown that a fragment of Dbf4 encompassing 
residues 1-296 binds Rad53 with similar affinity to wild-type Dbf4 (Duncker et al. 2002). 
Based on this, we generated several additional constructs, corresponding to larger fragments 
of Dbf4 which encompass the BRCT domain, and assessed their ability to interact with 
Rad53. Extending the C-terminal end to include residues 120-250 did not restore the 
interaction with Rad53. However, extending into the N-terminal region (65-220) did restore 
this interaction (Figure 4.2A). Fragments of Dbf4 that truncate portions of the BRCT domain 
despite starting at residue Leu65 (residues 65-179 and 65-109) did not support binding to 
Rad53 either, indicating that the BRCT domain is necessary for the interaction. 
To test if the N-terminal extension (residues 65-119) was simply required as a spacer 
between the BRCT domain and the N-terminal LexA fusion tag we generated a fragment of 
Dbf4 encompassing residues 1-221 but lacking the intervening Gln66-Ile119 region. This 
internal deletion changed the sequence connecting the LexA tag to the BRCT domain while 
maintaining a similar spacing between the two proteins. Notably, this fragment of Dbf4 (1-
221Δ66-119) did not support binding to Rad53 (Figure 4.2A), indicating that the integrity of 
the intervening region (residues 66-119) is also necessary for the Dbf4-Rad53 interaction. 
Collectively, this demonstrates that both the region encompassing residues Leu65 to Ile119 
and the intact BRCT domain (Met120-Leu221) are necessary for the Dbf4- Rad53 
interaction, while neither feature alone can support binding (Figure 4.2A). In turn, this 
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suggests that the fragment of Dbf4 encompassing residues Leu65-Leu221 may define a 
unique structure responsible for mediating the interaction with Rad53. 
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Figure 4.2: The fragment of Dbf4 including residues 105-221 is the minimal domain of Dbf4 
that mediates the interaction with Rad53. 
(A) Two-hybrid analysis using Rad53 as prey and either full-length Dbf4 (WT), empty 
vector (V), or regions of Dbf4 as indicated (numbering refers to amino acid positions 
within full-length Dbf4) as baits. The interaction is shown as β-galactosidase activity 
units, and in each case represents the average of three independent measurements. Error 
bars represent standard deviation. As a control, whole cell extracts were prepared from 
transformants following prey induction and analyzed by Western blot using rabbit anti-
LexA antibody (Cedarlane Laboratories) to detect bait protein and a mouse monoclonal 
anti- HA antibody (Sigma) to detect prey protein, along with Alexa Fluor 647 goat anti-
rabbit and 488 goat anti-mouse secondary antibodies (Invitrogen), respectively. Prior to 
detection, the membrane was stained with Ponceau S to assess relative protein loading. 
(B) Ribbon diagram of the H-BRCT domain of Dbf4 with α-helices shown in purple, β-
strands in orange and loops in light blue.  The N- and C-termini, as well as secondary 
structure elements are labeled. The additional N-terminal helix is labeled as α0 and the 
residues defining the hydrophobic core are shown as sticks and labeled. (C) Detail of 
the 2Fo-Fc electron density map around Trp116 contoured at 1σ.  The H-BRCT model 
is shown as color-coded sticks with the residues latching the N-terminal helix (α0) to the 
hydrophobic core of the H-BRCT domain (β4, β1, α3) labeled. (D) Two-hybrid analysis 
using Rad53 as prey and either full-length Dbf4 (WT), or fragments of Dbf4 
encompassing residues 65-221, 94-221 and 105-221 as baits. 
 
4.2.3 Structure of the sufficient domain of Dbf4 for the interaction with Rad53 
To elucidate whether this N-terminal extension (residues 65-119) altered the BRCT 
fold, we determined the crystal structure of the sufficient interaction region of Dbf4 (65-221). 
Crystals of this fragment diffracted X-rays to 2.6 Å resolution (Table 4.1), and contained 
only one molecule in the asymmetric unit, confirming that the filament seen in the previous 
structures was indeed a crystallographic artifact. Residues 98 to 221 were clearly defined in 
the electron density map, however the region encompassing residues 65-97 was not. We 
suspected that this fragment of Dbf4 was susceptible to degradation and, indeed mass 
spectrometry confirmed that the crystals contained a fragment of Dbf4 encompassing 
residues 84-221. As expected, residues 122-221 adopt the BRCT fold seen in the previous 
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structures of Dbf4 (Figure 4.1 and Appendix B Figure 1), while residues 107-121 form a 
well-defined amphipathic α-helix (α0) that is packed against the hydrophobic surface defined 
by the C-terminal end of α1, β1 and α3 (Figure 4.2B). Despite the low sequence 
conservation, the presence of a helix N-terminal to the BRCT domain is predicted in most 
Dbf4 homologues from lower eukaryotes (Appendix B Figure 2). The residues upstream of 
this helix (98-106) adopt an extended and relatively flexible conformation as judged by the 
quality of the electron density. To test whether helix α0 was the only relevant feature for 
binding Rad53 within the region encompassing residues 65-119, we repeated the yeast two-
hybrid analysis with shorter fragments of Dbf4. Constructs consisting of residues 94 to 221 
or just 105 to 221 were capable of binding Rad53 (Figure 4.2D; note the difference in scale 
compared to panel A). We therefore conclude that the region of Dbf4 encompassing residues 
105 to 221 is the minimal structural unit of Dbf4 required for binding to Rad53. Interestingly, 
the fragment encompassing residues 105-221 interacts with Rad53 more efficiently than 
Dbf4 itself, suggesting that the full-length protein has additional mechanisms that down-
regulate the interaction between the two proteins. This inhibitory effect may arise from other 
regions of the protein occluding the interaction interface or the competition between Rad53 
and other cellular Dbf4-binding proteins. Consistent with the latter model  it has been shown 
that Cdc5 interacts with Dbf4 through residues 83-93 and, hence, is conceivable that binding 
to endogenous Cdc5 restricts binding to Rad53 the in vivo two-hybrid assay (Chen & 
Weinreich 2010). 
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Figure 4.3: Mutation of the residues anchoring helix α0 to the core of the BRCT domain 
abolishes the interaction between Dbf4 and Rad53. 
Two-hybrid analysis carried out using full-length Rad53 as prey and either wild-type 
DBF4 (WT), empty vector (V), dbf4-L109A-W112D (L109A-W112D), dbf4-K112D-
R122E (K112D-R122E), dbf4-E111R-K118D (E111R-K118D) or dbf4-W116D-M120A 
(W116D-M120A) as baits. Data is presented as in Figure 4.2A. 
4.2.4 The H-BRCT fold is necessary for Dbf4-Rad53 interaction. 
Arguably, helix α0 could be an independent motif adjacent to the BRCT domain 
whose relative orientation had been determined by crystal packing. However, the side chains 
of Trp116 and Met120, and to a lesser extent Trp112, have extensive van der Waals and 
aromatic interactions with the hydrophobic core defined by residues Phe155, Trp202, Phe210 
and Leu214 (Figure 4.2B-C). Trp116 and Met120 are not strictly conserved in other Dbf4 
homologues, but aromatic or bulky hydrophobic residues are found at these positions 
(Appendix B Figure 2), suggesting a common mechanism to occlude the hydrophobic 
surface defined by Phe155, Trp202, Phe210 and Leu214 and hence supporting the role of this 
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helix in maintaining the structural integrity of the domain. Mutation of Trp116 and Met120 
abolishes the interaction between Dbf4 and Rad53 (Figure 4.3), indicating that the integrity 
of the hydrophobic core of the domain is critical for the interaction. These results confirm 
that the helix N-terminus to the BRCT domain is an inherent part of the domain of Dbf4 that 
we hereafter refer to as Helix-BRCT (H-BRCT). Recent work has shown that at least another 
BRCT domain also requires additional structural elements to perform its function (Kobayashi 
et al. 2010). However, the H-BRCT domain of Dbf4 constitutes the first example of a BRCT 
domain where this additional structural motif is an integral part of the folding unit. 
Interestingly, the hydrophobic and polar faces of the α0 helix contribute differently to 
the interaction with Rad53. Mutation of Trp112 and Leu109, that contribute only minimally 
to the hydrophobic core the H-BRCT domain, also abrogate the Dbf4-Rad53 interaction. 
Conversely, mutation of the polar face of the helix (K121D/R122E or E111R/K118D) did not 
affect the interaction (Figure 4.3). Collectively, these results indicate that the concave 
surface defined by α0, β4 and α3 is important for the interaction with Rad53. 
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Figure 4.4: Dbf4 mutants that are sensitive to genotoxic agents fail to interact with Rad53. 
(A) Two-hybrid analysis was carried out using Rad53 as prey and wild-type DBF4 
(WT), dbf4- GA159LL or dbf4-W202E as baits with data presented as in Figure 4.2A.  (B) 
Superimposition of Trp1718 from BRCA-1 (pink color-coded sticks) onto the structure 
of Dbf4-N. Dbf4-N is shown as a semitransparent white surface with the secondary 
structure elements shown as a ribbon diagram. Trp202 from Dbf4 is shown as yellow 
color-coded sticks. 
4.2.5 Point mutations that destabilize the H-BRCT fold disrupt the Dbf4-Rad53 
interaction. 
Internal deletions disrupting the H-BRCT fold disrupt the interaction with Rad53 
(Figure 4.2 and Appendix B Figure 3B,C), demonstrating that the tertiary structure of the 
H-BRCT domain is important to maintain this interaction. Therefore, we subsequently 
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investigated whether previously described mutations impairing Dbf4 function could also 
have folding defects. Three highly conserved residues within the H-BRCT domain (Gly159, 
Ala160 and Trp202) are important for Dbf4 function. Mutation of any of these residues 
causes increased sensitivity to both the DSB inducer bleomycin and the fork stalling agent 
hydroxyurea (Gabrielse et al. 2006). We found that the dbf4-W202E and dbf4- GA159LL 
variants also lost their ability to interact with Rad53 (Figure 4.4A). The side chain of Trp202 
lies at the hydrophobic pocket defined by the central β-sheet and the surrounding α0, α1 and 
α3 helices. While this residue is not conserved in other BRCT domains, a structurally 
equivalent tryptophan is found at the N-termini of helix α3 in most BRCT domains (Figure 
4.4B), reinforcing the idea that a hydrophobic, bulky residue at this position is necessary to 
stabilize the hydrophobic core of the H-BRCT domain. Therefore, the defects associated with 
mutating Trp202 are likely due to the structural destabilization of the H-BRCT domain. The 
Gly159-Ala160 doublet is located in the short loop connecting α1 and β2 that is 
conspicuously exposed to solvent. This loop reverses the orientation of the polypeptide chain 
and hence, the substitution of these two small and flexible residues with bulky and 
hydrophobic amino acids likely reduces the plasticity of the α1-β2 loop, potentially 
destabilizing the central β-sheet (Figure 4.1A). Indeed, the phi/psi angles adopted by Gly159 
to make this turn would not be favored for any residue other than glycine, in turn explaining 
the strict conservation of these two residues among BRCT domains. The H-BRCT-GA159LL 
variant was also insoluble when over-expressed in bacteria using identical conditions to those 
used to produce the H-BRCT domain (Appendix B Figure 4), reinforcing the idea that these 
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point mutations destabilize the H-BRCT fold. Together, these results strongly suggest that 
the integrity of the H-BRCT domain is critical for the interaction between Dbf4 and Rad53.  
 
Figure 4.5: Role of Thr171 and Thr175 in mediating the Dbf4-Rad53 interaction. 
(A) Ribbon diagram of the H-BRCT domain colored as in Figure 4 .2B. The side-
chains of the threonine residues found in the domain are shown as sticks.  The hydrogen 
bond network restraining the β3-α2 loop is shown as black dashed lines.  (B) Two-
hybrid analysis carried out using full- length Rad53 as prey and either full-length Dbf4 
or Dbf4 variants carrying point mutations at Thr171 as baits. Data is presented as in 
Figure 4.2A. (C) DBF4Δ cells transformed with CEN vectors (one copy per cell) 
expressing, either wild-type DBF4 (WT), dbf4-T171R or dbf4Δ135-179 (deletion of motif 
N) were spotted in 10-fold dilution series onto SC-Leu (synthetic complete medium, 
lacking leucine in order to select for plasmid maintenance) plates containing the indicated 
concentrations of HU or the alkylating agent methyl methanesulfonate (MMS). Each plate 
was incubated at 30ºC for three days. 
4.2.6 Thr171 aids the interaction between Dbf4 and Rad53. 
Arginine 70 within the FHA1 domain of Rad53 is important for the recognition of 
phosphothreonine (pThr) targets, and we have previously seen that mutation of Arg70 
weakens the interaction with Dbf4 (Duncker et al. 2002). This observation is consistent with 
a model whereby Rad53 interacts with Dbf4 through FHA1 medicated recognition of 
phosphoepitope in Dbf4. We therefore scanned the sequences of the H-BRCT domains from 
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various Dbf4 homologues to identify threonines that could potentially mediate the interaction 
with Rad53. Only two threonine residues, Thr171 and Thr175, are conserved in the H-BRCT 
domain of Dbf4 (Appendix B Figure 2). Thr175 is buried in the hydrophobic core of the H-
BRCT domain and is involved in a hydrogen-bond network that stabilizes the β3-α2 loop 
(Figure 4.5A). This loop is highly variable among BRCT domains, suggesting that Thr175 
may have a conserved structural role in Dbf4 by stabilizing the β3-α2 loop (Appendix B 
Figure 5). Due to its location in the domain, we did not expect Thr175 to be the 
phosphorylated site recognized by Rad53. Accordingly, mutation of Thr175 to alanine did 
not affect the interaction between Dbf4 and Rad53 (Appendix B Figure 3D). 
Conversely, Thr171 is relatively exposed (Figure 4.5A) and the equivalent serine in 
higher eukaryotes is part of a Chk1 kinase phosphorylation site (Kim et al. 2003). Mutation 
of Thr171 to either alanine or arginine significantly reduced binding to Rad53 (Figure 4.5B). 
Importantly, the dbf4-T171R variant also showed increased sensitivity to HU and MMS 
(Figure 4.5C), reinforcing the idea that this residue is important for the Rad53-dependent 
checkpoint response. However, the H-BRCT-T171A variant was also insoluble when 
overproduced in bacteria under identical conditions to those used to produce the H-BRCT 
domain (Appendix B Figure 4), suggesting that this mutation also destabilizes the H-BRCT 
fold. The side chain of Thr171 is hydrogen-bonded to the main chain of residue Arg125 and 
this interaction indirectly orients the α0 helix. Taking this into consideration it is likely that 
mutation of Thr171 destabilizes the H-BRCT fold and weakens the interaction between Dbf4 
and Rad53. 
  104 
We hypothesized that if Thr171 is the pThr recognized by Rad53, mutation of Thr171 
to a phosphomimetic residue should maintain, or even strengthen, the interaction between the 
two proteins. However, the dbf4-T171E variant also showed reduced binding affinity for 
Rad53 (Figure 4.5B). This result reinforces the idea that Thr171 plays a structural role, 
rather than being the phosphoepitope recognized by Rad53, although we cannot exclude the 
possibility that the Thr171Glu mutation is not a sufficient substitute for a pThr. Indeed, in 
studies using pThr-containing peptides that recognize FHA1 domains in the absence of any 
structural context, aspartate does not efficiently mimic a phosphorylated threonine (Durocher 
et al. 1999). 
We have demonstrated that the structural integrity of the H-BRCT domain of Dbf4 is 
important for its recognition by Rad53, and thus the structural context of the putative 
phosphoepitope must also be important. Furthering the idea that Thr171 plays a structural 
role in the stability of H-BRCT domain, double mutation of Thr171 and Thr175 to alanines 
completely disrupts the interaction between Dbf4 and Rad53 (Appendix B Figure 3D). 
Thus, these two destabilizing mutations synergistically act to undermine the structural 
integrity of the H-BRCT fold. 
Within the H-BRCT of Dbf4 several other Thr residues have been proposed as 
damaged-induced phosphorylation sites (Zegerman & Diffley 2010; Lopez-Mosqueda et al. 
2010; Duch et al. 2011). However, every non-conserved threonine residue within the H-
BRCT domain with the exception of Thr163, can be replaced without negatively impacting 
the Dbf4-Rad53 interaction. Interestingly mutation of Thr163, which resides on the same 
surface of the H-BRCT domain as Thr171, reduces the affinity of Rad53 for Dbf4 
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(Appendix B Figure 3A). Thus the location of these residues may contribute to delineating 
the interaction interface between FHA1 of Rad53 and the H-BRCT of Dbf4 (Figure 4.6). 
 
Figure 4.6: Putative Rad53-interaction interface of Dbf4. 
Orthogonal views of the H-BRCT domain shown as a color-coded ribbon inside a 
semi-transparent surface. Residues that are important for the interaction with Rad53 are 
colored in cyan, except Thr171 that is shown in purple for clarity. 
 
4.3 Discussion 
Here we present the first ever structure for a portion of Dbf4. We have shown that the 
motif N of Dbf4 comprises part of a unique structure built upon a BRCT domain that 
includes an additional α-helix strictly required for the function this domain. We refer to this 
domain as H-BRCT (Helix-BRCT) to signify the location and the nature of the additional 
structural motif. The H-BRCT domain is necessary and sufficient to mediate the interaction 
between Dbf4 and Rad53. Interestingly, other proteins containing single BRCT domains also 
include additional structural elements surrounding the domain that aid their function, 
suggesting that the BRCT fold is a core that complex structures with different specificities 
can be built upon. Tandem BRCT repeats are known to function as a single unit, and could 
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be considered one of the types of structures that can be built upon a single BRCT core. 
Similarly, single BRCT domains should be viewed as part of larger functional units, akin to a 
tandem BRCT repeat where one BRCT domain has been replaced by either a different 
domain, such as the case of Nbs1 or Chs5 (Martín-García et al. 2011; Lloyd et al. 2009; 
Williams et al. 2009), or additional structural elements that complement the BRCT fold. 
These observations in combination with our results suggest that other single BRCT domains 
may also require additional structural motifs, thereby explaining why no common mechanism 
of interaction exists between single BRCT domains and their binding partners. In turn, this 
would also justify why BRCT domains, which are commonly found in DNA replication and 
repair proteins, do not show a high degree of sequence conservation (Williams et al. 2001). 
The most variable regions within the BRCT domain are the loops connecting β2-β3 and β3-
α2, which may provide the means to establish specificity for different binding partners 
(Appendix B Figure 5). Here, we propose that additional secondary structural elements at 
either terminus of a BRCT domain can also increase target specificity and present the first 
example of a BRCT where the additional structural elements have become an integral part of 
the domain. 
The role BRCT and FHA domains play in DNA repair and checkpoint signaling as 
well as their mechanisms of pThr recognition and have been studied extensively (Durocher et 
al. 2000; Glover et al. 2004; Campbell et al. 2010). However, recent studies have identified 
novel mechanisms of interaction between FHA and BRCT domains (Lloyd et al. 2009; 
Williams et al. 2009). Thus the concept that the FHA1 domain of Rad53 recognizes a single 
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pThr in the absence of any structural context may no longer be the paradigm that best 
describes FHA domain interactions. 
Our results reveal that the structural integrity of the H-BRCT fold is more relevant 
than the presence of a phosphoepitope for the interaction between Dbf4 and Rad53. This 
finding was somewhat unexpected as we have previously seen that the inability of FHA1 to 
bind pThr reduces its affinity for Dbf4, leading to the hypothesis that Rad53 would recognize 
a phosphoepitope in Dbf4 (Duncker et al. 2002). Furthermore, previous structural work had 
shown that Rad53 recognizes phosphoepitopes in the absence of a structural context 
(Durocher et al. 2000). However, work with Rv1827 from Mycobacterium tuberculosis has 
shown that its FHA domain is able to recognize several binding partners in a 
phosphoindependent manner, while still using  residues integral to the canonical pThr-
binding surface (Nott et al. 2009). Therefore, it is conceivable that the FHA1 domain of 
Rad53 does not recognize a phosphoepitope in the H-BRCT domain of Dbf4, even though 
mutation of the conserved Arg70 in the FHA1 disrupts the interaction with Dbf4 (Duncker et 
al. 2002).The structurally unstable dbf4Δ135-179, dbf4-GA159LL, dbf4-W202A and dbf4-
T171R variants have both a weakened interaction with Rad53 and an increased sensitivity to 
HU, MMS, and bleomycin (this study; Gabrielse et al. 2006). Interestingly, Gly159, Ala160, 
Thr163, Thr171 and Trp202 are all in close proximity to helix α0, potentially demarcating 
the surface of Dbf4 that interacts with Rad53. 
The N-terminus of Dbf4 is known to mediate the interaction with Orc2 and origins of 
replication (Duncker et al. 2002; Hardy & Pautz 1996; Dowell et al. 1994), and mutation of 
the Leu158-Gly159 doublet or deletion of motif N (residues 126-160) has been observed to 
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abrogate the interaction between Dbf4 and origin DNA in a yeast one-hybrid assay (Ogino et 
al. 2001). We have observed that deletion of motif N (residues 135-179) delays cells entry to 
S-phase consistent with the reduced association with origins. Interestingly, mutations that 
disrupt the association of helix α0 with the BRCT fold disturb the interaction with Rad53 but 
do not cause a delay in entry to S-phase (Appendix B Figure 6) indicating that the 
association with origins of replication is intact. Thus the regions of Dbf4 that mediate the 
interaction between Rad53 and origins of replication overlap, but the mechanism of 
interaction does not appear to be the same. 
It has been observed that the region containing the BRCT domain of Dbf4 can be 
replaced by the BRCT domain found in Rev1 with little loss of viability when challenged 
with genotoxic stress; several other BRCT domains were unable to complement in the same 
manner suggesting that the BRCT domains of Rev1 and Dbf4 might share a common 
interaction partner (Harkins et al. 2009). However, the ability of this Rev1-Dbf4 chimera to 
interact with Rad53 and suppress late origin firing was not examined in that study. Indeed 
another study by the same group has shown that in a sld3-38A background Dbf4 lacking of 
the first 109 residues, which would truncate helix α0 of the H-BRCT domain, is unable to 
suppress late origin firing in the presence of HU (Chen et al. 2013). 
Collectively, our work indicates the presence of a phosphoindependent interaction 
between the FHA1 domain of Rad53 that relies on the unique H-BRCT domain found at the 
N-terminus of Dbf4. In a broader context, the identification of the H-BRCT domain suggests 
that other single BRCT domains may also require additional structural motifs for their 
function. The variable nature of these additional motifs would explain why the mechanisms 
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of interaction of single BRCT domains have remained elusive, while those of tandem BRCT 
domains have been characterized. 
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Chapter 5 
A novel non-canonical FHA binding interface mediates the interaction 
between Rad53 and Dbf4 
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5.1 Introduction 
ForkHead Associated (FHA) domains are ubiquitous phosphoepitope-binding 
modules present in a number of proteins that play critical roles in the DNA damage and 
replication stress response (Durocher & Jackson 2002). The replication checkpoint preserves 
the genomic integrity of the cell by stabilizing stalled forks, boosting DNA repair enzyme 
levels and pausing the cell cycle (Labib & De Piccoli 2011). Rad53 (the budding yeast 
homolog of the tumor suppressor Chk2) is an effector kinase with integral roles in the 
replication checkpoint (Branzei & Foiani 2006). In contrast to other FHA-containing 
proteins, Rad53 has two FHA domains (FHA1 and FHA2) that mediate independent 
interactions of Rad53 with upstream and downstream branches of the checkpoint. One of the 
binding partners of FHA1 is Dbf4 (Duncker et al. 2002), the regulatory subunit of the 
initiator kinase Cdc7 (Kitada et al. 1992; Jackson et al. 1993). The association of Rad53 and 
Dbf4 mediates the Rad53-dependent phosphorylation of Dbf4 and consequent inhibition of 
Cdc7, thus preventing late origin firing (Kihara et al. 2000; Zegerman & Diffley 2010; 
Lopez-Mosqueda et al. 2010; Duch et al. 2011). This interaction involves the N-terminal 
region of Dbf4 that folds as a modified Breast cancer-1 C-Terminal (BRCT) domain 
(Duncker et al. 2002; Varrin et al. 2005; Gabrielse et al. 2006; Matthews et al. 2012). 
BRCT domains are also commonly found in DNA damage and replication stress 
response proteins where they occur as single or multiple repeats (Leung & Glover 2011). 
Tandem BRCT repeats are phosphoepitope-binding modules with the phosphoepitope 
binding pocket residing at the interface between the two domains (Williams et al. 2004). 
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Conversely, single BRCT domains have diverse functions and their mechanisms cannot be 
extrapolated from one protein to another due to low sequence identity. Furthermore their 
specific functions remain elusive because many BRCT domains, like the one found in Dbf4, 
require additional structural elements to function (Matthews et al. 2012; Kobayashi et al. 
2010; Li et al. 2012). The BRCT domain of Dbf4 is immediately preceded by an α-helix that 
is integral to stabilize the domain and this modified domain has been denoted HBRCT 
(Matthews et al. 2012; Matthews & Guarné 2013). The HBRCT domain of Dbf4 is necessary 
and sufficient for the interaction with Rad53, but curiously does not contain any threonine 
residue that could serve as the phosphorylation site recognized by Rad53 (Duch et al. 2011; 
Lopez-Mosqueda et al. 2010; Matthews et al. 2012; Chen et al. 2013). A phosphorylated 
peptide derived from the N-terminal sequence of the HBRCT domain of Dbf4 including the 
canonical pT-X-X-E FHA-binding motif can interact weakly with the FHA1 domain of 
Rad53 (Chen et al. 2013). However, mutation of this threonine in full-length Dbf4 does not 
disrupt the interaction with the FHA1 domain of Rad53 (Matthews et al. 2012; Chen et al. 
2013). 
Phospho-threonine (pThr) binding to FHA domains has been extensively studied 
using short phosphopeptides (Durocher et al. 2000). However, there is some evidence 
indicating that interactions with full-length partners may involve additional interfaces. The 
FHA domain of Saccharomyces cerevisiae Dun1 requires the presence of a second pThr for 
specific binding (Lee et al. 2008), prompting the comparison of FHA domains to logic gates 
(Zhang & Durocher 2008). M. tuberculosis Rv1827 uses the pThr-binding pocket of its FHA 
domain to mediate both phosphorylation-dependent and phosphorylation-independent 
  113 
interactions (Nott et al. 2009). Dbf4 interacts preferentially with the FHA1 domain of Rad53 
(Duncker et al. 2002) while Rad9 interacts with its FHA2 domain (Sun et al. 1998), 
indicating that defined features in each FHA domain determine their binding specificities. In 
the present study, we exploited this characteristic of Rad53 to analyze how FHA domains 
increase binding specificity for their targets. We have uncovered a novel interface defined by 
one of the lateral surfaces of the FHA1 domain and characterized its interaction with the 
HBRCT domain of Dbf4. We find that the FHA1 domain of Rad53 can bind simultaneously 
to the HBRCT domain of Dbf4 and a pThr-containing phosphoepitope, suggesting that a 
bipartite interaction may modulate the interaction between Rad53 and Dbf4 in vivo. 
5.2 Results 
5.2.1 Characterization of the Dbf4 region that interacts with Rad53 
The minimal fragment of Dbf4 necessary and sufficient for the interaction with the 
FHA1 domain of Rad53 includes residues Thr105 to His220 (Matthews et al. 2012). Its 
crystal structure revealed that this fragment of Dbf4 folds as a modified BRCT domain that 
we named HBRCT domain because it includes an additional N-terminal helix (Figure 5.1A). 
In the crystal structure, this additional helix is stabilized by crystal contacts (Matthews et al. 
2012). Secondary structure chemical shifts measured for 15N,13CHBRCT indicated that 
residues 106-119 form a helix (Figure 5.1B). Furthermore, this helix exhibited HN-NOE 
values close to the theoretical maximum expected for a fully structured helix (Figure 5.1C), 
confirming that this region of the domain indeed forms a helix in solution. 
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Figure 5.1: The N-terminal domain of Dbf4 folds as a stable HBRCT in solution. 
(A) Ribbon diagram of the HBRCT domain of Dbf4 (PDB ID: 3QBZ) with α helices and β 
strands shown in yellow and teal, respectively. The side chains of the residues latching the 
α0 helix to the BRCT core, as well as residues in α3 deemed important for the interaction 
with Rad53, are shown as color-coded sticks and labeled. (B) Secondary structure 
probabilities (Pα and Pβ) of the HBRCT fragment of Dbf4 as a function of residue number. 
Positive values indicate α-helices and negative values indicate β-strands. (C) 1H-15N NOE 
values as a function of residue number. Closed circles represent the experimentally measured 
values at 306 K. The solid horizontal line close to 0.8 indicates the theoretical 1H-15N NOE 
values computed using HydroNMR based on the overall tumbling of HBRCT (PDB: 3QBZ) 
in the absence of internal ps-ns motions. The black dotted line represents the secondary 
structure of the crystal structure and is labeled as in (A). (D) Limited trypsin proteolysis of 
the HBRCT (left), the HBRCT-W116D/M120A (center), and the HBRCT-L109A/W112S 
(right) domains. From left to right each gel has molecular weight markers (MW, indicated in 
kDa), the HBRCT variant in the absence of trypsin, the HBRCT variant treated with 
increasing concentrations of trypsin (0.195 – 12.5 µg/mL) and the purified BRCT domain of 
Dbf4 in the absence of trypsin as a molecular weight reference. 
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We then checked whether the N-terminal helix is an integral part of the domain. Since 
the loop connecting this helix to the BRCT core includes several positively charged residues, 
its susceptibility to trypsin proteolysis should vary depending on whether α0 is anchored to 
the domain or free to move. Hence, we treated the HBRCT, HBRCT-W116D/M120A and 
HBRCT-L109A/W112S variants with increasing amounts of trypsin. We chose these variants 
because point mutations at these positions are known to disrupt the interaction with Rad53 
presumably by destabilizing the interaction between α0 and the BRCT core (Matthews et al. 
2012). We found that the HBRCT was degraded homogeneously, whereas the HBRCT-
W116D/M120A and HBRCT-L109A/W112S variants were degraded stepwise (Figure 
5.1D). The first step resulted in the formation of a fragment of similar size to a BRCT 
domain. The second step degraded the domain without the accumulation of any intermediate 
fragments, thereby confirming that the additional N-terminal helix is anchored to the BRCT 
core of the domain. 
5.2.2 The HBRCT domain of Dbf4 and the FHA1 domain of Rad53 interact in vitro 
The interaction between Rad53 and Dbf4 is transient, and it has only been studied in 
vivo by coimmunoprecipitation and two hybrid analysis (Duncker et al. 2002; Varrin et al. 
2005; Matthews et al. 2012; Chen et al. 2013). However, these in vivo assays cannot discern 
whether or not the interaction between Rad53 and Dbf4 is direct or if their association is 
mediated by a cellular intermediary. To identify if the interaction between Rad53 and Dbf4 is 
direct, we sought to characterize the interaction in vitro using purified proteins.  
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Figure 5.2: The FHA1 domain of Rad53 interacts with the HBRCT domain of Dbf4 in 
vitro. 
(A) Detailed view of the HSQC spectra of 15NFHA1 collected in the absence (orange) or 
presence (blue) of the HBRCT domain of Dbf4. The interaction is identified by residue-
specific intensity losses, as well as by the appearance of ten new peaks (labeled in black) in 
the spectra. (B) Same as in (A) but with the HBRCT domain replaced by the BRCT domain 
of Dbf4. This control experiment confirms that the FHA1:HBRCT interaction detected by 
NMR specifically requires the N-terminal helix α0. (C) The peak height from the HSQC 
spectrum of 15NFHA1 in the presence of the HBRCT domain measured as a percentage of the 
peak height of 15NFHA1 alone. The black line marks the mean percentage (46.0%) and the 
red line marks one standard deviation below this value (33.8%). Peaks reduced beyond one 
standard deviation are labeled. (D) Ribbon diagram of the FHA1 domain of Rad53 (PDB ID: 
1G6G), with the residues whose peak intensities were reduced beyond one standard deviation 
in the presence of the HBRCT domain shown as green sticks and labeled. The pThr-
containing peptide shown as an orange ribbon with the side chains of pT and pT+3 labeled. 
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Once we determined that the HBRCT was a stable domain in solution, we over-
expressed and purified the HBRCT (Dbf4 residues 105-220) and FHA1 (Rad53 residues 14-
164) domains. We collected HSQC spectra of uniformly labeled 15NFHA1 on its own or in 
the presence of equimolar amounts of unlabelled HBRCT domain. Since the HBRCT domain 
was not labeled and the experiments were collected in identical conditions, any differences in 
the HSQC spectrum are due to the direct interaction between the two domains. The main 
effect caused by the addition of the HBRCT domain was peak broadening for several 
15NFHA1 residues, which often is a reliable indicator of binding, as previously shown for 
other weakly interacting protein:protein complexes (Díaz-Moreno et al. 2005; Hagn et al. 
2011; Gunasekara et al. 2012).  
Additionally, ten new peaks appeared in the HSQC spectrum. To identify these 
residues, we assigned the HSQC spectrum of 15N,13CFHA1:HBRCT and found that they 
corresponded to amino acids Gln16, Leu19, Ile20, Glu21, Lys22, Phe23, Ser24, Gln25, 
Glu26 and Gln27, which are all located at the N-terminus of the domain (Figure 5.2A). 
These peaks were absent in the HSQC spectrum of 15NFHA1 collected in the presence of 
equimolar amounts of the BRCT fragment of Dbf4 (residues 120-220), which lacks the helix 
α0 and does not interact with Rad53 (Figure 5.2B and (Matthews et al. 2012)). Therefore, 
we conclude that the new peaks in the HSQC spectrum of 15NFHA1:HBRCT are caused by 
the direct and specific interaction between the two proteins. 
HSQC cross-peak intensity losses are useful to map the interface of protein:protein 
complexes (Matsuo et al. 1999; Walters et al. 2001). To determine whether the FHA1 
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residues involved in the interaction interface with Dbf4 could be identified this way, we 
compared the height of equivalent peaks in the 15NFHA1 and 15NFHA1:HBRCT HSQC 
spectra. We then integrated known peaks in the 15NFHA1 and 15NFHA1:HBRCT spectra and 
found that peak height was reduced to about 46% upon addition of the HBRCT domain, 
whereas it maintained 95% of the original height upon addition of the non-interacting BRCT 
domain, thereby confirming that peak broadening was caused by the interaction of the two 
domains.  
We integrated known peaks in the 15NFHA1 and 15NFHA1:HBRCT spectra and 
calculated their intensity loss (Figure 5.2C). Perturbed residues were defined as those whose 
peak height was reduced by at least one standard deviation (S.D.) from the mean. Nine 
residues in the core of the FHA1 domain met this criterion and they were located on strands 
β1 (Ile37), β7 (Asn112), β9 (Asn121, Leu123), β10 (Gly127), and β11 (Phe146, Ile147, 
Asn148). With the exception of Asn121 and Leu123, all these residues reside on the same 
lateral surface of the FHA1 domain (Figure 5.2D). Residues Thr15, Phe18 and Gln27, 
located at the N-terminus of the FHA1 domain also met this criterion, but they were not 
present in the FHA1 fragment used for the crystallization studies (Durocher et al. 2000), and 
thus are not shown in Figure 5.2D. Therefore, the comparative HSQC analyses suggest that 
the FHA1:HBRCT interaction affects two main areas of the FHA1 domain, namely its N-
terminus and one of the lateral surfaces.  
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5.2.3 The HBRCT domain of Dbf4 interacts with the lateral surface of the FHA1 
domain 
We decided to investigate whether either of these two surfaces defined the interface 
of the FHA1:HBRCT complex. If Rad53 interacts with Dbf4 through one of these surfaces, 
we would expect that surface to be conserved among Rad53 homologues. We have 
previously seen that Dbf4 binds preferentially to the FHA1 domain of Rad53 (Duncker et al. 
2002), thus any conserved features required for the interaction with Dbf4 should be present 
in FHA1 but not FHA2 domains.  
 
Figure 5.3: The FHA1 domain of Rad53 has a conserved lateral surface. 
(A-B) Surface representation of the FHA1 domain of Rad53 (PDB ID: 1G6G) with residue 
conservation shown as standard deviations from the mean where blue indicates conserved 
and yellow indicates variable. The FHA1 domain has two highly conserved areas on opposite 
faces of the molecule: the phosphopeptide binding pocket (A) and the lateral β-sheet 
composed of strands β2-β1-β11-β10-β7-β8 (B). The view in (B) is a 180° rotation from panel 
(A). (C) Ribbon diagram of the FHA1 domain of Rad53 (PDB ID: 1G6G), shown in the same 
orientation as in (B) and colored as in Figure 5.2D. Residues defining the conserved lateral 
region of FHA1 domain are shown as purple sticks and labeled. 
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We retrieved representative protein sequences homologous to yeast Rad53 from the 
non-redundant UniRef90 database using PSI-BLAST (Altschul et al. 1997). Twenty-eight 
full-length Rad53 homologues containing both FHA1 and FHA2 domains were retained and 
used to compare the degree of conservation of residues in FHA1 and FHA2. In addition to 
residues associated with the phosphoepitope binding sites on FHA1 and FHA2, we found a 
second conserved surface patch on FHA1 that was not present on FHA2 (Figure 5.3). This 
conserved patch includes residues on strands β1 (Arg35, Ile37, Thr39), β7 (Asn112, 
Gly113), β10 (Gln126, Asp128, Gln129), and β11 (Val144, Phe146), consistent with 
residues identified by NMR on the lateral surface of the domain. The lack of a corresponding 
conserved surface on FHA2 suggests that this conserved patch may mediate FHA1-specific 
interactions. 
Given the agreement between the NMR and bioinformatics analyses, we probed the 
in vivo biological relevance of this surface via yeast two-hybrid. We conducted these 
analyses using a previously characterized Rad53 (residues 1-165) construct (Duncker et al. 
2002) which includes the FHA1 domain, instead of the shorter fragment (residues 14-164) 
used for the NMR studies. Given the extent of the conserved lateral surface, we were 
concerned that the effect of single point mutations might result in changes too subtle to 
produce noticeable effects in our assay and thus we created variants of the FHA1 domain 
including both single and multiple mutations. Indeed, single point mutations on this surface 
had minimal effect (Figure 5.4B). Of the three mutation pairs (I37A/T39A, V144N/F146A, 
N112A/E129A) generated, only the N112A/E129A pair weakened the interaction with Dbf4 
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significantly (Figure 5.4A). However, combination of the N112A/E129A pair with any of 
the other two pairs completely abrogated the interaction (Figure 5.4C). Since all FHA1 
variants had comparable expression levels (Figure 5.4A-C), we attributed the reduced β-
galactosidase activity to a defect in the Rad53-Dbf4 interaction. 
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Figure 5.4: The lateral surface of the FHA1 domain of Rad53 is required for the 
interaction with the HBRCT domain of Dbf4. 
(A-C) Yeast two-hybrid analysis using Dbf4 as bait and either the FHA1 domain (residues 1-
165) of Rad53 (WT), empty vector (Empty) or variants of the FHA1 (residues 1-165) 
containing double (A), single (B), or multiple (C) mutations within the interaction surface 
predicted from NMR and bioinformatics analysis as preys. The double mutants and multiple 
mutants are labeled as: IT (I37A/T39A), VF (V144N/F146A), NE (N112A/E129A), NEIT 
(N112A/E129A/I37A/T39A), NEVF (N112A/E129A/V144N/F146A), ITVF 
(I37A/T39A/V144N/F146A), and ITNEVF (I37A/T39A/N112A/E129A/V144N/F146A). 
The interaction is shown as β-galactosidase activity units and in each case represents the 
mean of three independent measurements. Error bars represent standard deviation. (D) Yeast 
two-hybrid analysis using Dbf4 as bait and either the FHA1 domain (residues 1-165)  of 
Rad53 (WT), empty vector (Empty), the FHA1-V134D/I140A variant containing a double 
mutant in the β10-β11 loop (VI), or the shortened FHA1 variant (residues 22-165). To 
control for the two-hybrid bait and prey expression levels in A-C, whole cell extracts were 
prepared from transformants following prey induction and analyzed by Western blot using 
rabbit anti-LexA antibody (bait) and a mouse monoclonal anti-HA antibody (prey), along 
with Alexa Fluor 647 goat anti-rabbit and 488 goat anti-mouse secondary antibodies, 
respectively. Prior to detection, the membrane was stained with Ponceau S to assess relative 
protein loading.  
 
We then examined the ability of these Rad53 variants to complement the sensitivity 
seen in a Rad53 null strain upon exposure to replication stressors. In the presence of 
hydroxyurea (HU), a ribonucleotide reductase inhibitor that impairs DNA replication fork 
progression and induces the replication checkpoint, the rad53∆ strain had no detectable 
growth. However, the same strain when transformed with centromeric (CEN) plasmids 
encoding either RAD53, rad53-V144N/F146A (rad53-VF,) or rad53-N112A/E129A (rad53-
NE), resulted in growth comparable to wild-type (RAD53) cells at 50 mM HU, and near wild-
type growth at 150 mM HU (Figure 5.5). Conversely, cells expressing rad53-
N112A/E129A/V144N/F146A (rad53-NEVF) displayed sensitivity to HU, growing poorly at 
50 mM HU, and failing to grow at 150 mM HU. Similar results were obtained when we 
examined growth in the presence of methyl methanesulfonate (MMS), a DNA alkylating 
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agent known to cause fork stalling. The growth sensitivity observed in the presence of HU or 
MMS was not due to reduction in protein expression (Figure 5.5), supporting the idea that 
the conserved lateral surface of the FHA1 domain is important for checkpoint function. 
 
Figure 5.5: Lateral surface mutations on FHA1 that abrogate interaction with HBRCT 
results in sensitivity to genotoxic stress. 
The ability of Rad53 variants to complement a Rad53 null strain was assessed, and the 
sensitivity of these Rad53 mutants to genotoxic stress was tested in the presence of 
hydroxyurea (HU) or methyl methanesulfonate (MMS). The growth of the rad53Δ, sml1Δ 
strain in the presence of CEN plasmids encoding RAD53, rad53-NE, rad53-NEVF and, 
rad53-VF was compared on SC-Leu plates containing increasing concentrations of HU or 
MMS by spotting 10-fold serial dilutions. The RAD53/sml1Δ and rad53Δ/sml1Δ strains 
transformed with empty vector were used as controls for normal sensitivity or 
hypersensitivity to genotoxic agents, respectively. Rad53 expression was assessed using a 
goat anti-Rad53 antibody (Santa Cruz Biotech) and Alexa Fluor 488 donkey anti-goat 
secondary antibody. 
 
Additionally, we tested the effect of the loop connecting the β10 and β11 strands and 
found that mutation of V134D/I140A weakened the interaction with Dbf4 (Figure 5.4D). 
Interestingly, this loop is involved in a hydrogen bond network with the backbone of Arg70, 
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which is required for pThr binding. It also partially forms the pocket for the pThr+3 residue 
of a phosphorylated peptide, and this pocket is important for phosphoepitope specificity 
(Durocher et al. 2000). Thus, mutations in this loop may impair the ability of FHA1 to bind a 
phosphoepitope. The decrease in interaction with Dbf4 of this mutant indicates that the 
ability to bind to a phosphoepitope may still be required in vivo, consistent with our previous 
observations (Duncker et al. 2002). 
Although mutations on the lateral surface of FHA1 abrogated the interaction with 
Dbf4 (Figure 5.4), we wanted to confirm that the N-terminal region of the domain (residues 
15-29) were not necessary for the interaction with Dbf4. Therefore, we generated a variant of 
Rad53 corresponding to the minimum FHA1 fold (residues 22-165). This FHA1 variant 
interacted with the HBRCT domain of Dbf4 similarly to longer fragments of Rad53, 
confirming that the region immediately preceding the FHA1 domain is not necessary for the 
interaction between FHA1 and HBRCT (Figure 5.4D). Collectively, these results indicate 
that Rad53 likely interacts with Dbf4 through the lateral surface of the FHA1 domain defined 
by the β-sheet composed of strands β2-β1-β11-β10-β7-β8 (Figure 5.2D, Figure 5.3C). 
5.2.4 The pThr-binding pocket of FHA1 is not required for the interaction with Dbf4 
We have previously shown that a point mutation (Arg70Ala) in the phosphoepitope 
binding pocket of the FHA1 domain abrogates the interaction of this domain with Dbf4 
through yeast two-hybrid analysis (Duncker et al. 2002). We confirmed this observation 
using full-length Rad53, and observed that the Arg70Ala mutation and not a neighboring 
residue significantly reduces the interaction with Dbf4 (Figure 5.6B). The phosphorylated 
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peptide consisting of residues 98-113 from Dbf4 (including a phosphorylated threonine, 
pThr105) interacts with the FHA1 domain weakly (Chen et al. 2013). However, mutation of 
Thr105, or any other threonine within the HBRCT domain, does not disrupt the interaction 
with Rad53 (Matthews et al. 2012), suggesting that the HBRCT domain does not contain a 
phosphoepitope targeted by Rad53. To elucidate how the Arg70Ala mutation affects the 
FHA1:HBRCT interaction in vitro, we collected HSQC spectra for 15NFHA1 and 15NFHA1-
R70A to identify the residues that change their chemical environment due to the point 
mutation. Although a number of peaks exhibited chemical shift changes, addition of the 
HBRCT domain to the 15NFHA1-R70A sample still caused an overall decrease in intensity 
and the appearance of the ten peaks indicative of complex formation (Figure 5.6A), thereby 
confirming that FHA1-R70A interacts with the HBRCT domain of Dbf4 in vitro. Taken 
together these observations suggest the possibility that Rad53 interacts with Dbf4 through a 
bipartite interface involving both the recognition of a phosphoepitope and the interaction of 
the HBRCT domain with the lateral surface of the FHA1 domain. 
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Figure 5.6: The 15NFHA1-R70A variant interacts with the HBRCT domain. 
(A) Overlay of the HSQC spectra of 15NFHA1-R70A (black) and 15NFHA1-R70A in the 
presence of unlabeled HBRCT (red). Peaks indicative of the FHA1:HBRCT interaction are 
labeled in red. (B) Two-hybrid analysis was carried out as in Figure 5.4, with full-length 
DBF4 as bait and either RAD53 (WT), empty vector (Empty), rad53-R70A (R70A), or 
rad53-N71A (N71A), as prey. 
 
Among many other phosphorylated substrates, the FHA1 domain of Rad53 
recognizes a phospoepitope within Cdc7 (Aucher et al. 2010). We reasoned that Cdc7 might 
modulate the interaction between Rad53 and Dbf4, and thus we tested whether a Cdc7-
derived peptide (480DGESpTDEDDVVS491, herein referred to as pPEP) could outcompete 
the interaction of Rad53 with Dbf4.  To this end, we incubated a mixture of 15NFHA1 and 
HBRCT with increasing amounts of pPEP. HSQC spectra were collected at increasing 
concentrations of peptide corresponding to increasing ratios of pPEP:FHA1. We found that 
the presence of pPEP caused changes consistent with phosphopeptide binding, while the non-
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phosphorylated version of the peptide (PEP) did not induce any changes in the 15NFHA1 
HSQC spectrum (Figure 5.7). Importantly, the peaks indicative of the interaction between 
FHA1 and HBRCT were present at all pPEP concentrations, although the peak corresponding 
to Gln16 could not be monitored in this experiment because it overlapped with the peak 
corresponding to Glu117 during the titration. Collectively, our data demonstrates that Rad53 
is able to interact with a phosphoepitope and the HBRCT domain of Dbf4 through different 
surfaces of the FHA1 domain and that both these interactions can occur simultaneously. 
 
Figure 5.7: The HBRCT domain of Dbf4 does not bind to the phosphoepitope-binding 
pocket of the FHA1 domain. 
HSQC spectra monitoring the formation of the complex between 15NFHA1 and HBRCT at a 
1:1 ratio in the presence of stoichiometric amounts of either DGESpTDEDDVVS (A) or 
DGESTDEDDVVS (B). Some of the peaks corresponding to residues that undergo 
significant changes upon pPEP binding and the ten peaks signifying the interaction between 
with HBRCT are labeled in blue and red, respectively.  
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5.3 Discussion 
We have shown that the HBRCT domain of Dbf4 interacts with the lateral surface of 
the Rad53 FHA1 domain, rather than its phosphoepitope-binding surface. This lateral surface 
is not conserved in the FHA2 domain of Rad53, indicating that the FHA1 domain of Rad53 
gains specificity by engaging additional interaction surfaces. Additionally, FHA1 can 
simultaneously bind a phosphopeptide and the HBRCT domain. Therefore, the Rad53:Dbf4 
interaction in vivo may occur through a bipartite interaction. The phosphorylated peptide 
consisting of 98-113 of Dbf4 includes a canonical pT105-X-X-E108 FHA-binding motif and 
interacts with the FHA1 domain weakly (Chen et al. 2013). Mutation of Thr105 in the 
context of full-length Dbf4, however, does not disrupt the interaction between Dbf4 and 
Rad53 (Matthews et al. 2012). This same study has also shown that point mutations on the 
surface of the HBRCT domain defined by helices α0 and α3 abrogate the interaction with 
Rad53. This suggests that Thr105 may contribute to defining the interface between Rad53 
and HBRCT rather than providing a pThr target site.  
Several FHA domains have been shown to mediate bipartite interactions. For 
instance, the FHA domain of Dun1 requires the simultaneous interaction with two 
phosphorylated threonine residues (pThr) to recognize its target (Lee et al. 2008) and 
KIF13B interacts simultaneously with the ArfGAP and PH1 domains of CENTA1 (Tong et 
al. 2010). This has led to the analogy of FHA domains functioning as logic gates to integrate 
multiple inputs and generate a single output (Zhang & Durocher 2008). In the case of 
phosphopeptide binding, the FHA1 domain from Rad53 acts as an ‘OR’ logic gate as the 
domain can only bind to one pThr within a multiply phosphorylated peptide at a time. In 
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contrast, the FHA domain from Dun1 is considered an ‘AND’ logic gate because it must bind 
to two pThr simultaneously (Lee et al. 2008). If we extend the logic gate model to DDK 
targeting, the FHA1 domain of Rad53 also behaves as an ‘AND’ logic gate, requiring 
simultaneous binding of a phosphoepitope and engagement of the HBRCT domain of Dbf4 
through its lateral interface for their normal physiological interaction. FHA1 interactions 
functioning as an ‘AND’ logic gate would also explain why disabling either contact point 
abrogates the Rad53:Dbf4 interaction in a yeast two-hybrid assay and would have important 
ramifications during the checkpoint response. DDK-mediated phosphorylation of Mcm2 has 
a role in the response to replicative stress, likely as a result of replication fork stabilization 
(Stead et al. 2012). Therefore, the lateral surface interaction may guarantee the specificity of 
Rad53 to target the HBRCT domain of Dbf4, while the phosphopeptide binding surface may 
ensure the stress-dependency of the interaction, recognizing a phosphoepitope generated by a 
stress-activated kinase. Thus these two surfaces allow FHA1 to integrate multiple inputs to 
bind Dbf4 in vivo, resulting in checkpoint dependent regulation of DDK activity. 
Logic gates have emerged as critical components of biological signaling networks, 
and it is becoming increasingly clear that FHA domains function as highly specialized 
modules that integrate complex input signals (Zhang & Durocher 2008; Hasty et al. 2002; 
Lee et al. 2008; Li et al. 2002; this study). The Dbf4:Rad53 interface unveiled in this work is 
reminiscent of the BRCA1:Chk2 interaction, where the tandem BRCT repeat of BRCA-1 
must recognize two distal surfaces in the FHA domain of Chk2 simultaneously (Li et al. 
2002). In the BRCA1:Chk2 complex, the interaction involves the pThr-binding site and a 
conserved hydrophobic patch on one of the lateral surfaces of the FHA domain. Disruption of 
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either contact point prevents the interaction, and mutation of the hydrophobic patch has been 
linked to Li-Fraumeni syndrome, which predisposes patients to multi-organ cancers (Li et al. 
2002). However, Dbf4 and BRCA-1 do not interact with the same lateral surface of the FHA 
domains of Rad53 and Chk2. Furthermore, the hydrophobic patch found in the FHA domain 
of Chk2 is not conserved in FHA1 from Rad53 revealing the extreme plasticity of FHA 
domains to enhance binding specificity. The interactions of Rad53 with Dbf4 or Chk2 with 
BRCA-1 lead to inhibition of late origin firing and double strand break repair, respectively. 
Given the importance of these associations it is not surprising that cells have developed strict 
selectivity mechanisms to modulate these two interactions. However, while the need for 
bipartite interactions increases Rad53 and Chk2 binding specificities, it also underlines the 
experimental difficulty in detecting dual input FHA domains as eliminating one binding site 
abrogates the interaction, effectively masking the presence of a second binding site. 
Our work suggests that FHA domains may have a broader spectrum of interactions 
that have remained elusive due to the intrinsic limitations of studying ‘AND’ logic gates and 
it provides a novel approach to study functional interactions mediated by this highly 
prevalent signaling domain. 
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Chapter 6 
General conclusions and future directions 
6.1 The motif C zinc finger in Dbf4 is required for replication and response to genotoxic 
stress. 
 Here we find that mutation to conserved residues within Dbf4 motif C, but not 
deletions of this motif are able to complement the essential function of Dbf4. Mutation of 
conserved cysteine and histidine residues of motif C weaken interactions with origin DNA 
and the replicative helicase subunit Mcm2, while preserving interactions with the known 
Dbf4 binding partners Orc2, Rad53, and Cdc7. We see that this reduction in association with 
Mcm2 translates to reduced phosphorylation of recombinant Mcm2 by cellular extracts from 
cells containing mutations to motif C of Dbf4. Consistent with reduced association with 
origins of replication and decreased phosphorylation of Mcm2, cells harboring Dbf4 motif C 
mutations display slowed growth marked by delayed entry to and progression through S-
phase. Additionally, motif C mediates resistance to genotoxic stress, as mutants are sensitive 
to long-term exposure to both MMS and HU, but not short-term exposure. These 
observations support the notion that Dbf4/Cdc7 plays a role in the stabilization or restart of 
replication forks (Duncker & Brown 2003). 
To address the question of the involvement of DDK in replication fork stabilization, 
dense isotope substitution experiments could be used where motif C mutants are released into 
MMS or HU and replication progression can be monitored. Alternatively DNA combing 
experiments could be performed which would allow individual origins to be visualized, 
identifying fork collapse. An added benefit of this technique is that it would allow direct 
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observation of continued DNA replication from a stalled fork indicating restart. Furthermore, 
it would be possible to determine a relative rate of replication from track length.  
Chromatin immunoprecipitation (ChIP) can be used to track replisome components, 
such as Cdc45 or PolԐ, to identify the cause of the S-phase defects seen in motif C mutants. 
If enrichment for replisome components is seen at early origins for the wild-type and not for 
mutants, then the S-phase defects seen are likely the result of reduced origin firing. 
Conversely, if equal levels of enrichment are seen this may indicate that a reduced rate of 
fork progression is the cause of the extended S-phase. 
 While the Mcm2-7 complex, Cdc45, and polymerase alpha all have potential as 
targets of DDK to promote fork stability or restart, and it is still unclear exactly what is 
targeted by DDK. To identify the role of motif C in fork stability or restart, motif C mutants 
can be crossed to mutants of these essential candidates, sporulated, and the resultant double 
mutants assessed for positive or negative genetic interactions. Alternatively, motif C mutants 
could be screened in a synthetic gene array, against both the essential temperature sensitive 
gene array, and the non-essential deletion collection (described in Tong et al. 2001; 
Baryshnikova et al. 2010). 
 Recent work from our lab has shown that Dbf4 and Cdc7 promote replication through 
association with distinct subunits of the Mcm2-7 complex, Dbf4 with Mcm2 and Cdc7 with 
Mcm4 (Ramer et al. 2013). Combination of the mcm2ΔDDD and mcm4ΔDDD mutants 
lacking their DDK docking domains (DDD) resulted in synthetic lethality (Ramer et al. 2013; 
Sheu & Stillman 2006). It would be interesting to combine a Dbf4 motif C mutant with the 
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mcm4ΔDDD allele to see if the same lethality is observed, confirming that motif C of Dbf4 
promotes interaction with Mcm2. 
 Our results are consistent with a model whereby phosphorylation of the Mcm2-7 
complex promotes fork stability. Interestingly, it appears DDK phosphorylation of Mcm2 
imparts an inhibitory signal, slowing helicase activity by increasing the affinity with which it 
binds DNA (Stead et al. 2011). Inability of Dbf4/Cdc7 to phosphorylate Mcm2 has been 
shown to cause sensitivity to genotoxic stressors (Stead et al. 2011; Stead et al. 2012). In the 
context of checkpoint activity, the ability for DDK to slow the helicase might be important 
for replisome stability. As forks stall due to impediments to the polymerase, such as a lack of 
dNTPs, the helicase is still active and may uncouple from the rest of the replisome. This can 
result in large tracts of ssDNA, precarious sites, which have the potential to result in genomic 
instability. It is possible that during an invoked checkpoint, DDK phosphorylation of Mcm2 
is required to inhibit DNA unwinding and prevent uncoupling of the helicase thus preserving 
fork stability. 
6.2 Motif N of Dbf4 constitutes part of a larger modified BRCT domain required for 
interaction with Rad53. 
In this study we have determined the crystal structure of a portion of the amino-
terminus of Dbf4 and can verify that it folds as a bona fide BRCT domain. This domain on 
its own is not sufficient to mediate the interaction with Rad53. However, the restoration of 
fifteen amino acids preceding the BRCT domain reinstates the interaction with Rad53. 
Solving the crystal structure of a larger fragment of Dbf4 encompassing the BRCT domain 
shows that these extra amino acids form an additional α–helix which protrudes from the 
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BRCT domain, and we henceforth refer to this domain as HBRCT (Helix-BRCT). The 
additional helix forms an integral part of the domain, and mutations that destabilize 
association of the helix with the BRCT core abrogate the interaction with Rad53.  We 
demonstrate that Dbf4 mutations previously observed to result in sensitivity to genotoxic 
agents show an abrogated interaction with Rad53 which is a result of destabilization of the 
HBRCT fold. Additionally, we find that conserved threonines within the HBRCT domain of 
Dbf4 do not serve as phosphoepitopes for recognition by Rad53, but act to stabilize the 
domain. Collectively these results indicate the potential for a phosphorylation independent 
interaction between Dbf4 and Rad53, which relies on the structural integrity of the HBRCT 
domain. 
The amino terminus of Dbf4 is has been implicated in interactions with origins of 
replication and the origin recognition complex (Dowell et al. 1994; Hardy & Pautz 1996; 
Duncker et al. 2002). Mutations or deletions that completely disrupt the BRCT domain have 
been shown to abrogate the interaction with origin DNA in one-hybrid assays (Ogino et al. 
2001). Curiously, cells harboring mutations to Dbf4 that disrupt the anchoring of helix α0 to 
the BRCT domain do not display the delayed entry to S-phase seen in cells where the BRCT 
core is disrupted (Appendix B Figure 6). We do not know the minimal sufficient region of 
Dbf4 to mediate interaction with origins and these observations indicate it is likely not the 
HBRCT domain. However, the BRCT domain does appear to be required for timely entry to 
S-phase and for the interaction of Dbf4 with origin DNA. We have proposed the BRCT 
domain is a modular core around which accessory structures can be assembled. The structure 
of a subunit of human replication factor C (RFC) bound to DNA has shown that this subunit 
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of RFC uses its BRCT domain and an additional amino-terminal α–helix to bind DNA 
(Kobayashi et al. 2010). It would be interesting to see if an alternate structural element 
interacts with the BRCT core in Dbf4 to promote origin association, and thus a single BRCT 
domain may be able to contribute to two distinct modes of interaction. 
Dbf4 is a target of Rad53 in the block to late origin firing, and is removed from 
chromatin in a Rad53 dependent manner upon exposure to hydroxyurea (Zegerman & Diffley 
2010; Lopez-Mosqueda et al. 2010; Duch et al. 2011; Pasero et al. 1999). We have shown 
that abrogation or significant reduction in the interaction between Rad53 and Dbf4 by 
destabilizing the HBRCT domain imparts sensitivity to cells when exposed to genotoxic 
stress. However, the ability to regulate late origin firing has not been assessed with HBRCT 
mutations that compromise the interaction with Rad53, nor has the chromatin status of Dbf4 
in these mutants when exposed to HU. 
6.3 FHA1 of Rad53 recognizes the HBRCT of Dbf4 in a novel non-canonical manner. 
We have confirmed that a modified BRCT domain at the amino-terminus of Dbf4 
includes an additional amino-terminal α-helix and that this helix is integral to the domain, 
which we refer to as HBRCT. Using NMR spectroscopy we are able to identify that FHA1 of 
Rad53 and HBRCT of Dbf4 interact directly in vitro, and thus this interaction does not rely 
on the presence of any cellular intermediary. Bioinformatic and NMR analysis have 
identified a conserved surface specific to FHA1 that could mediate the interaction between 
the FHA1 and HBRCT domains. Mutational analysis of this surface confirms that it is 
required to mediate the FH1:Dbf4 interaction in vivo, as disruption of this extensive interface 
abrogates the interaction. Additionally, disruption of the conserved lateral surface of FHA1 
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in vivo results in sensitivity when cells are grown in the presence of hydroxyurea or methyl 
methanesulfonate. We also show that the ability of full-length Rad53 to interact with Dbf4 in 
vivo requires the ability of FHA1 to bind phosphoepitope, while the direct in vitro interaction 
between FHA1 and HBRCT does not require this ability. Coalescing these two observations, 
NMR spectra indicate that FHA1 is able to simultaneously bind to both a phosphopeptide and 
HBRCT, using different surfaces of the FHA domain.  
It is interesting to note that mutations to the lateral patch of FHA1 abrogating the 
interaction with Dbf4 do not appear equivalent to HBRCT mutations that abrogate this 
interaction. The rad53-N112A/E129A/V144N/F146A (NEVF) allele for which the lateral 
surface of FHA1 is mutated displays higher sensitivity when exposed to genotoxic agents 
than the dbf4-ΔN (deletion of residues 135-179), dbf4-GA159LL or dbf4-W202E HBRCT 
mutants (Varrin et al. 2005; Gabrielse et al. 2006). This indicates that the lateral surface of 
FHA1 may mediate other interactions aside from the HBRCT of Dbf4. Indeed, Rad53 is 
known to interact with several other proteins through its FHA1 domain including the RecQ 
like helicase Sgs1, and the essential replication fork component Cdc45 (Bjergbaek et al. 
2005; Aucher et al. 2010). What is particularly interesting about these two proteins is that 
they have been implicated to interact with FHA1 in a phosphorylation dependent manner. 
Sgs1 contains an amino-terminal acidic region, phosphorylated by Mec1, required to interact 
with FHA1 and mutation of potential Mec1 target sites within this region reduces the 
interaction (Hegnauer et al. 2012). Similarly, Thr189 in Cdc45 has been shown to mediate 
the interaction with FHA1 of Rad53, and mutation of this residue reduces the interaction 
between the two (Aucher et al. 2010). While both Sgs1 and Cdc45 appear to interact with 
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FHA1 in a phosphorylation dependent manner, this does not preclude the possibility that 
their interaction with FHA1 is bipartite. As we have seen with the interaction between Dbf4 
and Rad53, disruption of one surface in a bipartite interaction model is sufficient to disrupt 
interaction, thus mutations that implicate a phosphorylation dependent interaction may mask 
the presence of a second interaction with the lateral surface of FHA1. 
It is of interest to take our understanding of how FHA1 mediates its interactions and 
extend that to other FHA domains. Our observations indicate that the lateral conserved patch 
of FHA1 is not found in FHA2, and may be poorly conserved in other yeast FHA domains. 
The presence of a second conserved patch in other FHA domains may indicate an ability to 
interact with partners in a bipartite manner and thus phosphorylation independent interactions 
could be a common feature of FHA domains. The presence of the same second patch in other 
FHA domains may be an indicator of commonly shared interaction partners. If the laterally 
conserved surface found on FHA1 is indeed unique to only FHA1 there may be other 
mechanisms by which FHA domains mediate phosphorylation independent and multipartite 
interactions. The FHA domain of Rv1827 from Mycobacterium tuberculosis mediates 
interactions with three related enzyme complexes independent of phosphorylation using 
residues integral to the canonical phosphoepitope binding domain (Nott et al. 2009). It has 
been seen with mammalian Chk2, and with Rad53 in this study, that intermolecular 
interactions are mediated by the canonical phosphoepitope binding site and an accessory 
lateral surface (Li et al. 2002).  Thus FHA domains may mediate phosphorylation 
independent and dependent interactions in different ways, and perhaps there is not a universal 
mechanism for how FHA domains recognize their partners. It would be particularly 
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interesting to utilize the same bioinformatic approach used in this study to identify additional 
conserved surfaces in other FHA domains, and query the in vivo function of any such 
conserved region. 
6.4 Role of Dbf4/Cdc7 in cancer 
The body of this study deals with understanding the fundamental mechanisms by 
which Dbf4 interacts with DNA replication and checkpoint machinery. Failure to ensure true 
and faithful replication is a leading cause of genomic instability, a hallmark of cancers, and it 
is the purpose of cell cycle checkpoints to ensure the fidelity of the genome is maintained 
(discussed in Abbas et al. 2013; Negrini et al. 2010). While we do not directly examine these 
mechanisms in cancerous cells, or a mammalian system, the degree to which these processes 
are conserved, even in single celled eukaryotes, means that the underlying functions we 
uncover can apply to metazoan systems. Our discovery of how Dbf4 interacts with its 
cellular partners helps to understand the ways in which Dbf4/Cdc7 performs its roles during 
DNA replication and under checkpoint conditions. Understanding the ways normal cells 
function can provide a comparative basis to help explain errant cellular behavior. Thus, 
elucidating the role of Dbf4/Cdc7 can help to shed light on what may be occurring in 
abnormal or cancerous cells when the levels and molecular interactions of Dbf4/Cdc7 are 
perturbed. 
Indeed the examination of several cancers and tumor derived cell lines has implicated 
up-regulation of Dbf4/Cdc7 (Nambiar et al. 2007; Bonte et al. 2008; Kulkarni et al. 2009; 
Cheng et al. 2013). In a study of patient derived dysplastic nevi, primary cutaneous 
melanomas, cutaneous melanoma metastases, and melanoma derived cell lines, over 
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expression of Dbf4 was documented compared to controls. Specifically, up-regulation was 
found in 66.7% of patients with primary cutaneous melanoma and 86.7% of those with 
cutaneous melanoma metastases, showing a median overexpression of 17.9 and 13.2 fold 
respectively (Nambiar et al. 2007). This study also revealed that Dbf4 overexpression in 
melanomas was associated with a higher percent (30.6%) of relapse at 186 weeks (Nambiar 
et al. 2007). In a study involving oral squamous cell carcinomas Cdc7 overexpression was 
found in 91.4% of primary tumors examined (Cheng et al. 2013). Similarly, in a study 
examining 62 tumor derived cell lines, representing lung, colon, brain, breast, prostate, and 
kidney cancers, approximately 50% were found to have increased Cdc7 levels and most of 
these cell lines were found to also have increased Dbf4 levels (Bonte et al. 2008). The same 
study also found up-regulation of Cdc7 expression in primary breast, colon, and lung tumors, 
where a high degree of p53 loss was seen in primary breast cancers expressing increased 
Dbf4/Cdc7 (Bonte et al. 2008). 
Curiously, this brings about the question of whether Dbf4/Cdc7 overexpression is 
causative or merely correlative with cancers due to its required role in replication. Increased 
Cdc7 levels have been linked to advanced tumor stages which are associated with accelerated 
cell cycle rates and reduced length of G1 in primary ovarian tumors (Kulkarni et al. 2009; 
Williams & Stoeber 2007; Kulkarni et al. 2007). Alternatively increased expression of Dbf4 
and Cdc7 in CHO cells has been seen to trigger cell cycle arrest (Guo et al. 2005). 
While the jury still seems to be out on the causative or correlative nature of 
Dbf4/Cdc7 activity, their potential as prognostic biomarkers is clear. Early diagnosis and 
treatment are the current best methods to combat cancers and improve patient survival. 
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Cancerous cells are by nature fast growing and it can be expected that increased cellular 
expression of replication proteins or any others that promote proliferation would facilitate 
fast growth. Traditional biomarkers, such as PCNA or Ki67, have taken advantage of the 
concept of increased levels of factors associated with proliferation to identify cancers 
(discussed in Semple & Duncker 2004). Cdc7 kinase levels have been shown to be a strong 
predictor of survival in epithelial ovarian carcinoma, providing great potential as a prognostic 
biomarker (Kulkarni et al. 2009). In a cohort of 143 individuals with epithelial ovarian 
carcinoma, increased Cdc7 expression was associated with advanced clinical stage, genomic 
instability, aggressive tumors, and conventional indicators of poor clinical outcome such as 
tumor anaplasia (Kulkarni et al. 2009). Similarly, increased Cdc7 expression levels are 
associated with poor patient outcome in oral squamous cell carcinoma, but do not correlate 
with conventional indicators of  poor clinical outcome (Cheng et al. 2013). 
Interestingly, increased expression of Cdc7 in oral squamous cell carcinoma cell lines 
promotes increased cell survival from apoptosis in the presence of HU, the topoisomerase 
inhibitor Camptothecin, or UV radiation, by increasing the expression of anti-apoptotic 
proteins (Cheng et al. 2013). Conversely, siRNA knockdown of Cdc7 in HeLa cells has been 
shown to cause cell death by apoptosis or aberrant cell division (Montagnoli et al. 2004). 
However, normal fibroblasts do not undergo this cell death, instead activating a p53 
dependent replication checkpoint preventing an abortive cell cycle, and maintaining viability 
under conditions of limiting Cdc7 (Montagnoli et al. 2004). This phenomenon has also been 
seen in the breast cancer derived BT549, MDAMB157, and MDAMB45 cell lines as well as 
the ovarian cancer derived SKOV3 and Caov-3 cell lines (Rodriguez-Acebes et al. 2010; 
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Kulkarni et al. 2009). The potential for a cancer therapeutic that specifically targets 
cancerous cells is of great interest and medical relevance. The loss of checkpoint function, 
specifically p53, seen in cancerous cells makes Cdc7 a very promising candidates for 
treatment (reviewed in Montagnoli et al. 2010; Swords et al. 2010). 
Several Cdc7 inhibitors have been characterized and are in various stages of 
development (Natoni et al. 2013; Koltun et al. 2012; Montagnoli et al. 2008; Swords et al. 
2010; Montagnoli et al. 2010). With the solved crystal structure now available for human 
Dbf4 bound to Cdc7 there is potential to develop new specific small molecule inhibitors of 
Cdc7. In the original study that solved the structure of Dbf4 bound to Cdc7, two ATP 
competitive small molecule inhibitors of Cdc7 (XL413 and PHA767491) were also co-
crystallized with Dbf7/Cdc7, providing a mechanistic understanding of how these 
compounds are able to specifically inhibit Cdc7 (Hughes et al. 2012). The promise Cdc7 
inhibitors hold as additions to the arsenal of treatments for cancers is high, and indeed several 
inhibitors are in pre-clinical and early stage clinical trials (Koltun et al. 2012; discussed in 
Swords et al. 2010; Montagnoli et al. 2010). 
While cancer biology has not been the focus of this body of work, the fundamental 
mechanisms we explore are nonetheless conserved in mammals. The insight gained into the 
underlying mechanisms we study contributes to understanding how Dbf4 interacts with its 
cellular partners and these interactions have important consequences in the progression of 
cancers. 
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Appendix A Figure 1: Dbf4-AAHA and AAAA mutants are no further impaired for interaction 
with Mcm2 than other motif C mutants 
Two-hybrid analysis of Dbf4 motif C AAAA and AAHA mutants. Indicated Dbf4 mutants, 
along with wild-type Dbf4 (WT) and empty pEG202 vector (V) were used as baits with 
Mcm2 as prey in two-hybrid assays as described in materials and methods. β-galactosidase 
activity values represent the averages of three independent experiments, and the error bars 
indicate standard deviation. 
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Appendix A Figure 2: Mcm2 overexpression in motif C mutant strains increases sensitivity to 
hydroxyurea. 
Isogenic wild-type and motif C mutant strains transformed with either empty vector 
(pCM190) or a Mcm2 expression construct (pCM190-Mcm2), were spotted in 10-fold 
dilution series onto selective medium plates containing the indicated concentrations of HU. 
Each plate was incubated at 30oC for three days. Levels of Mcm2 expression in the pCM190-
Mcm2 transformants was confirmed by Western blot, using a mouse monoclonal anti-Myc 
antibody (Sigma) and Alexa Fluor 488 goat anti-mouse IgG polyclonal secondary antibody 
(Invitrogen). 
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Appendix A Figure 3: Dbf4 motif C mutation when combined with deletion of components of 
the translesion synthesis pathway results in synergistic sensitivity to genotoxic stress. 
A mating type alpha dbf4-CCHC mutant was mated to strains lacking Rad5, Rev3, or Rad30 
(Polη), the resulting diploids were then sporulated and screened to isolate haploid double 
mutants. Wild-type, CCHC, ΔRad5, ΔRev3, ΔRad30, and double mutant strains 
ΔRad5/CCHC, ΔRev3/CCHC, ΔRad30/CCHC were spotted in 10-fold dilution series onto 
YPD plates containing the indicated concentrations of phleomycin or MMS. Each plate was 
incubated at 30°C for three days. 
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Appendix B Figure 1: Oligomerization of the BRCT domain of Dbf4. 
(A) Orthogonal views of the 5-fold helical filament defined by the 10 molecules found in the 
asymmetric unit of the (6xHis)BRCT crystals. Strands β1' and β2 are labeled and colored 
orange and red, respectively. (B) Ribbon diagram of the BRCT domain crystallized in the 
absence of the hexa-histidine tag colored as in Figure 4.2. The C-terminal region of the 
domain (residues 225-242, colored in green) was ordered in one of the molecules of the 
asymmetric unit due to crystal contacts with a symmetry mate. (C) Organization of the 
asymmetric unit of the BRCT crystals. The five molecules form a 5-five helical filament very 
similar to the one seen in the structure of with tag. (D) Size exclusion chromatography 
profiles of three variants of Dbf4 over a Superdex-75 column (GE Healthcare). From left to 
right: Dbf4 (residues 120-250), Dbf4 (residues 65-221) and the sufficient domain of Dbf4 for 
the interaction with Rad53 (residues 105-220). The three samples elute as apparent 
monomers. The molecular markers used to calibrate the column are: a) albumin (67 kDa); b) 
ovoalbumin (43 kDa), c) chymotrypsinogen A (25 kDa) and d) ribonuclease A (13.7 kDa). 
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Appendix B Figure 2: Sequence alignment of the region of Dbf4 that mediates the interaction 
with Rad53. 
Structure-based sequence alignment of the H-BRCT domains found in Dbf4 homologues 
from S. cerevisiae (Sc), S. pombe (Sp), S. japonicus (Sj), M. musculus (Mm), H. sapiens 
(Hs), as well as the first BRCT domain found in human BRCA-1 (32). Secondary structure 
elements of ScDbf4 and BRCA-1 are shown as arrows (strands) and cylinders (helices) 
and colored as in Figure 1A. Conserved hydrophobic (yellow), positive-charged (blue) 
and negative-charged (red) residues are highlighted. The positions of the conserved 
Thr171 and Thr175 are marked with an asterisk. Residues of BRCA1 necessary for the 
recognition of a pSer residue are marked with a blue dot and those involved in stabilizing 
the BRCT repeat with a purple dot. 
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Appendix B Figure 3: Effect of point mutation or deletion to Dbf4 on the interaction with 
Rad53. 
(A-D) Two-hybrid analysis was carried out using full-length Rad53 as prey and either (A) 
wild-type DBF4 (WT), empty vector (V), dbf4-T157A (T157A), dbf4-T157R (T157R), dbf4-
T163A (T163A), dbf4-T163R (T163R), dbf4-T224A (T224A), or dbf4-T224R (T224R) (B) 
wild-type DBF4 (WT), empty vector (V), dbf4Δ135-179 (Δ135-179), dbf4-T105R (T105R), 
dbf4-T114A (T114A), or dbf4-T95R (T95R) (C) wild-type DBF4 (WT), empty vector (V), or 
dbf4Δ168-178 (Δ168-178), (D) DBF4 (WT), empty vector (V), dbf4-T175A (T175A), or 
dbf4-T171A-T175A (T171A T175A), as bait. (E) FHA1 (residues 4-165) was used as prey 
and either DBF4 (WT), empty vector (V), or dbf4-T168A-T169A (T168A T169A), as bait. 
The interaction strength is shown as β-galactosidase activity units, and each graph 
represents the average of three independent trials with error bars representing standard 
deviation. 
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Appendix B Figure 4: Solubility assays of Dbf4 variants encompassing H-BRCT-destabilizing 
point mutations. 
15% SDS-polyacrylamide gels showing the levels of expression of H-BRCT (residues 105-220) 
variants as indicated.  From left to right, molecular weight markers (M), uninduced cell lysate (-), 
induced cell lysate (+), soluble fraction of the cell lysate (S) and insoluble fraction of the cell lysate 
(I) is shown for every Dbf4 variant. The band corresponding to Dbf4 is marked with a black dot and 
that corresponding to lysozyme is marked with an arrowhead. 
 
 
Appendix B Figure 5: Superimposition of multiple bona fide BRCT domains onto the structure 
of Dbf4. 
Stereo view of the BRCT domain of Dbf4 shown as a pink Cα-tracing with the Cα atoms of Thr171 
and Thr175 shown as spheres (blue and orange, respectively) and secondary structure motifs labeled. 
BRCT domains from proteins containing single or multiple BRCT repeats (PDB IDs: 1JNX, 1CDZ, 
1GZH, 2NTE, 3L3E and 3L46) reveals that the β2-β3 (shown in blue) and β3-α2 (shown in orange) 
loops are the most variable regions of the domain. 
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Appendix B Figure 6: Mutations that disrupt the anchoring of helix α0 to the BRCT fold in 
Dbf4 do not impair S-phase progression. 
Dbf4 null cells were transformed with the pRS315 CEN vector expressing, either wild-type 
DBF4 (WT), dbf4Δ135-179 (deletion of motif N), dbf4-W116D-M120A (W116D-M120A), 
or dbf4-T171R (T171R). Cultures were grown to a concentration of 5 x 106 cells/ ml, arrested 
in late G1 phase for 3 h with 5 µg/ml α-factor, washed once in sterile dH2O, then 
resuspended in fresh medium without α-factor to release them from the block. Shown is 
FACS analysis of culture aliquots taken at the indicated time points following release from 
the a-factor block as well as from the original asynchronous cultures (Async). The positions 
of 1C and 2C DNA peaks are indicated.  
 
